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1. 1. Porcine reproductive and respiratory syndrome virus with 
emphasis on pathogenesis, clinical disease and vaccination 
 
1.1.1. Introduction 
 
In 1987, a new disease characterized by reproductive failure in breeding pigs and 
respiratory disease problems in nursery and fattening pigs, was observed in the USA and 
Canada (Keffaber, 1989; Hill, 1990).  Three years later, a similar syndrome was reported 
in Germany (Ohlinger et al., 1991).  Subsequently, the disease spread rapidly through the 
major swine-producing areas of Western Europe.  In 1991, the causative agent of the 
disease was isolated and identified as Lelystad virus (Terpstra et al., 1991; Wensvoort et 
al., 1991).  A similar virus was subsequently isolated in the USA (Collins et al., 1992).  A 
wide variety of names have been designated to the disease including mystery swine 
disease, swine infertility and respiratory syndrome, porcine epidemic abortion and 
respiratory syndrome, and blue-eared pig disease.  Since 1992, “porcine reproductive and 
respiratory syndrome (PRRS)” is the internationally recognized name applied to the 
syndrome (Collins et al., 1992) and the causative agent is named “porcine reproductive 
and respiratory syndrome virus (PRRSV)”. 
The first introduction of PRRSV in the susceptible swine population was characterized 
by acute outbreaks of late-term reproductive failure in breeding pigs and increased pre-
weaning mortality and respiratory disease problems in nursery and fattening pigs.  At 
present, the virus is enzootic in the swine population and its exact role in reproductive 
and respiratory disease problems is still under debate. 
 
1.1.2. The virus 
 
PRRSV is a small enveloped positive-strand RNA virus that belongs to the 
Arteriviridae family together with equine arteritis virus, lactate dehydrogenase-elevating 
virus of mice, and simian hemorrhagic fever virus (Cavanagh, 1997).  PRRSV virions are 
spherical with a diameter ranging from 45 to 65 nm for European isolates (Ohlinger et al., 
1991; Wensvoort et al., 1991) and from 48 to 83 nm for North American isolates 
(Benfield et al., 1992; Dea et al., 1992).  The structure is given in Figure 1. 
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Fig. 1. Schematic representation of a PRRSV virion. 
 
The inner part of the virion consists of an isometric nucleocapsid, 25 to 35 nm in 
diameter, composed by the single-strand, positive-sense RNA (15 kilobase pairs) and the 
15-kD nucleocapsid (N) protein.  The nucleocapsid is surrounded by a lipid bilayer, the 
envelope, which contains six structural proteins: P2b, GP2a, GP3, GP4, GP5, and M.  The 
18- to 19-kD major non-N-glycosylated matrix (M) protein forms disulfide-linked 
heterodimers with the 25-kD major glycoprotein 5 (GP5), also called the envelope (E) 
protein.  Recently, a 10-kD 2b protein (P2b) was identified (Wu et al., 2001).  The 29- to 
30-kD glycoprotein 2a (GP2a) and the 31- to 35-kD glycoprotein 4 (GP4) of PRRSV were 
identified as minor glycoproteins of the virion.  Conflicting data exist about the presence 
of a 45- to 50-kD glycoprotein 3 (GP3) in the envelope, since it has been demonstrated in 
Lelystad virus particles (van Nieuwstadt et al., 1996), but not in the Canadian IAF-klop 
isolate (Mardassi et al., 1998). 
PRRSV is stable at –70 and –20°C.  At higher temperatures, the half-life of PRRSV is 
140 hours at 4°C, 20 hours at 21°C, 3 hours at 37°C and 6 minutes at 56°C (Benfield et 
al., 1992; Bloemraad et al., 1994). 
PRRSV replicates only in a limited number of cell types.  Of many swine cell types, 
only pulmonary alveolar macrophages (PAMs) and aged blood monocytes support a 
productive replication of PRRSV in vitro.  Despite the fact that PAMs are the most 
sensitive cell type for PRRSV, these cells show some restriction to a PRRSV infection 
when they are freshly isolated.  The susceptibility clearly increases after one-day 
cultivation, suggesting that the state of macrophage differentiation plays an important 
role in determining their susceptibility to PRRSV (Duan et al., 1997b).  PRRSV can also 
M
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N 
GP3 
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be cultivated in three established non-porcine cell lines: MARC-145 (Kim et al., 1993) 
and CL-2621 cells (Benfield et al., 1992), both originating from the embryonic monkey 
kidney cell line MA-104, and CRL-11171 cells (Meng et al., 1996).  It has been reported 
by several researchers that the susceptibility of the different cell types differs among 
strains.  Bautista et al. (1993b) demonstrated that, when using PAMs and CL-2621 cells, 
nearly one third of PRRSV isolates grown in one cell type failed to grow in the other one.  
Pol et al. (1997b) reported that Lelystad virus replicated very fast and efficiently in 
PAMs, while North American strains preferably replicated in CL-2621 cells. 
PRRSV entry in macrophages occurs via receptor-mediated endocytosis and two 
PRRSV receptors were identified on PAMs (Duan et al., 1998b; Delputte et al., 2002).  
One PRRSV receptor was identified by generation of two monoclonal antibodies 
(MAbs), which were able to block PRRSV infection (Duan et al., 1998a).  A protein with 
a molecular weight of approximately 210-kD was immuno-precipitated by these MAbs.  
This protein was identified as the porcine homologue of the mouse and the human 
sialoadhesin (Vanderheijden et al., 2002).  Delputte et al. (2002) showed that addition of 
heparin or heparan sulfate to the virus, or heparinase treatment of PAMs, clearly reduced 
PRRSV infection, indicating that cell surface heparan sulfate glycosaminoglycans are a 
PRRSV receptor.  Following binding to the cell receptors, virus particles become 
internalized by a microfilament-dependent process through small clathrin-like coated 
vesicles.  During this stage, an acidic pH is required to trigger fusion between the viral 
envelope and the endosomal membrane allowing the viral nucleocapsid to enter the 
cytoplasm for replication (Nauwynck et al., 1999).  Viral antigens are detected within the 
cytoplasm of PAMs as soon as 6 hours after inoculation.  From this time on, the 
nucleocapsid buds at the smooth endoplasmatic reticulum (Pol et al., 1992).  Virions 
seem to mature between the endoplasmatic reticulum and the Golgi apparatus, since 
budding and accumulation of enveloped virus particles can only be observed between 
these organels (Dea et al., 1995).  One replication cycle of PRRSV takes about 9 to 12 
hours (Pol, 1992).  Cytopathic effect is visible after 24 hours (Paton et al., 1992; 
Bloemraad et al., 1994).  The exact mechanism of cell death is unknown, but is likely to 
be through apoptosis.  The GP5 protein of the virus has been shown to induce apoptosis in 
vitro (Suárez et al., 1996a). 
 
1.1.3. Antigenic and genetic differences 
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PRRSV isolates are classified into two distinct serotypes, namely the European and 
the North American serotype (Wensvoort et al., 1992; Bautista et al., 1993a).  GP5 is the 
most variable structural protein, with only 51 to 55% amino acid identity between 
European and North American isolates, whereas the M and 2b proteins are the most 
conserved structural proteins, with 78 to 81% and 74% amino acid identity, respectively 
(Meng et al., 1994; Kapur et al., 1996; Wu et al., 2001). 
Nucleotide sequencing of all genes of European and North American isolates 
confirmed the existence of two subtypes.  The Lelystad strain is, on the average, 35% 
divergent from North American isolates (Kapur et al., 1996).  European and North 
American PRRSV isolates are genetically seen two distinct clusters of the same ancestor 
virus.  It has been speculated that European and North American PRRSV isolates may 
have evolved from a lactate dehydrogenase-elevating virus-like ancestor (Plagemann, 
1996; Nelsen et al., 1999).  The large differences in genomic sequence indicate that the 
two viruses diverged before clinical disease was described in the late 1980s (Magar et al., 
1995; Kapur et al., 1996).  However, the almost simultaneous emergence of the syndrome 
on the two continents makes the theory of divergent evolution difficult to believe.  A high 
degree of genetic diversity has been demonstrated within North American isolates (Magar 
et al., 1995; Kapur et al., 1996; Pirzadeh et al., 1998).  Early reports suggested that 
European isolates exhibit a low degree of variability (Suárez et al., 1996b; Le Gall et al., 
1998).  However, more recently it was shown that isolates from Great Britain, Russia, 
Czech Republic, Denmark, Italy, Austria, Poland, and Lithunia are 9 to 18% divergent 
from the prototype Lelystad virus (Drew et al., 1997; Andreyev et al., 2000; Indik et al., 
2000; Forsberg et al., 2001; Bignotti et al., 2002; Forsberg et al., 2002; Schmoll et al., 
2002; Stadejek et al., 2002). 
 
1.1.4. Epidemiology 
 
PRRS was first observed in the USA in 1987 (Keffaber, 1989; Hill, 1990).  There is, 
however, evidence that PRRSV has entered the domestic swine population several years 
before the clinical disease became visible.  Swine sera collected in the mid-1980s in 
Canada, Korea, Japan, and Eastern Germany tested positive for PRRSV-specific 
antibodies (Kramer et al., 1993; Shin et al., 1993; Murakami, 1994; Carman et al., 1995; 
Dewey, 2000; Ohlinger et al., 2000). 
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PRRSV is highly infectious for pigs of all age.  The virus is transmitted by direct pig-
to-pig contact, by fomites (boots and coveralls) and via semen (Yaeger et al., 1993; 
Swenson et al., 1994; Christopher-Hennings et al., 1995a,b; Albina, 1997; Otake et al., 
2002b).  There are a lot of conflicting data about airborne transmission of the virus.  The 
rapid spread of PRRSV through Western Europe immediately after the first outbreak in 
Germany suggested an easy airborne transmission of the virus.  It has been demonstrated 
that PRRSV can be transmitted via the air at distances of about 3 km (Albina, 1997).  One 
study even mentioned an airborne transmission of the virus at a distance of 20 km (de 
Jong et al., 1991).  Le Potier et al. (1997), on the other hand, observed that many farms 
(45%) located in a 500 m radius around PRRSV outbreaks became infected, whereas only 
few (2%) became infected in the zone 1 to 2 km from an outbreak.  Komijn et al. (1991) 
reported that airborne spread is generally enhanced during winter when temperature is 
low, humidity high, and when wind speed and ultra-violet light exposure are low.  Some 
research groups were able to reproduce airborne transmission using two pig units, placed 
at a distance of 0.5-1 meter of each other and connected by pipes (Torremorell et al., 
1997; Lager & Mengeling, 2000; Kristensen et al., 2002).  Other research groups, 
however, did not succeed to achieve aerosol spread experimentally (Wills et al., 1994; 
Otake et al., 2002a).  Thus, the role of aerosols in transmission of PRRSV is still under 
debate.  Zimmerman et al. (1997) showed that some avian species may be involved in the 
epidemiology of PRRSV, since pigs, which were intranasally inoculated with PRRSV 
isolated from feces of mallard ducks, became viremic, seroconverted and transmitted the 
virus to sentinel pigs.  Although mallard ducks may not be significant vectors in the field, 
it does indicate that birds can carry the virus and infect pigs.  Rodents are not susceptible 
to PRRSV (Hooper et al., 1994).  Otake et al. (2002c,d) reported that blood-borne 
transmission of PRRSV can be achieved by contaminated needles and by mosquitoes. 
Once infected, pigs shed virus in nasal secretions, saliva, urine, and feces until at least 
28 days after infection (Christianson et al., 1993; Yoon et al., 1993; Rossow et al., 1995).  
The low frequency of virus-positive fecal samples suggests that PRRSV is shed 
intermittently and at low levels in feces.  Furthermore, it has been reported that PRRSV is 
rapidly inactivated in fecal slurry (Pirtle & Beran, 1996).  Boars have been shown to shed 
infectious virus in their semen for up to 43 days (Swenson et al., 1994).  Viral RNA in 
semen has been detected for up to 92 days (Christopher-Hennings et al., 1995a).  It has 
been demonstrated that sows inoculated late in gestation shed PRRSV in mammary gland 
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secretions (Wagstrom et al., 2001).  Shedding appeared to occur sporadically and at low 
levels.  Senn et al. (1998) postulated that colostrum or milk can be a source of PRRSV. 
The pattern of PRRSV infections on herd level has been studied by Houben et al. 
(1995).  Most pigs are born from immune sows and thus have maternally derived 
antibodies during their first weeks of life.  When an infection takes place, maternally 
derived immunity is replaced by active immunity.  In the absence of infection, maternally 
derived antibodies do not persist beyond 10 to 11 weeks of age (Dee et al., 1993; Albina 
et al., 1994; Houben et al., 1995).  The exact age of infection is variable between herds 
and even between litters in the same herd.  A serological follow-up on 20 farrow-to-finish 
herds in Belgium showed that 40% of the pigs had been infected by 10 weeks of age, 
while 82% had seroconverted by 16 weeks of age and 92.5% had been infected by the 
end of the fattening period (Mateusen et al., 2002).  Thus, many pigs become infected 
some time after entering the fattening units. 
 
1.1.5. Pathogenesis 
 
Pigs of all ages are susceptible to a PRRSV infection.  Experimental infection can be 
achieved following intranasal, intratracheal, oronasal, oral, intramuscular, intrauterine, 
intravenous, or intraperitoneal inoculations (Wensvoort et al., 1991; Christianson et al., 
1992; Collins et al., 1992; Christianson et al., 1993; Rossow et al., 1994; Swenson et al., 
1994; Wills et al., 1994; Pol et al., 1997a; Van Reeth et al., 1999; Yoon et al., 1999).  
Under natural circumstances, the virus most frequently enters via the respiratory tract, but 
viraemia and dissemination throughout the body rapidly occur.  The kinetics of a PRRSV 
infection in the lungs and lymphoid organs have been described in detail by Duan et al. 
(1997a) and Beyer et al. (2000).  In both studies, inoculation with PRRSV rapidly 
resulted in viraemia and virus replication in several organs.  From 2 to 4 days after 
inoculation onwards, it was possible to isolate PRRSV from lungs, tonsils, lymph nodes, 
thymus, spleen, and blood.  The highest virus titres in tonsils and lungs were reached at 
14 days after inoculation, whereas the highest virus titres in lymph nodes were reached at 
3 days after inoculation.  From tonsils, lymph nodes and thymus, virus isolation was 
possible up to 21 days after inoculation.  From lungs, infectious virus was recovered until 
35 days after inoculation.  PRRSV-infected cells were mostly located in the alveolar 
spaces of the lungs and in germinal centers of lymphoid follicles in lymph nodes and 
spleen.  Viraemia was detected until 21 to 28 days after inoculation.  The latter finding 
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was confirmed by other researchers (Halbur et al., 1996; Wills et al., 1997).  However, 
viraemia of up to 5-9 weeks duration has also been reported (Yoon et al., 1993; Bilodeau 
et al., 1994; Sur et al., 1997).  During viraemia, the virus may be distributed to various 
organs.  In boars, the virus may infect the reproductive tract and be shed in semen 
(Swenson et al., 1994; Christopher-Hennings et al., 1995a,b).  In pregnant sows, PRRSV 
is able to cross the placenta.  The efficiency by which PRRSV crosses the placenta 
depends on the stage of gestation.  At early- and mid-gestation, transplacental infection is 
rarely observed (Christianson et al., 1993; Mengeling et al., 1994).  However, during late 
gestation (93 days of gestation), transplacental infection occurs easily (Christianson et al., 
1992).  These differences may be explained by differences in placental permeability 
during gestation (Christianson et al., 1993).  The virus has further been detected in nasal 
turbinates, kidneys, brains, liver, trachea, bone marrow, and choroid plexus (Pol et al., 
1991; Rossow et al., 1994; Halbur et al., 1995; Rossow et al., 1995; Beyer et al., 2000).   
Cells of the monocyte/macrophage lineage are the main target cells for PRRSV.  The 
susceptibility of these cells to PRRSV varies, however, in different organs.  Macrophages 
in lungs, tonsils, lymph nodes, and spleen are permissive to PRRSV infection (Duan et 
al., 1997a,b; Thanawongnuwech et al., 1997; Beyer et al., 2000), whereas virus infection 
was not detected in macrophages of liver, kidneys and heart, or in macrophage precursor 
cells such as blood mononuclear cells and bone marrow cells (Duan et al., 1997a,b).  
Virus replication has also been shown in microglial cells (Molitor et al., 1996).  It is 
remarkable that only 2% of the alveolar macrophages, which are the main target cells in 
vivo, become infected, even at the peak of virus replication in the lungs (Mengeling et al., 
1995; Duan et al., 1997a).  Thus, PRRSV appears to have a preference for certain subsets 
of macrophages in vivo.  A number of publications described PRRSV antigens in a low 
number of epithelial cells in bronchi (Pol et al., 1991; Rossow et al., 1995), of epithelial 
cells in the nasal mucosa (Rossow et al., 1996), of type II pneumocytes (Halbur et al., 
1994) and of endothelial cells (Halbur et al., 1995, 1996).  In contrast to these findings, 
Duan et al. (1997a) and Beyer et al. (2000) did not observe PRRSV antigens in these cell 
types.  Since macrophages are ubiquitously distributed cells that display a variety of 
morphological phenotypes (Rutherford et al., 1993), it is possible that the viral antigen-
positive epithelial and endothelial cells represent in fact monocytes/macrophages during 
their migration through tissues.  Indeed, Teifke et al. (2001) and Howerth et al. (2002) 
recently ruled out the previously postulated role of epithelial and endothelial cells in the 
replication of PRRSV. 
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The tropism of PRRSV for pulmonary macrophages has led to the central hypothesis 
that lung defense mechanisms may be suppressed following PRRSV infection.  Indeed, 
macrophages play important roles both in innate and acquired immunity, performing a 
large variety of functions that include phagocytosis, killing of micro-organisms, 
scavenging at sites of tissue injury, processing and presentation of antigens to 
lymphocytes, and cytokine production.  Consequently, several studies have been 
undertaken to determine whether there is local or systemic immunosuppression following 
PRRSV infection, but the results of these studies appear to be rather ambiguous.  Several 
researchers have investigated the phagocytic and microbicidal capacity of macrophages 
following a PRRSV infection, but their results were variable.  Chiou et al. (2000) 
demonstrated that the phagocytic capacity of PAMs against Candida albicans was 
significantly inhibited, whereas the ability of PAMs to internalize Staphylococcus aureus 
or Escherichia coli was not affected (Thanawongnuwech et al., 1997; Oleksiewicz & 
Nielsen, 1999).  Galina et al. (1994a), on the other hand, demonstrated that the 
phagocytic capacity of PAMs against Streptococcus suis was increased.  The bactericidal 
activity of macrophages following a PRRSV infection has been shown to be reduced in 
most studies (Molitor et al., 1992a; Thanawongnuwech et al., 1997; Chiou et al., 2000), 
but Galina et al. (1994a) reported that PRRSV increases the ability of PAMs for 
intracellular killing of bacteria.  The results of studies, which dealt with the oxidative 
burst capacity of macrophages following a PRRSV infection, were more uniform.  
Indeed, all studies revealed that PRRSV decreases the ability of macrophages to release 
superoxide anions and hydrogen peroxide (Molitor et al., 1992a; Zhou et al., 1992; 
Thanawongnuwech et al., 1997; Chiou et al., 2000; López-Fuertes et al., 2000a).  
Nevertheless, Chiou et al. (2000) reported that the amount of production of these oxygen 
metabolites was enhanced when measured on a per viable cell basis.  Thanawongnuwech 
et al. (1998) demonstrated that PRRSV markedly reduces the clearance capacity of the 
lungs, since the ability of pulmonary intravascular macrophages to clear copper particles 
was significantly reduced between 7 and 14 days after inoculation.  PRRSV also affects 
the processing and presentation of antigens to lymphocytes.  An enhanced immune 
response against some pathogens following a PRRSV infection has been described.  
Molitor et al. (1992b) showed that pseudorabies virus and Brucella abortus antibody 
titres and delayed type hypersensitivity responses were significantly enhanced in 
PRRSV-infected pigs.  The latter finding was confirmed by Albina et al. (1998), who 
demonstrated that PRRSV did not impair the immune response following pseudorabies 
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virus vaccination.  On the contrary, the total number of white blood cells and the number 
of IgM+, CD2+ and CD8+ cells of pigs previously infected with PRRSV and then 
challenged with virulent pseudorabies virus were increased.  Brun et al. (1994) similarly 
demonstrated that PRRSV enhanced the antibody production after a virulent challenge 
with swine influenza virus.  Another study showed no differences in antibody titres 
against pseudorabies virus between PRRSV- and non-infected control pigs (De Bruin et 
al., 2000).  Finally, PRRSV also interferes with the production of pro-inflammatory 
cytokines.  López-Fuertes et al. (2000b) demonstrated that PRRSV strongly reduced the 
interleukin (IL)-1 and tumour necrosis factor-alpha (TNF-α) mRNA expression in PAMs.  
The latter finding was supported by Chiou et al. (2000), who showed that the level of 
bioactive TNF-α secretion was markedly reduced soon after PRRSV infection.  Zhou et 
al. (1992), on the other hand, demonstrated that expression of IL-1 was enhanced in 
PAMs from PRRSV-infected pigs at 1 week after inoculation.  In conclusion, research 
into the macrophage functions following a PRRSV infection is very scanty and 
inconclusive. 
A particular feature of PRRSV is its capacity to persist for long periods of time after 
initial infection.  Evidence for persistence came from several publications.  Virus 
transmission by direct contact between susceptible pigs and 8 to 16 weeks earlier infected 
pigs have been reported (Zimmerman et al., 1992; Albina et al., 1994; Bilodeau et al., 
1994; Bierk et al., 2001; Wills et al., 2002).  There are some conflicting data about the 
exact duration and site of PRRSV replication during the persistent stage.  To our opinion, 
detection of infectious virus, either by virus isolation or swine bioassay, is required to 
classify animals as persistently infected.  Some studies strongly indicate that pulmonary 
macrophages are the major source of persistent infection.  In studies by Duan et al. 
(1997a) and Beyer et al. (2000), lungs and alveolar macrophages were the only tissues in 
which PRRSV was persistently detected for 35 days after inoculation.  Further evidence 
for virus persistence in pulmonary macrophages has been obtained by Mengeling et al. 
(1995) and Shibata et al. (1997).  They demonstrated that PAMs obtained by broncho-
alveolar lavage were virus-positive up to days 49 or 70 after inoculation.  Other studies, 
however, suggest PRRSV persistence in lymphoid organs, especially in the tonsils.  
Rossow et al. (1994) could isolate PRRSV exclusively from tonsils, spleen, and lymphoid 
tissues and not from the lungs at 28 days after inoculation.  Further, PRRSV could be 
isolated from tonsil homogenates until 84 (Allende et al., 2000) to 105 (Horter et al., 
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2000) days after inoculation.  Wills et al. (1997) reported that infectious virus was 
isolated up to 157 days after inoculation from oropharyngeal swabs.  The latter authors, 
however, postulated that due to the sampling process, oropharyngeal samples may have 
consisted of blood traces, saliva, lacrimae, nasal secretions, and respiratory tract 
secretions.  PRRSV is also able to persist in the reproductive tract of boars.  Swenson et 
al. (1994) detected infectious virus in the semen of experimentally infected boars for as 
long as 43 days following exposure.  Using the polymerase chain reaction (PCR), viral 
RNA in semen has been detected until 92 days after inoculation (Christopher-Hennings et 
al., 1995a).  A PCR was used because virus isolation on semen is troublesome 
(Christopher-Hennings et al., 1995b).  The source of PRRSV in semen is unknown, but 
PRRSV has been detected in the bulbo-urethral gland until 101 days after inoculation 
(Christopher-Hennings et al., 1995a) or in testes until 25 days after inoculation (Sur et al., 
1997). 
 
1.1.6. Disease 
 
PRRS initially emerged as a devastating disease, characterized by reproductive failure 
in pregnant sows and gilts and respiratory disease problems in pigs of all ages, but 
particularly in nursery pigs.  Later on, it became clear that the major characteristic of the 
disease is a high variability of clinical signs with a wide range of severity of clinical 
signs, including a subclinical course of infection. 
During its epizootic phase, PRRS in sow herds was characterized by reproductive 
disorders, including late-term abortions, early farrowings and the birth of weak and 
stillborn pigs (Ohlinger et al., 1991; Wensvoort et al., 1991).  Sometimes these signs were 
clearly evident but often they were only detectable after analyzing detailed herd records.  
Decreased farrowing rates and a delayed return to oestrus were persistent features.  A less 
common finding described in Europe, but not in the United States was a transient 
discoloration (cyanosis) of the ears, abdomen and vulva (Wensvoort, 1993).  On a farm 
basis, the reproductive disorders lasted 1 to 4 months.  Concurrently, the disease in young 
pigs was characterized by respiratory disorders, increased pre-weaning mortality and 
growth retardation (Ohlinger et al., 1991; Wensvoort et al., 1991).  These clinical signs 
were largely age-dependent, i.e. they were usually more severe in nursery pigs and mild 
in fattening pigs. 
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Currently, PRRSV is enzootic in most pig-producing countries throughout the world 
and it is generally accepted that most PRRSV infections in breeding pigs are subclinical.  
However, in some infected herds, periodic reproductive failure in breeding pigs and 
recurrent respiratory disease problems in nursery and fattening pigs have been reported 
(Keffaber et al., 1992; Stevenson et al., 1993; Zeman et al., 1993; Dee & Joo, 1994; Done 
& Paton, 1995).  Furthermore, veterinarians and farmers have reported an increase in 
respiratory disease problems and poor productivity in nursery and fattening pigs since the 
enzootic appearance of PRRSV (Done & Paton, 1995).  In the majority of experimental 
PRRSV infection studies, overt respiratory signs and poor doing were difficult to 
reproduce.  The most prominent finding was a transient fever 2 to 3 days after inoculation 
(Pol et al., 1991; Paton et al., 1992; Plana-Durán et al., 1992; Ramos et al., 1992; Yoon et 
al., 1992; Albina et al., 1994; Van Reeth et al., 1996; Segalés et al., 1999).  In some 
studies, anorexia and depression have also been recorded (Fichtner et al., 1993; Depner et 
al., 1999).  More severe respiratory signs have been observed with some North American 
isolates (Halbur et al., 1993; Rossow et al., 1994; Halbur et al., 1995; Loemba et al., 
1996).  Experimental inoculations with other North American isolates remained, 
however, subclinical (Mengeling et al., 1996).  Thus, some North American isolates are 
seemingly more virulent than others and than the European Lelystad virus (Halbur et al., 
1995).  In conclusion, it can be stated that respiratory disease problems under field 
circumstances, especially in Europe, can hardly be attributed to single PRRSV infections 
and that other factors have to be involved. 
In herds with respiratory disease problems, PRRSV has been isolated in combination 
with a mixture of bacteria, including Actinobacillus pleuropneumoniae, Mycoplasma 
hyopneumoniae, Mycoplasma hyorhinis, Haemophilus parasuis, Arcanobacterium 
pyogenes, Pasteurella multocida, Escherichia coli, Salmonella Choleraesuis, and 
Streptococcus suis, and in combination with common respiratory viruses, such as swine 
influenza viruses and porcine respiratory coronavirus (Hopper et al., 1992; Morrison et 
al., 1992; Halbur et al., 1993; Stevenson et al., 1993; Zeman et al., 1993; Kay et al., 1994; 
Done & Paton, 1995; Kamogawa et al., 1996; Kawashima et al., 1996; Kobayashi et al., 
1996).  These observations supported the idea that PRRSV may cause respiratory disease 
problems and/or poor doing in combination with other infectious agents.  This has 
stimulated research into the combined effects of PRRSV and other pathogens. 
Consequently, a large number of workers have investigated the effects of dual infections 
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with PRRSV and bacteria and/or viruses, but their findings were rather ambiguous.  A 
summary of their findings is listed in Table 1. 
 
 
 
 
 
 
 Table 1. Clinical, pathological and microbiological effects of experimental dual infections with PRRSV and bacteria or viruses. 
Secondary agent Authors Combination Effect on … 
   disease* lesions* bacterial colonization* 
Haemophilus parasuis Cooper et al., 1995 PRRSV-7 d-H. parasuis - - - 
 Solano et al., 1997 PRRSV-5 d-H. parasuis - - - 
 Segalés et al., 1999 PRRSV-5 d-H. parasuis - not studied - 
 Brockmeier et al., 2002 PRRSV-7 d-H. parasuis - - + 
Pasteurella multocida Cooper et al., 1995 PRRSV-2 or 7 d-P. multocida - - - 
 Carvalho et al., 1997 PRRSV-5 d-P. multocida - - not studied 
 Brockmeier et al., 2001 PRRSV-7 d-P. multocida - - - 
Streptococcus suis Galina et al., 1994b PRRSV-7 d-S. suis + + + 
 Cooper et al., 1995 PRRSV-2 or 7 d-S. suis - - - 
 Thanawongnuwech et al., 2000 PRRSV-7 d-S. suis + + + 
 Halbur et al., 2000 PRRSV-7 d-S. suis + + + 
 Schmitt et al., 2001 PRRSV-7 d-S. suis + + + 
Salmonella Choleraesuis Cooper et al., 1995 PRRSV-7 d-S. Choleraesuis - - - 
 Wills et al., 2000 S. Choleraesuis-3 d-PRRSV + - + 
Actinobacillus pleuropneumoniae Pol et al., 1997a PRRSV-7 d-A. pleuropneumoniae not studied + not studied 
Bordetella bronchiseptica Brockmeier et al., 2000 PRRSV-0 d-B. bronchiseptica + + + 
Mycoplasma hyopneumoniae Albina et al., 1995 PRRSV-21 d-M. hyopneumoniae - - not studied 
  M. hyopneumoniae-21 d-PRRSV - - not studied 
 Van Alstine et al., 1996 PRRSV-7 d-M. hyopneumoniae - - - 
 Thacker et al., 1999 PRRSV-0 or 10 d-M. hyopneumoniae + + - 
  M. hyopneumoniae-21 d-PRRSV + + - 
 Table 1. Continued. 
Secondary agent Authors Combination Effect on … 
   disease* lesions* bacterial colonization* 
influenza virus Brun et al., 1994 PRRSV-0 or 4 d-H1N1 - not studied  
 Pol et al., 1997a PRRSV-7 d-H3N2 not studied -  
 Van Reeth et al., 1996 PRRSV-3 d-H1N1 + not studied  
 Lee et al., 1999 PRRSV-7 d-H1N1 not studied +  
 Van Reeth et al., 2001 PRRSV-3 d-H1N1 + not studied  
  PRRSV-7 d-H1N1 + not studied  
  PRRSV-14 d-H1N1 - not studied  
porcine respiratory coronavirus Van Reeth et al., 1996 PRRSV-3 d-PRCV + not studied  
transmissible gastroenteritis virus Wesley et al., 1998 PRRSV-14 d-TGEV - not studied  
porcine circovirus type 2 Harms et al., 2000 PRRSV-0 d-PCV type 2 + +  
 Allan et al., 2000 PRRSV-0 d-PCV type 2 - +  
 Rovira et al., 2002 PRRSV-7 d-PCV type 2 + +  
pseudorabies virus Chen et al., 1998 PRRSV-10 d-PRV + +  
classical swine fever virus Depner et al., 1999 PRRSV-3 d-CSFV - not studied  
*+: aggravating effect; -: no effect 
 
 
N
ot applicable
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Dual infections of PRRSV with bacteria 
Haemophilus parasuis - Cooper et al. (1995) were unable to potentiate infections by 
super-exposure of four- to five-week-old specific pathogen-free (SPF) pigs to 
Haemophilus parasuis after inoculation with a North American PRRSV strain.  Solano et 
al. (1997) and Segalés et al. (1999) showed also that a dual infection of conventional pigs 
with PRRSV followed by Haemophilus parasuis did not result in an increased bacterial 
polyserositis and replication as compared to their controls.  Brockmeier et al. (2002), on 
the other hand, demonstrated that PRRSV increased the colonization of the upper 
respiratory tract with Haemophilus parasuis.  Furthermore, the PRRSV infection 
predisposed the pigs to a pulmonary infection with Haemophilus parasuis. 
Pasteurella multocida - A dual infection with PRRSV and Pasteurella multocida did 
not enhance lung lesions and had little effect on bacterial colonization of the lungs 
(Cooper et al., 1995; Carvalho et al., 1997; Brockmeier et al., 2001). 
Streptococcus suis - Galina et al. (1994b), using a virulent strain of Streptococcus suis 
in SPF pigs, observed that only pigs, which had previously been inoculated with PRRSV, 
developed severe clinical signs, a suppurative meningitis and large numbers of bacteria in 
several tissues, including the brains and meninges.  The latter findings were supported by 
Thanawongnuwech et al. (2000), Halbur et al. (2000) and Schmitt et al. (2001).  Two- to 
four-week-old conventional pigs, which were inoculated with PRRSV followed 7 days 
later by Streptococcus suis, exhibited more frequent and severe clinical central nervous 
system disease and lesions typical of a Streptococcus suis infection.  They had also more 
widespread tissue dissemination of the bacteria, including the lungs, had a severe 
decrease in pulmonary copper clearance, and experienced significantly higher mortality 
than pigs infected with Streptococcus suis alone.  Feng et al. (2001) reported that piglets 
infected in utero with PRRSV at 98 days of gestation and challenged with Streptococcus 
suis 5 days after birth displayed significantly higher mortality rates and infections of 
joints and brains compared to controls.  In contrast, Cooper et al. (1995) were unable to 
potentiate infections by super-exposure with Streptococcus suis in PRRSV-infected pigs. 
Salmonella Choleraesuis – Cooper et al. (1995) reported that a dual infection with 
PRRSV and Salmonella Choleraesuis did not enhance lung lesions and had no effect on 
bacterial colonization of the lungs.  In contrast, Wills et al. (2000) reported that pigs 
which were dually infected with PRRSV and Salmonella Choleraesuis exhibited 
unthriftiness, rough hair coats, dyspnoea and diarrhea, whereas no clinical signs were 
observed in pigs inoculated with only PRRSV or only Salmonella Choleraesuis. 
Introduction – Porcine reproductive and respiratory syndrome virus 17 
________________________________________________________________________________________ 
Actinobacillus pleuropneumoniae - Pol et al. (1997a) obtained ambiguous results in 
dual infections of PRRSV and Actinobacillus pleuropneumoniae in SPF pigs.  
Actinobacillus pleuropneumoniae lesions were enhanced in dually infected pigs 
compared to single Actinobacillus pleuropneumoniae-infected pigs in one experiment, 
but the authors were unable to repeat their results upon two subsequent attempts. 
Bordetella bronchiseptica - Brockmeier et al. (2000) showed that the clinical outcome, 
including respiratory signs, fever and decreased weight gain, was far more pronounced in 
pigs inoculated with PRRSV and Bordetella bronchiseptica than in pigs inoculated with 
either organism alone.  Furthermore, the PRRSV infection predisposed the pigs to a 
pulmonary infection with Bordetella bronchiseptica.  Brockmeier et al. (2001) further 
demonstrated that a co-infection with PRRSV and Bordetella bronchiseptica predisposed 
pigs to infection of the upper respiratory tract and lungs with Pasteurella multocida. 
Mycoplasma hyopneumoniae - Attempts to demonstrate an interaction between 
PRRSV and Mycoplasma hyopneumoniae have shown contradictory results.  Albina et al. 
(1995) showed no increased prevalence of clinical signs in PRRSV-Mycoplasma 
hyopneumoniae dually infected pigs.  The latter finding was confirmed by Van Alstine et 
al. (1996), who showed that inoculation of pigs with Mycoplasma hyopneumoniae seven 
days after inoculation with a North American PRRSV strain did not result in exacerbation 
of the disease.  Thacker et al. (1999), on the other hand, showed that pigs, which had 
been inoculated with both PRRSV and Mycoplasma hyopneumoniae, had more severe 
respiratory signs than pigs inoculated with PRRSV or Mycoplasma hyopneumoniae 
alone.  At 4 to 5 weeks after PRRSV inoculation, Mycoplasma hyopneumoniae-infected 
pigs still exhibited lesions typical of PRRSV-induced pneumonia, whereas the lungs of 
pigs, which had received only PRRSV, were essentially normal. 
 
Dual infections of PRRSV with viruses 
Orthomyxoviridae - Van Reeth et al. (1996,2001) demonstrated that Lelystad virus 
interacted with H1N1-influenza virus to produce more severe disease.  Combined 
PRRSV-H1N1 infections in ten-week-old conventional pigs resulted in enhanced fever, 
respiratory distress and growth retardation as compared to the respective single virus 
infections.  However, the clinical effects of the dual PRRSV-H1N1 infections were not 
reproducible to the same level in subsequent groups of experimental pigs.  Lee et al. 
(1999) reported that dual infection of conventional pigs with PRRSV followed by H1N1-
influenza virus seven days later resulted in more severe lung lesions.  Brun et al. (1994), 
18  Chapter 1 
________________________________________________________________________________________ 
on the other hand, failed to induce more severe clinical signs in PRRSV-H1N1 dually 
infected pigs.  Pol et al. (1997a) likewise demonstrated that dual infection of SPF pigs 
with PRRSV followed by H3N2-influenza virus seven days later did not result in more 
severe lung lesions. 
Coronaviridae – Van Reeth et al. (1996) demonstrated that dual infection of ten-week-
old conventional pigs with PRRSV and porcine respiratory coronavirus resulted in 
enhanced fever, respiratory signs and growth reduction compared to the respective single 
virus controls.  Wesley et al. (1998) demonstrated that the clinical course of transmissible 
gastroenteritis virus (TGEV) disease was not markedly affected by infection of pigs with 
TGEV two weeks after they had been infected with PRRSV. 
Circoviridae – Several reports have demonstrated that dual infections of pigs with 
PRRSV and porcine circovirus (PCV) type 2 significantly increased the severity of 
PRRSV-induced lung lesions (Harms et al., 2000; Allan et al., 2000; Rovira et al., 2002).  
Pesch et al. (2000) reported that co-infections with PRRSV and PCV type 2 caused 
severe respiratory signs, which were similar to those observed in pigs with proliferative 
necrotizing pneumonia. 
Herpesviridae - Chen et al. (1998) demonstrated that dual infection of SPF pigs with 
PRRSV followed by pseudorabies virus (PRV) resulted in an enhanced severity of a PRV 
infection.  Pigs inoculated with PRV only showed depression, whereas dually inoculated 
pigs showed ataxia, convulsion, peddling and death. 
Pestiviridae - Depner et al. (1999) reported that inoculation of conventional pigs with 
classical swine fever virus during the early phase of a PRRSV infection did not 
significantly potentiate the clinical course of classical swine fever.   
 
Thus, the results of these studies ranged from no interaction to increased incidence and 
severity of disease, sometimes with conflicting results for the same combination of 
infectious agents.  This ambiguity may be due to a number of factors, including 
differences in the age of the pigs, the virus dose, the inoculation method, the strain of 
PRRSV and/or the secondary pathogen, the timing of infections, and the sanitary status of 
the pigs.  Van Reeth et al. (2001) demonstrated that the interval between a PRRSV and a 
subsequent H1N1-influenza virus infection can determine the clinical outcome.  Though 
PRRSV replicates in the lungs for long periods of time (Mengeling et al., 1995; Duan et 
al., 1997a), disease was only observed if H1N1-influenza virus inoculation occurred 
sooner than 14 days after PRRSV inoculation.  The latter authors also reported that only 
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20% of caesarean-derived colostrum-deprived pigs developed typical clinical signs after 
an experimental PRRSV-H1N1 influenza virus dual infection, whereas in conventional 
pigs, morbidity was 100% and disease severity was higher.  Thus, it appears that severe 
clinical signs develop more readily in pigs of a lower sanitary status. 
 
1.1.7. Immunity 
 
PRRSV-infected pigs develop a humoral immune response that can easily be detected 
by the presence of serum antibodies to the virus.  Most serologic assays indicate that 
serum antibodies appear at 1 to 2 weeks after infection, reach a maximum by 5 to 6 
weeks and persist for 42 weeks.  Both immunoglobulins M and G are involved in the 
specific humoral immune response to PRRSV.  IgM antibodies are first detected at day 7, 
peak at 14 to 21 days and rapidly decrease, being undetectable by 35 to 42 days.  IgG 
antibodies appear by day 11 to 14 after infection, peak at 21 to 28 days and are detectable 
for several months (Loemba et al., 1996; Vézina et al., 1996).  Antibodies with a virus-
neutralizing activity appear more slowly.  They are usually detected first at 4 to 6 weeks 
after infection and reach a maximal titre about 10 to 12 weeks after infection (Morrison et 
al., 1992; Yoon et al., 1995; Loemba et al., 1996; Albina et al., 1998; Wu et al., 2001).  
Meier et al. (2000) detected virus-neutralizing antibodies not earlier than 11 to 13 weeks 
after infection.  Studies of the immune response to individual viral proteins have shown 
that the antibody responses are mounted primarily to the nucleocapsid protein (N) and, to 
a lesser extent, to the matrix (M) and the major envelope (E or GP5) proteins 
(Meulenberg et al., 1995; Loemba et al., 1996; Kwang et al., 1999).  Antibodies to GP5 
were demonstrated as early as 6 days after infection, whereas antibodies to the N and M 
proteins were detected only by the end of the second week after infection (Loemba et al., 
1996; Kwang et al., 1999).  Antibodies to the 2b protein appeared by 18 days after 
infection, and by 39 days all pigs had antibodies against this protein (Wu et al., 2001).  
The differences in antibody responses to these viral proteins have been attributed to their 
relative portion within the virion, rather than to their immunogenicity (Loemba et al., 
1996). 
The role of humoral immunity in protection upon challenge is questionable, since a 
common feature of a PRRSV infection is the co-existence of viraemia and antibodies 
(Rossow et al., 1994; Halbur et al., 1996; Duan et al., 1997a).  Furthermore, it has been 
demonstrated that with a few North American PRRSV isolates early antibodies rather 
20  Chapter 1 
________________________________________________________________________________________ 
enhance than inhibit virus infection through Fc receptor-mediated attachment of virus-
antibodies complexes to susceptible macrophages.  This process is recognized as 
“antibody-dependent enhancement of infectivity (ADEI)” (Choi et al., 1992; Christianson 
et al., 1993; Yoon et al., 1994; Yoon et al., 1996).  The possibility to isolate virus in spite 
of the presence of neutralizing antibodies indicates that neutralizing antibodies are not the 
only immune components involved in the complete elimination of the virus.  The immune 
system of the host is ultimately able to clear PRRSV and seems to do it in the majority of 
the animals by 150 days after inoculation or shortly thereafter (Allende et al., 2000).  The 
mechanisms by which the virus is finally cleared are not known. 
Little is known about the cellular immune response to a PRRSV infection.  Bautista & 
Molitor (1997) and López-Fuertes et al. (1999) demonstrated a clear T lymphocyte 
proliferation to PRRSV.  This T lymphocyte proliferation was first detected at 4 weeks 
after infection, peaked at 7 weeks and appeared to decline after 11 weeks.  The 
proliferation involved mainly CD4+ T lymphocytes, but also CD8+ T lymphocytes.  An 
elevated level of CD8+ T lymphocytes from 3 to 5 weeks after infection has been 
demonstrated by several researchers (Shimizu et al., 1996; Albina et al., 1998; 
Janutenaite et al., 2002).  The biological significance of this change in CD8+ cell numbers 
is not clear, but in the study of Albina et al. (1998), viraemia started to decline shortly 
after the proliferation of these CD8+ cells.  Bautista et al. (1999) demonstrated that the T 
lymphocyte proliferation response was largest after stimulation with the product of open 
reading frame (ORF) 6, suggesting that the matrix protein (M) is specifically recognized 
by T lymphocytes from PRRSV-infected pigs.  In another study, performed by Meier et 
al. (2000), T lymphocyte proliferation was first detected at 3 weeks after infection and 
appeared to increase steadily from 11 to 13 weeks.  The latter authors also reported that 
the frequency and quality of a T lymphocyte-mediated interferon-gamma (IFN-γ) 
response, as detected by ELISPOT, was low and very poor during the first 9 to 10 weeks 
after infection. 
1.1.8. Vaccination 
 
The important economic impact of PRRSV on the swine industry (Polson et al., 1992) 
has led to the development of PRRSV vaccines.  Because of safety reasons, the very first 
vaccines consisted of inactivated viruses.  These vaccines, however, appeared to lack 
immunogenicity, resulting in a poor protection against a challenge with wild-type virus 
(Plana-Durán et al., 1997a).  Subunit vaccines were also constructed, consisting of ORFs 
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incorporated into baculoviruses to produce the protein in vitro (Plana-Durán et al., 1997b; 
Kwang et al., 1999; Qiu et al., 2000).  The baculovirus ORF7 product induced antibodies 
upon vaccination, but did not provide immunity against a challenge with wild-type 
PRRSV (Plana-Durán et al., 1997b).  Pigs, immunized with a plasmid encoding GP5, on 
the other hand, were protected from viraemia upon challenge with wild-type PRRSV 
(Pirzadeh & Dea, 1998).  Rogan et al. (2000) were able to elicit neutralizing antibodies in 
pigs immunized with a vacciniavirus ORF2 product. 
Today, several modified live vaccines, developed by different companies, have been 
licensed and are commercially available for use in feeder pigs and sows.  Vaccines 
containing either European or North American serotypes are available.  All these 
vaccines have been evaluated for efficacy and safety. 
 
Efficacy testing of modified live vaccines 
With regard to the efficacy of modified live PRRSV vaccines, there is one major issue 
of concern: the degree of cross-protection between the European and the North American 
serotype. 
When a vaccine is claimed to protect against PRRSV-induced respiratory problems, a 
vaccination/challenge model in young pigs is performed.  Owing to the fact that clinical 
signs are mostly absent among non-vaccinated challenge control pigs (van Woensel et al., 
1998; Labarque et al., 2000), it is not possible to assess the efficacy of vaccines based on 
clinical signs alone.  Therefore, the efficacy of vaccination is usually assessed by 
determining the reduction in viraemia after challenge with a virulent virus.  These studies 
have clearly demonstrated that the virological protection was significantly better after a 
homologous challenge than after a heterologous one.  Vaccination with a North American 
strain suppressed the replication of European wild-type virus to some extent, but a far 
more effective suppression of replication of the challenge virus was obtained in pigs 
vaccinated with a European strain (van Woensel et al., 1998; Labarque et al., 2000).  
When the challenge was performed with a North American wild-type virus, the mean 
cumulative virus titres in blood were clearly reduced in pigs vaccinated with a North 
American serotype vaccine when compared with those of non-vaccinated challenge 
control pigs and pigs vaccinated with a European serotype vaccine (Labarque et al., 
2000).  On the other hand, Nielsen et al. (1997) demonstrated an effective suppression of 
replication of the challenge virus in pigs, vaccinated with a North American serotype 
vaccine and challenged with a European wild-type virus.  In this study, the vaccine was 
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administered intranasally instead of parenterally.  Nodelijk et al. (2001) reported that, 
despite the fact that both the duration and the level of viraemia upon a heterologous 
challenge were significantly reduced in pigs vaccinated with a North American serotype 
vaccine, no reduction of transmission of virulent PRRSV was obtained by the 
vaccination. 
When a vaccine is claimed to protect against PRRSV-induced reproductive failure, a 
vaccination/challenge model in pregnant sows is performed.  Since sow studies are 
expensive and difficult to manage, most of them have been performed with a low number 
of sows.  Sows, immunized with a North American serotype PRRSV vaccine (Ingelvac® 
PRRS MLV, Boehringer Ingelheim Vetmedica) 3 to 9 weeks before breeding and 
challenged at approximately 90 days of gestation with virulent PRRSV strains, showed a 
clearly better farrowing performance compared to non-immunized challenge control sows 
(Gorcyca et al., 1996; Benson et al., 2000; Medveczky et al., 2002).  Benson et al. (2000) 
and Medveczky et al. (2002) reported that still a considerable number of the piglets of the 
immunized sows were viraemic at birth.  Though, the immunized sows gave birth to less 
viraemic piglets than the non-immunized challenge control sows (8 to 10% versus 42 to 
44%).  Hesse et al. (1996a) did not observe viraemic piglets when sows were immunized 
with another North American serotype PRRSV vaccine (Prime Pac® PRRS, Schering 
Plough Animal Health Corporation) 4 to 6 weeks before breeding and challenged at 85 
days of gestation with a North American wild-type strain.  When the challenge was 
performed with a European wild-type strain, this resulted in the birth of stillborn pigs, 
mummies and viraemic pigs (Hesse et al., 1996b).  The immunized sows gave birth to 
27% dead piglets and 5% viraemic piglets, whereas the percentages in non-immunized 
challenge control sows were 64 and 69%, respectively.  Scortti et al. (1999) reported that 
when sows, immunized 3 weeks before breeding with either of two European serotype 
PRRSV vaccines (Amervac-PRRS®, Hipra Laboratorios and Pyrsvac-183®, Syva 
Laboratorios, respectively), were challenged with European wild-type strains at 90 days 
of gestation, 7 and 24% of the offspring, respectively, were viraemic.  Mengeling et al. 
(1999) reported that 4% of the offspring of sows, immunized with Ingelvac® PRRS MLV 
at 60 days of gestation and challenged with a North American wild-type strain 30 days 
later, were viraemic.  When the challenge was performed with a European wild-type 
strain, 32% of the piglets were viraemic (Canals et al., 2000).  Non-immunized challenge 
control sows in these studies gave birth to 57 (Mengeling et al., 1999) and 76% (Canals et 
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al., 2000) viraemic piglets.  In conclusion, results of these studies indicate that 
vaccination cannot completely avoid the transplacental transmission of challenge virus to 
piglets.  Nevertheless, the farrowing performance in vaccinated sows and gilts was 
clearly better than that of non-vaccinated ones. 
 
Safety testing of modified live vaccines 
The main safety concerns relating to modified live PRRSV vaccines are (i) 
pathogenicity of the vaccine strain, (ii) dissemination of the vaccine throughout the body 
and ability to spread, (iii) reversion to virulence and (iv) recombination with field strains. 
 
(i) Pathogenicity of the vaccine strain 
It has been reported that clinical signs and lesions caused by vaccine viruses are 
minimal.  It has been shown by Kang et al. (1996) that Ingelvac® PRRS MLV does not 
induce clinical signs after parenteral administration.  Opriessnig et al. (2002) further 
demonstrated that this vaccine virus does not induce lung lesions after intranasal 
administration.  Similarly, it has been demonstrated that Porcilis® PRRS (Intervet NV) 
does not induce disease after parenteral administration (Stadejek & Pejsak, 1998; Astrup 
& Riising, 2002). 
 
(ii) Dissemination of the vaccine throughout the body and ability to spread 
No much information is available about the dissemination of vaccine viruses 
throughout the body after vaccination.  It has been demonstrated that vaccine viruses can 
be isolated from blood (Christopher-Hennings et al., 1996; Bøtner et al., 1997; Stadejek 
& Pejsak, 1998; Astrup & Riising, 2002), but information about the replication of vaccine 
viruses in target organs, such as lymphoid organs and lungs, is scarce.  Thacker et al. 
(2000) reported that Ingelvac® PRRS MLV can be isolated from lungs after parenteral 
administration.  After vaccinating boars, vaccine virus can be detected in semen 
(Christopher-Hennings et al., 1996; Bøtner et al., 1997; Nielsen et al., 1997). 
Ingelvac® PRRS MLV has been shown to be shed and infect naive contact pigs held in 
the same pen and in adjacent pens (Torrison et al., 1996).  The latter authors also reported 
transmission to a non-adjacent pen, raising the possibility of aerosol transmission.  Bøtner 
et al. (1997) reported spread of this vaccine virus to non-vaccinated sows and subsequent 
transplacental infection of fetuses.  Stadejek & Pejsak (1998) reported no spread of 
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Porcilis® PRRS from vaccinated pigs to sentinel pigs, since no seroconversion was 
observed in any of the sentinels.  Sipos et al. (2002) and Astrup & Riising (2002), on the 
other hand, demonstrated that this vaccine virus has ability to spread from vaccinated to 
susceptible pigs. 
  
(iii) Reversion to virulence 
PRRSV is an RNA virus and as compared to DNA viruses, RNA viruses have a 
tendency to mutate at a high rate.  When these mutations occur in vaccine strains, this can 
possibly result in an increased virulence.  Recently, it was indeed demonstrated that 
Ingelvac® PRRS MLV can undergo mutations under field conditions (Storgaard et al., 
1999; Nielsen et al., 2001).  The implications of these findings, however, are still under 
debate. 
 
(iv) Recombination with field strains 
Recombination with viruses is possible when the host cell is simultaneously infected 
with two different strains of the same virus.  Thus, simultaneous infection of a pig with a 
vaccine and a field strain of PRRSV could theoretically lead to recombination of genetic 
material.  Bøtner et al. (1999) postulated that recombination is very unlikely between 
European and North American type PRRSV isolates, because of their large genetic and 
antigenic differences.  Murtaugh et al. (2002) demonstrated that genetic recombination 
between two attenuated PRRSV vaccine strains can occur in vitro in PAMs and in MA-
104 cells, but they could not confirm their findings in vivo.  The theoretical 
recombination of a vaccine and a field strain could only result in a strain that is not more 
virulent than the original field strain.  Recombination of vaccine strains with a field strain 
has not been reported until now. 
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1.2. Lipopolysaccharides and role in respiratory disease 
 
1.2.1. Introduction 
 
Respiratory disease in pigs has a multi-factorial background and several infectious 
agents, both viral and bacterial, have been associated with this problem.  However, non-
infectious airborne contaminants may also contribute to the development of respiratory 
disease in swine.  The major airborne contaminants in swine confinement buildings are 
organic dust, toxic gases (ammonia and hydrogen sulphide being the most important), 
and biologically active components such as peptidoglycans, beta-1,3-glucans and 
endotoxins (Donham, 1994).  Epidemiological studies have documented a close 
relationship between endotoxin concentrations and the prevalence of respiratory disease 
in both pigs and pig farmers (Donham, 1991; Heederik et al., 1991).  Exposure to 
endotoxins can occur in a number of ways.  Massive amounts of endotoxins are released 
locally in the lungs during infections with Gram-negative bacteria (Pugin et al., 1992).  
The treatment of Gram-negative bacterial infections with antibiotics may also result in 
the release of endotoxins in the lungs (Morrison, 1998).  Finally, endotoxins are present 
in dust in swine units at concentrations ranging from 0.04 to 1.2 µg/m3 air (Rylander, 
1994; Zejda et al., 1994).  These concentrations may increase during activities, such as 
cleaning, feeding, moving or sorting of animals (Donham, 1990; Malmberg & Larsson, 
1993; Donham, 1994).  Since airborne endotoxins are bound to cell membranes, 
endotoxin concentrations are often underestimated by the standard Limulus Amoebocyte 
Lysate (LAL) assay (Rylander et al., 1989).  When measured with gas chromatography-
mass spectrometry, endotoxin concentrations up to 4.9 µg/m3 air were measured in dust in 
swine units during weighing activities (Zhiping et al., 1996). 
 
1.2.2. Structure of lipopolysaccharides 
 
Endotoxins are a major constituent of the cell wall of Gram-negative bacteria 
(Rylander, 1994).  Lipopolysaccharide (LPS) is the main component of endotoxin and it 
is formed by a glucosamine-based phospholipid, called lipid A, that is covalently linked 
to a hydrophilic heteropolysaccharide (Rietschel et al., 1994).  Lipid A is responsible for 
most of the toxic properties of endotoxin (Rietschel et al., 1993).  The polysaccharide part 
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is made up of two parts, an oligosaccharide with a composition varying with bacterial 
species (O-specific chain) and a rather invariable core section, which is located between 
the oligosaccharide and the lipid A.  The chemical structure of LPS is shown in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Structure of Salmonella LPS. 
Gal: galactose; GalNAc: N-acetyl-galactosamine; Glc: glucose; GlcNAc: N-acetyl-glucosamine; Hep: 
heptose; P: phosphate; EtN: ethanolamine; KDO: 2-keto-3-deoxyoctonoic acid; R1 and R2: 
phosphoethanolamine or aminoarabinose; Ra to Re indicate incomplete forms of LPS. 
 
Although the terms endotoxin and LPS are often used interchangeably, the two terms 
are not synonymous.  Endotoxin refers to the Gram-negative bacterial cell wall 
containing the LPS and other naturally occurring compounds in the bacterial cell wall.  
Thus, exposure under real life conditions also includes bacterial proteins and other 
bacterial cell wall constituents.  LPS, on the other hand, implies a chemically purified 
endotoxin with no or only trace amounts of bacterial cell wall proteins, obtained by 
extraction procedures, and not present in organic dust (Rylander, 1994).  LPS is used in 
most experimental exposure studies. 
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1.2.3. Cellular signaling pathway of lipopolysaccharides 
 
LPS exert their biological effects through interaction with specific receptors.  
Monocytes/macrophages and epithelial cells have been identified as the primary target 
cells for LPS (Thorn, 2001).  LPS first binds to the LPS-binding protein (LBP) and is 
then delivered to the cell surface receptor CD14.  Next, LPS is transferred to the 
transmembrane signaling Toll-like receptor 4 (TLR4) and its accessory protein MD2.  
LPS then stimulates the activation of various intracellular signaling pathways.  These 
signaling pathways directly or indirectly phosphorylate and activate various transcription 
factors, which coordinate the induction of many genes encoding inflammatory mediators 
such as cytokines, chemokines, arachidonic acid metabolites, and oxygen metabolites 
(reviewed by Guha & Mackman, 2001). 
 
1.2.4. Biological effects of lipopolysaccharides 
 
Systemic and respiratory responses to LPS have been extensively investigated after 
intravenous administration, but we will focus on the effects of LPS when inhaled or 
administered to the lungs by either nebulization or direct intratracheal administration.  
The effects of LPS on the respiratory health of pigs, which often are continuously 
exposed throughout their lifetime, have not been studied extensively.  Indeed, most LPS 
inhalation-challenge studies have been performed in small laboratory animals and 
humans.  Nevertheless, we will focus on the biological effects of LPS in humans and 
pigs. 
 
Clinical signs 
Humans – In humans, LPS has been shown to cause influenza-like symptoms (Rylander 
et al., 1989; Michel et al., 1997).  Chronic coughing, excessive sputum and phlegm 
production, chest tightness, wheezing, and dyspnoea are common respiratory symptoms.  
In addition, general symptoms, such as fever, headache, tiredness, chilling, joint and 
muscle pain, nausea, eye irritation, and malaise have been reported.  The doses needed to 
induce such symptoms under experimental conditions were high, especially when 
compared with endotoxin levels found in dust in field studies (Rylander, 1997).  This 
discrepancy may be due to the bioavailability of endotoxin and/or to the presence of other 
agents in dust (Thorn, 2001).  Most often, clinical recovery occurs spontaneously within a 
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few days after withdrawal from exposure.  Nevertheless, continuous exposure to 
endotoxins is thought to be responsible for a number of occupational diseases including 
occupational asthma (Donham et al., 1989), byssinosis (Rylander, 1982), swine workers’s 
disease (Donham et al., 1989) and farmers’s lung disease (Thelin et al., 1984). 
Pigs – The clinical effect of inhalation or intratracheal inoculation of LPS in pigs has not 
been documented extensively.  Except for infrequent coughing, no clinical signs have 
been observed after nebulization of LPS at concentrations found in pig buildings (Urbain 
et al., 1999).  After intrabronchial LPS administration (dosage 200 µg/kg body weight), 
pigs appeared very weak, but no increase in body temperature was recorded (Urbain et 
al., 1996).  When very high doses of LPS (1 mg/kg body weight) were administered to 
specific-pathogen free (SPF) pigs by intratracheal route, general signs, including fever, 
depression, anorexia, and transient vomiting and diarrhea were reported (Liggett et al., 
1986).  The latter authors did not report respiratory signs. 
 
Lung functional changes 
Humans – Studies in humans have demonstrated that inhalation of LPS leads to impaired 
lung function.  A decrease in forced expiratory volume in one second and forced vital 
capacity has been reported (Vogelzang et al., 1998).  Although the decrease of both lung 
function parameters is suggestive of an obstructive type of lung disease, other researchers 
observed lung functional changes indicative of a restrictive pattern (Herbert et al., 1992; 
Michel et al., 1995).  The latter authors demonstrated a reduction of the alveolar-capillary 
diffusion capacity after inhalation of LPS.  In total, the balance of studies in humans 
suggests development of obstructive rather than restrictive pulmonary disease. 
Pigs – To our knowledge, no information is available about lung functional changes 
following LPS exposure in pigs. 
 
Lung inflammatory changes 
Humans – Exposure of humans to LPS can induce inflammatory responses in the lungs 
without any effect on the lung functions.  If high amounts of LPS (50 µg/kg body weight) 
are administered to humans, clinical signs and decreased lung function are observed, 
whereas smaller LPS doses (5 µg/kg body weight) cause a mild inflammation only 
(Michel et al., 1997).  The most prominent inflammatory change following LPS exposure 
is a rapid and massive influx of inflammatory cells, mainly neutrophils, into the airways 
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(Snella & Rylander, 1982; Sandström et al., 1992; Wesselius et al., 1997).  Significant 
increases have also been found for macrophages and lymphocytes (Sandström et al., 
1992; Michel et al., 1997).  The cellular influx is associated with an increase in broncho-
alveolar lavage (BAL) fibronectin, interleukin (IL)-8 and leukotriene B4, which are all 
chemoattractants for neutrophils and other cells (Sandström et al., 1992; Wang et al., 
1997; Nichtingale et al., 1998).  LPS exposure also results in the production of different 
pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-α) and IL-1 
(Clapp et al., 1994; Jagielo et al., 1996; Wesselius et al., 1997).  Many of the biological 
effects of LPS may be attributed to the release of these cytokines.  These cytokines 
indeed mediate leukocyte recruitment and activation in the lungs, increased lung 
microvascular permeability and pulmonary dysfunctions (Bielefeldt-Ohmann, 1995).       
Pigs – There are few publications on the lung inflammatory response to inhalation or 
direct intratracheal administration of LPS in pigs.  Holst et al. (1994) reported increased 
numbers of neutrophils in BAL fluid of pigs, exposed to dustborne endotoxins (8.6 µg/m3 
air) and fed endotoxin-contaminated feed (100 mg/pig), but the effect of inhalation was 
not evaluated separately.  Jolie et al. (1998) reported that 15 weeks of exposure (5 
days/week; 8 hours/day) to feed dust with artificially added endotoxin (42 ng/m3) led to 
an increased neutrophil count in BAL fluid.  Liggett et al. (1986) reported airway 
infiltration by both neutrophils and macrophages 24 hours after intratracheal 
administration of LPS to six-week-old SPF pigs, but only when very high doses were 
used (1 mg/kg body weight).  Urbain et al. (1996) similarly reported an increase in the 
number of neutrophils and macrophages in BAL fluid after nebulization of LPS (400 
µg/kg body weight).  According to the latter authors, the cellular response was 30 times 
higher after intrabronchial administration than after nebulization.  That a more moderate 
reaction was obtained after nebulization of LPS was ascribed both to the ability of the 
upper airways to act as a filter and/or to the fact that the LPS is dispersed and thus diluted 
throughout the respiratory tract after aerosolization.  Urbain et al. (1999) reported that 
inhalation of LPS at concentrations similar to those found in swine buildings (2.5 µg/m3 
air) did not affect the respiratory tract.  Like in humans, LPS (≥5 mg/kg body weight) has 
been shown to induce the release of TNF-α and IL-1 in BAL fluid of pigs (Van Reeth et 
al., 2000). 
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Aims of the thesis 
 
 
Multi-factorial respiratory disease problems in young pigs are responsible for 
important financial losses in the swine industry.  A variety of respiratory pathogens and 
adverse environmental conditions contribute to the development of these problems with 
porcine reproductive and respiratory syndrome virus (PRRSV) as an important factor.  
The general aims of the present thesis were to extend the knowledge on the pathogenesis 
of a PRRSV infection in the lungs of pigs, to examine if there exists a clinical synergy 
between PRRSV and lipopolysaccharide (LPS), and to evaluate the safety and efficacy of 
modified live PRRSV vaccines. 
The specific aims can be defined as follows: 
(1) To study a number of pathogenetic events in the lungs during a PRRSV 
infection in detail (virus replication, changes in the broncho-alveolar lavage 
(BAL) cell population and humoral immunity). 
 
(2) To study the kinetics of apoptosis in the lungs and BAL cells during a PRRSV 
infection and to examine if correlations exist between virus replication, the 
presence of apoptosis and the production of cytokines. 
 
(3) To study the clinical outcome of inoculations with virulent PRRSV followed 
by LPS and the effect of the timing and frequency of LPS administrations. 
 
(4) To study the safety aspects of attenuated PRRSV strains using virological and 
clinical parameters. 
 
(5) To evaluate the efficacy of commercially available modified live PRRSV 
vaccines using virological and clinical parameters of protection. 
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Summary 
 
Twenty-two four- to five-week-old gnotobiotic pigs were inoculated intranasally with 
106.0 TCID50 of porcine reproductive and respiratory syndrome virus (PRRSV) (Lelystad 
virus) and euthanized at different time intervals post inoculation (PI).  Broncho-alveolar 
lavage (BAL) cell populations were characterized, together with the pattern of virus 
replication and appearance of antibodies in the lungs.  Total BAL cell numbers increased 
from 140 x106 at 5 days PI to 948 x106 at 25 days PI and remained at high levels till the 
end of the experiment.  The number of monocytes/macrophages, as identified by 
monoclonal antibodies 74-22-15 and 41D3, increased 2- to 5-fold between 9 and 52 days 
PI with a maximum at 25 days PI.  Flow cytometry showed that the population of 
differentiated macrophages was reduced between 9 and 20 days PI and that between the 
same time interval, both 74-22-15-positive and 41D3-negative cells, presumably 
monocytes, and 74-22-15- and 41D3-double negative cells, presumably non-phagocytes, 
entered the alveolar spaces.  Virus replication was highest at 7 to 9 days PI, decreased 
slowly thereafter and was detected until 40 days PI.  Anti-PRRSV antibodies were 
detected starting at 9 days PI but neutralizing antibodies were only demonstrated in one 
pig euthanized at 35 days and another at 52 days PI.  The decrease of virus replication in 
the lungs from 9 days PI can be attributed to (i) shortage of susceptible differentiated 
macrophages, (ii) lack of susceptibility of the newly infiltrated monocytes and (iii) 
appearance of anti-PRRSV antibodies in the lungs.  Neutralizing antibodies may 
contribute to the clearance of PRRSV from the lungs. 
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Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) was first observed in the 
United States in 1987 as a new viral disease of swine (Hill, 1990) and appeared in Europe 
in 1990 (Terpstra et al., 1991).  Since then, the virus spread to all major swine-producing 
countries worldwide.  The porcine reproductive and respiratory syndrome virus 
(PRRSV), the causative agent of the disease, was first isolated in the Netherlands in 1991 
(Wensvoort et al., 1991) and subsequently in the United States in 1992 (Collins et al., 
1992).  A PRRSV infection in swine is clinically characterized by reproductive failure in 
sows and gilts and respiratory distress in young pigs.  However, overt respiratory signs 
are difficult to reproduce and in most experimental studies, the infection is subclinical or 
a transient fever is the only clinical sign (Van Reeth et al., 1996).  Based on the similarity 
in morphology, genomic organization, and strategy of gene expression, PRRSV has been 
classified as a member of the family of the Arteriviridae (Cavanagh, 1997).  All viruses 
of this family have common features in so far that (i) cells of the monocyte/macrophage 
lineage are the primary or the only target cells in vivo and that (ii) they cause persistent 
infections in their respective hosts (Plagemann & Moennig, 1992). 
PRRSV has a strong tropism for cells of the monocyte/macrophage lineage.  However, 
replication of the virus in these cells is subject to several restrictions.  It is confined to 
well-differentiated cells of the monocyte/macrophage lineage in lungs and lymphoid 
tissues and is not detected in progenitor cells such as bone marrow cells and peripheral 
blood monocytes (Duan et al., 1997b).  This restricted cell tropism for PRRSV is partly 
due to the expression of the PRRSV receptor on the membrane of susceptible pulmonary 
alveolar macrophages (PAMs), which is not detectable on refractory peripheral blood 
monocytes (Duan et al., 1998b).  Also, PRRSV replicates only at a certain stage of 
differentiation and maturation of the alveolar macrophages (Choi et al., 1994; Duan et al., 
1997b).  The complex effect of phenotype on the susceptibility of alveolar macrophages 
forms probably the basis for the low percentage of PRRSV antigen-positive broncho-
alveolar lavage (BAL) cells after infection even in the period of the most extensive virus 
replication in the lungs (Mengeling et al., 1995; Duan et al., 1997a). 
PRRSV is able to persist in different organs.  It can be detected in lungs till 35 (Duan 
et al., 1997a) to 49 days after inoculation (Mengeling et al., 1995), in tonsils till 21 days 
after inoculation (Duan et al., 1997a), in semen till 92 days after inoculation 
(Christopher-Hennings et al., 1995) and in serum till 58 days after inoculation (Sur et al., 
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1997) and persistence occurs despite the onset of a PRRSV-specific humoral and cell-
mediated immune response.  The mechanism of persistence is unknown. 
The purpose of the present experiment was to study a number of pathogenetic events 
in the lungs during a PRRSV infection in gnotobiotic pigs in detail.  The BAL cell 
population was examined, consisting of quantification of cells, determination of cell 
viability, morphological and phenotypical characterization of different subpopulations 
with specific attention to the population of cells of the monocyte/macrophage lineage and 
determination of presence of the PRRSV receptor and these events were correlated with 
virus replication (titration and quantification of viral antigen-positive cells) and 
appearance of neutralizing and non-neutralizing antibodies.  These studies show that a 
single PRRSV infection causes multiple marked changes in the lungs even though 
clinical signs remain absent. 
 
Materials and Methods 
 
Virus strain.  PRRSV (Lelystad virus) (Wensvoort et al., 1991) was used in the present 
study.  Virus used for inoculation was at the fifth passage in PAMs, which had been 
obtained from four- to six-week-old gnotobiotic pigs. 
 
Pigs and inoculation.  A total of twenty-nine caesarean-derived colostrum-deprived 
(CDCD) pigs were used.  They were housed in isolation facilities.  Twenty-two pigs were 
inoculated intranasally at the age of 4 to 5 weeks with 106.0 TCID50 Lelystad virus in 3 ml 
phosphate-buffered saline (PBS) (1.5 ml in each nostril).  The remaining seven pigs were 
left non-inoculated and served as negative controls.  One to three of the PRRSV-
inoculated pigs were euthanized at 1 (n=1), 3 (n=2), 5 (n=2), 7 (n=3), 9 (n=3), 14 (n=3), 
20 (n=1), 25 (n=2), 30 (n=1), 35 (n=2), 40 (n=1), and 52 (n=1) days post inoculation (PI) 
by intraperitoneal injection with an overdose of barbiturates (Natriumpentobarbital® 20%, 
IC KELA).   
The control pigs were euthanized at 4 (n=2), 5 (n=1), 6 (n=1), 8 (n=2), and 10 (n=1) 
weeks of age.  The right lung was used for broncho-alveolar lavage and samples from the 
left apical, cardiac and diaphragmatic lung lobes were collected for virological 
examinations (virus titration and quantification of viral antigen-positive cells). 
Broncho-alveolar lavage (BAL) cell analysis.  The right lung was lavaged with 60 to 
120 ml Dulbecco's PBS without Ca2+ and Mg2+  via an 18-gauge blunt needle inserted 
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through the trachea.  The left main bronchus was cross-clamped to prevent lung lavage 
fluid from entering the left lung.  About 75-90% of the initial volume of the lavage fluid 
was recovered.  The BAL fluid was centrifuged (400xg, 10 minutes, 4°C) to separate the 
cells and the cell-free lavage fluid. 
Fractions of the cell-free lavage fluid were either stored at –70°C until virus titration 
on PAMs or concentrated 10 times by dialysis against a 20% w/v solution of 
polyethylene glycol (MW 20,000) and cleared of residual virus by ultracentrifugation at 
100,000xg (Van Reeth et al., 1999) for determination of anti-PRRSV antibodies. 
Cell pellets were resuspended in PBS and the total number of BAL cells was 
determined.  Cell viability was assessed using trypan blue dye exclusion.  Cytocentrifuge 
preparations of BAL cells were made by centrifuging at 140xg for 5 minutes.  One 
preparation was stained with DiffQuick (Baxter) to determine the percentage of 
mononuclear cells and neutrophils, another was fixed in acetone for 20 minutes at –20°C 
to determine the percentage of viral antigen-positive cells using a streptavidin-biotin 
immunofluorescence technique.  Cells were first incubated with a pool of monoclonal 
antibodies (MAbs) against the PRRSV nucleocapsid protein (dilution 1/100 of WBE1 and 
WBE4-6) (Drew et al., 1995), subsequently with 1/100 biotinylated sheep anti-mouse 
antibodies (Amersham), and finally with 1/100 streptavidin-fluorescein isothiocyanate 
(FITC) (Amersham).  Finally, cells were washed, mounted in a glycerin-PBS solution 
(0.9:0.1, v/v) with 2.5% 1,4-diazobicyclo-2.2.2-octane (DABCO) (Janssen Chimica) and 
viral antigen-positive cells were counted by fluorescence microscopy (Leica DM RBE, 
Wild Leitz).  The specificity was confirmed by absence of fluorescence in BAL cells of 
uninoculated control pigs. 
Flow cytometric analyses of the BAL cells were done with a Becton-Dickinson 
FACSCaliburTM equipped with a 15mW aircooled argon ion laser and interfaced to a 
Macintosh Quadra 650 computer (Apple Computer) using BD Cellquest software.  Three 
parameters were stored for further analysis: forward light scattering (FSC), sideward light 
scattering (SSC) and green fluorescence (FL1).  At least 10,000 cells were analysed for 
each sample. 
For the phenotypic identification of neutrophils and cells of the monocyte/macrophage 
lineage, MAb 74-22-15 (Pescovitz et al., 1984) was used.  The percentage of cells of the 
monocyte/macrophage lineage was determined by subtracting the percentage of 
neutrophils, as determined by DiffQuick, from the 74-22-15-positive cells.  The 
percentage of BAL cells with expression of the PRRSV receptor on their cell membrane 
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was determined using MAb 41D3 (Duan et al., 1998a).  The reactivity of both 
monoclonal antibodies against the specific cell surface determinants was flow 
cytometrically evaluated by an indirect immunofluorescence technique.  To determine the 
number of 74-22-15- and 41D3-positive BAL cells, 5 x106 cells were incubated with 
1/300 74-22-15 or 1/1000 41D3, respectively for 1 hour at 4°C.  Subsequently, the BAL 
cells were incubated with 1/30 FITC-labelled goat anti-mouse IgG (Molecular Probes) for 
1 hour at 4°C.  Three washings were done with cold PBS before and after each 
incubation.  BAL cells which were only incubated with FITC-labelled goat anti-mouse 
IgG were included as controls. 
 
Virological examinations of lung tissue and BAL fluid. Twenty percent suspensions of 
lung tissue were made with cold PBS.  The suspensions were clarified by centrifugation.  
Fifty µl of tenfold serial dilutions of the supernatants of the lung suspensions and of the 
cell-free lavage fluids were inoculated on one-day cultivated PAMs, which were obtained 
from four- to six-week-old pigs from PRRSV-negative farms.  After incubation for 1 
hour at 37°C, the samples were replaced by medium.  After 72 hours at 37°C, the PAMs 
were washed once with PBS and further stained using an immunoperoxidase monolayer 
assay (IPMA) as described by Wensvoort et al. (1991). 
Tissue samples from the lungs were embedded in methylcellulose medium and frozen 
at –70°C.  Cryostat sections (5-8 µm) were made and fixed in acetone for 20 minutes at –
20°C.  A streptavidin-biotin immunofluorescence technique, similar as described for 
BAL cells, was used to count and localize the viral antigen-positive cells in lung tissue. 
 
Serological examinations.  Anti-PRRSV antibody titres were determined in sera and 
BAL fluids using an IPMA.  IPMAs with MARC-145 cells were set up to determine the 
immunoglobulin (Ig) isotypes of the PRRSV-specific antibodies.  Briefly, MARC-145 
cells were seeded in 96-well cell culture plates, inoculated with 50 µl of a Belgian isolate 
of PRRSV (94V360) and incubated for 18 hours (37°C, 5% CO2).  Then, the culture 
medium was removed, cells were washed in PBS and dried at 37°C for 1 hour.  The 
plates were kept at –70°C until use.  Plates were thawed and then fixed in 4% 
paraformaldehyde for 10 minutes.  Paraformaldehyde was removed, the cells were 
washed twice with PBS and a solution of 1% hydrogen peroxide in methanol was added.  
Plates were washed twice with PBS and serial four-fold dilutions of the sera and BAL 
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fluids were added.  Sera and BAL fluids were incubated for 1 hour at 37°C.  Plates were 
washed three times with PBS plus 1% Tween 80 and 50 µl of 1/10 mouse anti-swine 
IgG1, 1/10 mouse anti-swine IgG2, 1/100 mouse anti-swine IgM, and 1/160 mouse anti-
swine IgA (Van Zaane & Hulst, 1987), respectively were added per well and incubated at 
37°C for 1 hour.  Plates were washed three times and 50 µl of 1/3000 goat anti-mouse 
antibodies conjugated with peroxidase (Dako) were added per well and incubated at 37°C 
for 1 hour.  Plates were washed three times and 50 µl of a substrate solution of 3-amino-
9-ethylcarbazole in 0.05 M acetate buffer, pH 5 with 0.05% H2O2 were added to each 
well and incubated at room temperature for 20 minutes.  Then, the reaction was blocked 
by replacing the substrate by acetate buffer and the result was examined with a 
microscope. 
Neutralizing antibodies were determined in sera and BAL fluids using a virus 
neutralization test on MARC-145 cells as described by Swenson et al. (1994).  A MARC-
145-adapted Lelystad strain was used in this assay. 
 
Results 
 
BAL cell analysis. Total BAL cell numbers of non-inoculated control pigs ranged 
between 114 and 383 x106.  BAL cells consisted of 97-98% of cells of the 
monocyte/macrophage lineage, 1% of neutrophils and 1-2% of non-phagocytes, 
presumably lymphocytes (BAL cells minus 74-22-15-positive cells).  Cell viability of 
BAL cells ranged between 93 and 98%.  BAL cell populations in PRRSV-infected pigs 
are shown in Figure 1.  Their number and composition were similar to those of the non-
inoculated control pigs during the first 5 days PI.  Mean BAL cell numbers increased 
from 140 x106 at 5 days PI to 948 x106 at 25 days PI and then remained at high levels till 
the end of the experiment with numbers ranging between 642 and 782 x106.  The absolute 
number of cells of the monocyte/macrophage lineage, as identified by MAb 74-22-15, 
increased 2- to 5-fold between 9 and 52 days PI with a maximum at 25 days PI.  BAL 
cells consisted of 55-92% of cells of the monocyte/macrophage lineage, 1-15% of 
neutrophils (33% in one pig euthanized at 9 days PI) and 6-31% of non-phagocytes.  Cell 
viability of BAL cells ranged between 84 and 98%. 
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Fig. 1. Quantification and characterization of broncho-alveolar lavage (BAL) cells 
(x106/lung half) throughout a PRRSV infection. 
*Cells of the monocyte/macrophage lineage = 74-22-15-positive cells – neutrophils; **Lymphocytes = BAL 
cells – 74-22-15-positive cells. 
 
 
In the non-inoculated control pigs, the percentage of BAL cells with the PRRSV 
receptor (41D3-positive cells) varied between 93 and 95%.  In PRRSV-infected pigs, 
their percentage was similar to that of the controls during the first 3 days PI.  At 5, 7, 9, 
14, 20, and 25 days PI, respectively, 41D3-positive BAL cells represented 83 ± 1, 63 ± 5, 
38 ± 14, 41 ± 9, 53 ± 0, and 75 ± 4% of total BAL cells.  From 30 days PI, the percentage 
of 41D3-positive BAL cells reached the percentage of cells of the monocyte/macrophage 
lineage. 
The different patterns of scattering light characteristics [cell size (FSC) and granularity 
(SSC)] of the BAL cell population throughout a PRRSV infection are presented in Figure 
2 (dot-plot diagrams). 
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Fig. 2. Different patterns of light-scattering characteristics [FSC (cell size) and SSC 
(granularity)] of the broncho-alveolar cell population throughout a PRRSV infection. 
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Fig. 3. Changes in the number of cells of broncho-alveolar lavage (BAL) cell populations 
P1, P2 and P3 (x 106/lung half) throughout a PRRSV infection. 
 
Cellular changes and humoral immunity  65 
________________________________________________________________________________________ 
 
In the non-inoculated control pigs, the majority of BAL cells were flow cytometrically 
recognized as large (high FSC value) (population P1) and small (low FSC value) 
(population P2) cells with a strong granularity (high SSC value).  Based on their 
scattering light properties and their surface expression of a specific monocyte/granulocyte 
marker (recognized by MAb 74-22-15) and of the PRRSV receptor (recognized by MAb 
41D3), these two cell populations were characterized as cells of the 
monocyte/macrophage lineage.  The particles with the lowest scattering light properties 
(population P3) were characterized as non-phagocytes (74-22-15- and 41D3-double 
negative cells) and fragments of cells of the monocyte/macrophage lineage (74-22-15-
single positive and 74-22-15- and 41D3-double positive).  The evolution of the number of 
cells of BAL cell populations P1, P2 and P3 throughout the infection are presented in 
Figure 3.  In PRRSV-infected pigs, the scattering light characteristics of the BAL cell 
population were similar to those of the non-inoculated control pigs during the first 5 days 
PI.  Between 9 and 20 days PI, the number of 41D3-positive cells of the 
monocyte/macrophage lineage in populations P1 and P2 was reduced.  From 7 days PI, 
an increase of very small particles with low scattering light properties was observed 
(population P4) and these particles stained positive for both 74-22-15 and 41D3.  From 7 
till 20 days PI, very large and strongly granulated cells were present in the BAL fluid.  
They exceeded the maximal FSC and SSC values shown on the dot-plot diagrams in 
Figure 2 (population P5).  Between the same time interval, populations of small cells 
were entering the alveolar spaces.  The slightly granulated (low SSC value) cells 
(population P6) were characterized as, on the one hand 74-22-15-positive and 41D3-
negative cells, representing probably monocytes and, on the other hand 74-22-15- and 
41D3-double negative cells, representing probably non-phagocytes (presumably 
lymphocytes).  The strongly granulated cells (high SSC value) were only observed at 9 
and 14 days PI (population P7).  These cells were also 74-22-15-positive and 41D3-
negative.  From 25 till 52 days PI, the majority of BAL cells were recognized as 74-22-
15- and 41D3-positive cells of the monocyte/macrophage lineage and 74-22-15- and 
41D3-double negative cells, presumably lymphocytes. 
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Virological examinations of lung tissue and BAL fluid. The results of virus titrations 
of lung tissue and BAL fluid are presented in Figure 4. 
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Fig. 4. Course of PRRSV titres in lung tissue (log10 TCID50/gram) and broncho-alveolar 
lavage (BAL) fluid (log10 TCID50/ml) throughout a PRRSV infection (: lung tissue; z: 
BAL fluid). 
 
All non-inoculated control pigs were negative for PRRSV.  In the inoculated pigs, 
PRRSV titres of apical, cardiac and diaphragmatic lung lobes were similar and the pattern 
of virus titres in lung tissue resembled that in BAL fluid.  The highest virus titres were 
reached in BAL fluid at 7 days PI (107.3 TCID50/ml) and in lung tissue at 9 days PI (107.1 
TCID50/gram).  Afterwards, virus titres decreased slowly during the next five weeks.  
Virus was not detected in the pig euthanized at 52 days PI. 
Viral antigen-positive BAL cells were first observed at 1 day PI, increased to a 
maximum of 3% at 9 days PI, decreased to 0.5% at 14 days PI and remained at levels of 
0.1-0.2% until 40 days PI.  The quantification of viral antigen-positive cells and/or foci in 
lung tissue throughout a PRRSV infection is presented in Figure 5.  Single viral antigen-
positive cells were observed from 3 until 35 days PI with a maximal number of 45 
cells/100 mm2 lung tissue at 7 days PI.  Viral antigen-positive foci were defined as areas 
in lung tissue consisting of groups of viral antigen-positive cells and cellular debris.  
Viral antigen-positive foci were found from 3 until 14 days PI with a maximal number of 
37 foci/100 mm2 lung tissue at 9 days PI.  The intact viral antigen-positive cells in lung 
tissue and BAL fluid were morphologically recognized as macrophage-like cells.  Viral 
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antigen-positive cells were not observed in lung tissue and BAL fluid of non-inoculated 
control pigs. 
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Fig. 5. Quantification of single viral antigen-positive cells and viral antigen-positive foci 
in lung tissue (/100 mm2) throughout a PRRSV infection. 
 
Antibodies in sera and BAL fluids. The antibody titres against PRRSV in sera and BAL 
fluids of PRRSV-inoculated pigs are presented in Figure 6 (on a logarithmic scale).  
PRRSV-specific antibodies in sera and BAL fluids were first detectable by the IPMA at 9 
days PI.  IPMA titres in serum rose to 10,240 (213.3) at 20 days PI, whereas IPMA titres in 
BAL fluid rose to 2560 (211.3) at 25 days PI.  The distribution of the immunoglobulin 
isotypes of PRRSV-specific antibodies in sera and BAL fluids throughout the infection is 
presented in Figure 7 (on a logarithmic scale). 
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Fig. 6. Antibody titres against PRRSV in sera (squares) and broncho-alveolar lavage 
(BAL) fluids (bullets) of PRRSV-inoculated pigs. 
 
The first detectable IPMA antibodies in sera and BAL fluids of PRRSV-inoculated 
pigs were antibodies of the IgM and IgG isotype (IgG1 subclass).  IgM antibodies in sera 
and BAL fluids were detected only at 9 and 14 days PI, whereas IgG antibodies were 
detected until 52 days PI.  IgG1 IPMA titres in sera and BAL fluids followed the curve of 
total IPMA titres.  The curve of IgG2 IPMA titres in sera and BAL fluids was similar to 
that of IgG1 IPMA titres, but was at a lower level.  IgA antibodies in sera were detected 
starting from 14 days PI, increased to a maximum of 1280 (210.3) at 25 days PI and were 
detected until 35 days PI.  IgA antibodies in BAL fluids were highest at 14 days PI (26.0) 
and were detected until 35 days PI.  Neutralizing antibodies in sera were detected from 25 
days PI.  The titres remained at a low level (21-3.6) until the end of the study.  Neutralizing 
antibodies in BAL fluids were only detected in two pigs, one euthanized at 35 days and 
one at 52 days PI. 
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Fig. 7. Distribution of immunoglobulin isotypes of PRRSV-specific antibodies in sera 
and broncho-alveolar lavage (BAL) fluids of PRRSV-inoculated pigs. 
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Discussion 
 
The present study showed clear relations between PRRSV replication, morphological 
and phenotypical changes in the broncho-alveolar lavage (BAL) cells, and onset and 
presence of non-neutralizing and neutralizing antibodies. 
The most striking morphological and phenotypical changes in the BAL cell population 
consist of (i) the reduction of the population of susceptible well-differentiated 
macrophages and (ii) the massive influx of both 74-22-15-positive and 41D3-negative 
cells of the monocyte/macrophage lineage, probably monocytes, and 74-22-15- and 
41D3-double negative cells, probably non-phagocytes. 
Between 9 and 20 days PI, a reduction of the population of 41D3-positive cells of the 
monocyte/macrophage lineage was observed.  The reduction of this cell population is 
probably caused by a combination of cell lysis due to virus replication and apoptosis.  
The highest virus titres and numbers of viral antigen-positive cells in lungs and BAL 
fluids were indeed detected at 7 to 9 days PI and apoptosis in the lungs between 1 and 10 
days PI was earlier demonstrated by Sirinarumitr et al. (1998) and Sur et al. (1998).  
These authors reported that apoptotic cells were pulmonary alveolar and intravascular 
macrophages and mononuclear cells in the alveolar septa and showed that they were more 
abundant than viral antigen-positive cells.  The increased number of very small and 
slightly granulated particles, which stained positive for both 74-22-15 and 41D3, in the 
BAL cell population from 7 days PI on, may represent an increase of lysed infected 
macrophages and apoptotic bodies from macrophages in apoptosis.  The very large and 
strongly granulated cells, found in the BAL cell population from 7 till 20 days PI, may 
represent strongly activated macrophages phagocytizing the apoptotic bodies.  The 
biological significance of apoptosis in the pathogenesis of a PRRSV infection remains to 
be clarified. 
Throughout the PRRSV infection in the lungs of gnotobiotic pigs, the total number of 
BAL cells continuously increased from 5 days PI till 25 days PI mainly due to an influx 
of both 74-22-15-positive and 41D3-negative cells, probably monocytes, and 74-22-15- 
and 41D3-double negative cells, probably non-phagocytes (lymphocytes).  This 
observation is supported by the flow cytometric analysis of the BAL cell population, 
evaluating the evolution of size (FSC), granularity (SSC) and presence of markers on the 
cell surface throughout the infection.  The mechanism by which PRRSV induces the 
specific influx of monocytes is not yet known, but Van Reeth et al. (1999) suggested that 
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chemotactic cytokines produced by PRRSV-infected macrophages mediate the influx of 
new cells of the monocyte/macrophage lineage. 
Despite the continuous increase of the number of cells of the monocyte/macrophage 
lineage from 9 till 25 days PI, the number of viral antigen-positive cells in lung tissue and 
BAL fluid decreased from 9 days PI.  This is probably the result of (i) shortage of 
susceptible well-differentiated lung macrophages (see above), (ii) lack of susceptibility of 
the newly infiltrated blood monocytes (Duan et al., 1997b) and (iii) appearance of anti-
PRRSV antibodies in the lungs.  It is remarkable that viral antigen-positive cells and 
cellular debris were mainly localized in foci in lung tissue until 14 days PI and that, 
thereafter, only single viral antigen-positive cells were observed.  It is possible that 
infected cells in foci are destroyed by antibody-dependent cell lysis.  Single viral antigen-
positive cells, morphologically recognized as macrophage-like cells, were observed until 
35 and 40 days PI in lung tissue and BAL fluid, respectively.  These single viral antigen-
positive cells were the source of the virus detected in lung tissue and BAL fluid until 40 
days PI.  Why these single viral antigen-positive cells are able to persist despite the 
presence of the humoral immunity is not known, but may be attributed to either the cell or 
the virus.  Therefore, a full phenotypical characterization of this specific subpopulation of 
cells will be performed.  An alternative explanation may be the appearance of so-called 
quasispecies throughout the PRRSV infection.  A recent study of Rowland et al. (1999) 
revealed the emergence of a distinct PRRSV subpopulation during infection of pigs, 
identified by a single amino acid change in the ectodomain of glycoprotein 5.  Studies 
using lactate dehydrogenase-elevating virus of mice, another member of the family of the 
Arteriviridae, demonstrated how a small number of mutations in the ectodomain of the 
open reading frame (ORF) 5 protein can alter the cell tropism and the interaction of the 
virus with neutralizing antibodies, favouring persistence of the virus in its host 
(Plagemann, 1996 ; Chen et al., 1997). 
Immunoglobulin M, A, G1 and G2 (IgM, IgA, IgG1, and IgG2) antibodies were all 
involved in the specific humoral immune response to PRRSV.  IgM antibodies appear 
rather late during a PRRSV infection, which is in contrast with infections with other 
respiratory viruses such as influenza virus (Lee et al., 1995) and Aujeszky’s disease virus 
(Rodak et al., 1987), where IgM antibodies were detected as early as 3 and 7 days PI, 
respectively.  The kinetics of the isotypes of anti-PRRSV antibodies in BAL fluids were 
similar to those in sera, indicating that these antibodies are the result of a leakage from 
systemic antibodies. 
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Clearance of PRRSV from the lungs coincided with the appearance of neutralizing 
antibodies in sera and BAL fluids.  However, since low amounts of PRRSV remain in the 
lungs in spite of the presence of neutralizing antibodies in sera and BAL fluids, other 
immune factors or mechanisms, such as cell-mediated immunity, are probably involved 
in the complete elimination of the virus at this site.  Why neutralizing antibodies appear 
so late in infection and remain at rather low levels (titres ranging between 2 and 12) is not 
yet known. 
Based on the results of the present study, a hypothetical model of the series of events 
in the pathogenesis of a PRRSV infection in the lungs of gnotobiotic pigs can be made.  
After inoculation, primary replication of the virus takes place in well-differentiated lung 
macrophages.  Subsequently, a reduction of the resident macrophages takes place, which 
is accompanied with an influx of new cells of the monocyte/macrophage lineage in the 
lungs, which are initially refractory to PRRSV.  Lack of susceptible cells and the 
appearance of PRRSV-specific antibodies cause a decrease in the number of viral 
antigen-positive cells starting at 9 days PI.  Nevertheless, a low number of single viral 
antigen-positive cells persists in the lungs for several weeks.  Clearance of PRRSV from 
the lungs coincides with the appearance of specific neutralizing antibodies.  Most likely, 
other mechanisms, such as cell-mediated immunity, are necesarry for a complete 
elimination. 
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Summary 
 
Apoptosis was studied in the lungs of pigs during an infection with a European strain 
of porcine reproductive and respiratory syndrome virus (PRRSV) with the purpose to find 
its potential role in the pathogenesis.  Additionally, it was examined if cytokines are 
involved in the induction of apoptosis.  Twenty-two four- to five-week-old gnotobiotic 
pigs were inoculated intranasally with 106.0 TCID50 of Lelystad virus and euthanized 
between 1 and 52 days post inoculation (PI).  Lungs and broncho-alveolar lavage (BAL) 
cells were assessed both for virus replication and apoptosis; BAL fluids were examined 
for interleukin (IL)-1, tumour necrosis factor-alpha (TNF-α) and IL-10.  Double-
labelings were conducted to determine the relation between virus replication and 
apoptosis and for phenotypical identification of the apoptotic cells.  Apoptosis occurred 
in both infected and non-infected cells.  The percentages of infected cells, which were 
apoptotic, ranged between 9 and 39% in lung tissue and between 13 and 30% in BAL 
cells.  The majority of apoptotic cells (> 99%) were non-infected.  Non-infected apoptotic 
cells in lung tissue were predominantly monocytes/macrophages, whereas these in the 
broncho-alveolar spaces were predominantly lymphocytes.  The peak of apoptosis in lung 
tissue at 14 days PI was preceded by a peak in IL-1 and IL-10 production in BAL fluids 
at 9 days PI, suggesting a possible role of these cytokines in the induction of apoptosis in 
non-infected interstitial monocytes/macrophages.  However, the latter hypothesis was not 
confirmed by in vitro studies, since blood monocytes or alveolar macrophages did not 
undergo apoptosis after treatment with recombinant porcine IL-1 or IL-10.  Apoptosis of 
non-infected interstitial monocytes/macrophages seems to be a homeostatic mechanism 
that serves to regulate the number of monocytes/macrophages during the massive influx 
of monocytes into the lungs of PRRSV-infected pigs. 
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Introduction 
 
Apoptosis is a physiological mechanism of cell death important for normal cellular 
turnover that is characterized by internucleosomal DNA degradation and pronounced 
morphological changes (Wyllie et al., 1980).  It also occurs during viral infections and 
there is mounting evidence that it can contribute directly to the viral pathogenesis 
(Collins, 1995). 
Recently, it has been demonstrated that porcine reproductive and respiratory syndrome 
virus (PRRSV) induces apoptosis in lungs (Sirinarumitr et al., 1998; Sur et al., 1998; 
Labarque et al., 2001; Choi & Chae, 2002).  On a morphological basis, the apoptotic cells 
were assumed to be alveolar and pulmonary intravascular macrophages and mononuclear 
cells in the alveolar septa.  Double-labeling experiments indicated that most apoptotic 
cells were non-infected (Sirinarumitr et al., 1998; Sur et al., 1998). 
An infection of lungs with PRRSV has some peculiar cellular features that may be 
attributed to apoptosis.  Firstly, it is characterized by changes in the population of 
broncho-alveolar monocytes/macrophages, consisting of a reduction of the population of 
well-differentiated macrophages and an influx of new monocytes (Labarque et al., 2000).  
Since apoptosis is an important mechanism of cell population control in normal tissue 
homeostasis, it may be involved in the regulation of the number of 
monocytes/macrophages during this massive influx of new monocytes.  Secondly, 
PRRSV causes only minimal lung inflammation (Pol et al., 1991) and neutrophil 
infiltration (Van Reeth et al., 1999; Labarque et al., 2000), which also may be attributed 
to the involvement of apoptotic processes, since apoptotic bodies are phagocytised by 
resident macrophages without provoking an inflammatory response. 
Viral glycoprotein GP5 has been shown to be involved in apoptosis of the PRRSV-
infected cell (Suárez et al., 1996).  However, the mechanism of apoptosis in the non-
infected cell is unknown.  It has been demonstrated that cytokines, such as tumour 
necrosis factor-alpha (TNF-α) (Larrick & Wright, 1990), interferon-alpha (IFN-α) 
(Suzuki et al., 1996), interleukin (IL)-1 (Dunger et al., 1996; Castigli et al., 2000) and IL-
10 (Estaquier & Ameisen, 1997; Wang et al., 2001) can induce apoptosis.  A PRRSV 
infection generally fails to induce substantial amounts of IFN-α (Albina et al., 1998; 
Trebichavsky & Valicek, 1998; Van Reeth et al., 1999).  This argues against a possible 
role of this cytokine in PRRSV-induced apoptosis.  IL-1, however, is produced to high 
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levels in the lungs of PRRSV-infected pigs from 3 till 10 days after inoculation (Van 
Reeth et al., 1999) and a weak TNF-α production was demonstrated at 12 and 13 days 
after inoculation (Van Reeth, 1998).  Further, the induction of IL-10 mRNA in alveolar 
macrophages has been reported in PRRSV-infected pigs (Thanawongnuwech et al., 
2000). 
In the present study, the kinetics of apoptosis both in the lungs and in broncho-alveolar 
lavage (BAL) cells were investigated in gnotobiotic pigs upon infection with a European 
strain of PRRSV, with the purpose to have a better understanding of its potential role in 
the pathogenesis.  Further, it was examined if IL-1, TNF-α and IL-10 may be involved in 
the induction of apoptosis during a PRRSV infection.  
 
Materials and Methods 
 
Virus strain. A fifth passage on pulmonary alveolar macrophages (PAMs) of the 
Lelystad strain of PRRSV (Wensvoort et al., 1991) was used. 
 
Pigs and experimental design. A total of twenty-nine caesarean-derived colostrum-
deprived (CDCD) pigs were used.  They were housed in isolation facilities.  Twenty-two 
pigs were inoculated intranasally at the age of 4 to 5 weeks with 106.0 TCID50 of Lelystad 
virus in 3 ml phosphate-buffered saline (PBS) (1.5 ml in each nostril).  The remaining 
seven pigs were left non-inoculated and served as negative controls.  One to three of the 
PRRSV-inoculated pigs were euthanized at 1 (n=1), 3 (n=2), 5 (n=2), 7 (n=3), 9 (n=3), 14 
(n=3), 20 (n=1), 25 (n=2), 30 (n=1), 35 (n=2), 40 (n=1), and 52 (n=1) days post 
inoculation (PI) by intraperitoneal injection with an overdose of barbiturates 
(Natriumpentobarbital® 20%, IC KELA).  The control pigs were euthanized at 4 (n=2), 5 
(n=1), 6 (n=1), 8 (n=2), and 10 (n=1) weeks of age.   
The right lung was used for broncho-alveolar lavage and samples from the left apical, 
cardiac and diaphragmatic lung lobes were collected for quantification of infected cells 
and detection of apoptosis. 
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Collection of samples. The right lung was lavaged using a previously described method 
(Van Reeth et al., 1999).  The BAL fluid was centrifuged (400xg, 10 minutes, 4°C) to 
separate cells and cell-free lavage fluid.   
Cytocentrifuge preparations of BAL cells were made by centrifuging at 140xg for 5 
minutes.  Preparations were fixed in acetone for 20 minutes at –20°C for quantification of 
infected cells, or in 4% paraformaldehyde for 10 minutes at room temperature for 
detection of apoptosis.  
Cell-free BAL fluids were concentrated 10 times by dialysis against a 20% w/v 
solution of polyethylene glycol (MW 20,000), cleared of residual virus by ultra-
centrifugation at 100,000xg (Van Reeth et al., 1999), aliquoted and stored at –70°C, until 
analysis in cytokine bioassays (IL-1, TNF-α) or cytokine ELISA (IL-10). 
Tissue samples from the left lung lobes were embedded in methylcellulose medium 
and frozen at –70°C.  Cryostat sections (5 to 8 µm) were made and fixed in acetone for 
20 minutes at –20°C for quantification of infected cells, or in 4% paraformaldehyde for 
10 minutes at room temperature for detection of apoptosis. 
 
Virological examinations. PRRSV-infected cells in lung tissue and BAL cells were 
quantified using a streptavidin-biotin immunofluorescence technique (Labarque et al., 
2000). 
 
Detection of apoptosis. Cytocentrifuge preparations of BAL cells and cryostat sections 
of lung tissue were processed for enzyme terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick end labeling (TUNEL) using an In Situ Cell Death Detection Kit, 
Fluorescein (Boehringer Mannheim) according to the manufacturer’s instructions.  
Briefly, cytocentrifuge preparations and cryostat sections, fixed in 4% paraformaldehyde, 
were treated with Triton X-100 (0.1%) at 4°C for two minutes.  Then, the preparations 
were subjected to an enzymatic incorporation of digoxygenin-labeled nucleotide with 
TdT.  Finally, the preparations were washed with PBS, mounted in a glycerin-PBS 
solution (0.9:0.1, v/v) with 2.5% 1,4-diazobicyclo-2.2.2-octane (DABCO) (Janssen 
Chimica) and apoptotic cells were detected and enumerated by fluorescence microscopy 
(Leica DM RBE, Wild Leitz). 
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Double-labeling experiments. Double-labeling experiments were conducted to 
determine the relation between PRRSV replication and apoptosis.  Briefly, cytocentrifuge 
preparations and cryostat sections, fixed in 4% paraformaldehyde, were treated with 
Triton X-100 (0.1%) at 4°C for two minutes.  The preparations were first incubated with 
a pool of monoclonal antibodies (MAb) against the PRRSV nucleocapsid protein 
(dilution 1/100 of WBE1 and WBE4-6) (Drew et al., 1995).  Subsequently, the 
preparations were subjected to an enzymatic incorporation of digoxygenin-labeled 
nucleotide with TdT and then incubated with goat anti-mouse TexasRed (dilution 1/100) 
(Amersham). 
Double-labeling experiments were conducted to determine the percentages of 
apoptotic cells in the subpopulations of 41D3+ cells (monocytes/macrophages), CD2+ 
cells (T lymphocytes and natural killer cells), CD4+ cells (T helper cells), CD8+ cells 
(cytotoxic T cells and natural killer cells), and IgM+ cells (B lymphocytes).  The 
percentages in the subpopulation of monocytes/macrophages were determined using 
MAb 41D3 (Duan et al., 1998).  Briefly, cytocentrifuge preparations of BAL cells and 
cryostat sections of lung tissue, fixed in 4% paraformaldehyde, were treated with Triton 
X-100 (0.1%) at 4°C for two minutes.  The preparations were first incubated with MAb 
41D3 (dilution 1/100).  Subsequently, the preparations were subjected to an enzymatic 
incorporation of digoxygenin-labeled nucleotide with TdT and then incubated with goat 
anti-mouse TexasRed (dilution 1/100) (Amersham).  The percentages of apoptotic cells in 
the subpopulations of CD2+, CD4+, and CD8+ cells were determined using MAbs MSA4 
(Pescovitz et al., 1994a), 74-12-4 (Pescovitz et al., 1994b), and 76-2-11 (Zuckermann et 
al., 1998), respectively.  The percentages in the subpopulation of B lymphocytes were 
determined using MAb 76-7-4 (Denham et al., 1994).  Briefly, cytocentrifuge 
preparations of BAL cells were first incubated with the respective MAbs and 
subsequently with goat anti-mouse TexasRed (dilution 1/100) (Amersham).  Then, the 
preparations were treated with Triton X-100 (0.1%) at 4°C for two minutes.  
Subsequently, the preparations were subjected to an enzymatic incorporation of 
digoxygenin-labeled nucleotide with TdT. 
 
Cytokine bioassays and ELISA. IL-1 was determined in a proliferation assay using 
D10(N4)M cells (Hopkins & Humphreys, 1989, 1990).  One unit of IL-1 activity was 
defined as the reciprocal of the dilution producing 50% proliferation of D10(N4)M cells.  
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To assign bioactivity to IL-1, monoclonal rat anti-mouse IL-1 receptor type 1 antibodies 
(R&D Systems) were included in the assay. 
TNF-α was determined in a cytotoxicity assay in PK(15) subclone 15 cells (Bertoni et 
al., 1993).  One unit of TNF-α activity was defined as the reciprocal of the dilution 
producing 50% cytotoxicity.  Cytotoxic activity was confirmed to be induced by TNF-α 
by neutralization of samples with rabbit anti-human TNF-α (Innogenetics). 
IL-10 was determined in a commercial ELISA for porcine IL-10 (Biosource 
International) according to the manufacturer’s instructions. 
 
In vitro experiments. Porcine peripheral blood mononuclear cells (PBMCs) were 
isolated from heparinized venous blood by Ficoll-PaqueTM Plus (Amersham Biosciences) 
density sedimentation.  PBMCs were seeded in 24-well cell culture plates (Nunc) at a 
concentration of 107 cells per well.  Monocytes were isolated from PBMCs by adherence 
on culture flask for 2 hours at 37°C, 5% CO2.   Non-adherent cells were removed by 
washing and the adherent cells were cultured at 37°C overnight.  After an additional 
washing, the final adherent population was used as the source of blood monocytes.  
Porcine alveolar macrophages were obtained by means of a broncho-alveolar lavage and 
seeded in 24-well cell culture plates (Nunc) at a concentration of 106 cells per well.  One 
day after seeding, blood monocytes and alveolar macrophages were treated with 
recombinant porcine IL-1β (gift from A. Billiau, Leuven, Belgium) at a concentration of 
200 U/ml (75 x103 ng/ml) or with recombinant porcine IL-10 (Biosource International) at 
concentrations of 1, 10, or 100 ng/ml.  Functional activity of both recombinant porcine 
IL-1β and recombinant porcine IL-10 had been proven in a proliferation assay using 
D10(N4)M cells (Hopkins & Humphreys, 1989, 1990) and the mouse mast cell line D36 
(Schlaak et al., 1994), respectively.  Untreated cells were included as controls.  
Morphological analysis of the cells was performed daily with a contrast-phase Olympus 
microscope.  Cells were harvested at 96 hours after treatment.  Cytocentrifuge 
preparations were made, fixed in 4% paraformaldehyde for 10 minutes at room 
temperature and processed for enzyme terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick end labeling (TUNEL) using an In Situ Cell Death Detection Kit, 
Fluorescein (Boehringer Mannheim) according to the manufacturer’s instructions.  
Apoptotic cells were detected and enumerated by fluorescence microscopy (Leica DM 
RBE, Wild Leitz) 
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Results 
 
Quantification of PRRSV-infected and apoptotic cells in lung tissue. The 
quantification of infected and apoptotic cells in lung tissue throughout a PRRSV infection 
is presented in Figure 1.  PRRSV-infected cells were observed from 3 until 25 days PI 
with a maximal number of 61 cells/100 mm2 at 7 days PI.  Viral antigen-positive foci, 
defined as areas in lung tissue containing groups of three or more PRRSV-infected cells 
and cellular debris (Labarque et al., 2000), were observed between 3 and 14 days PI with 
a maximal number of 37 foci/100 mm2 at 9 days PI (not shown). 
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Fig. 1. Quantification of infected and of apoptotic cells in lung tissue (/100 mm2) 
throughout a PRRSV infection. 
 
Apoptotic cells were detected in lung tissue of both non- and PRRSV-inoculated pigs.  
In non-inoculated control pigs, the mean number was 1350 cells/100 mm2.  In PRRSV-
inoculated pigs, mean numbers were similar to those of non-inoculated pigs until 3 days 
PI.  Mean numbers increased from 1800 cells/100 mm2 at 3 days PI to a level of 4800-
4967 cells/100 mm2 at 7-9 days PI and then peaked at 8330 cells/100 mm2 at 14 days PI.  
From 20 days PI, mean numbers returned to those of non-inoculated pigs. 
Double-labelings revealed that within the population of infected cells, apoptosis was 
detected from 5 until 25 days PI with percentages ranging between 9 and 39%.  The 
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majority of apoptotic cells (> 99%) were non-infected.  There was a spatial correlation 
between sites of PRRSV replication and apoptosis.  Non-infected apoptotic cells were 
more abundant in viral antigen-positive foci and they were frequently seen in close 
proximity to infected cells. 
Double-labeling experiments with MAb 41D3 revealed that 76 to 88% of the apoptotic 
cells were of the monocyte/macrophage lineage. 
 
Quantification of PRRSV-infected and apoptotic cells in the broncho-alveolar 
spaces. The quantification of infected and apoptotic BAL cells throughout a PRRSV 
infection is presented in Figure 2.  PRRSV-infected cells were first observed at 1 day PI 
(3 x106 cells), increased to a maximum of 15 x106 cells at 9 days PI, decreased to 3 x106 
cells at 14 days PI and remained at levels of 0.5-1 x106 cells until 40 days PI. 
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Fig. 2. Quantification of infected and of apoptotic broncho-alveolar lavage (BAL) cells (x 
106/lung half) throughout a PRRSV infection. 
 
Apoptotic cells were detected in broncho-alveolar spaces of both non- and PRRSV-
inoculated pigs.  In non-inoculated control pigs, the mean number was 5.3 x106.  In 
PRRSV-inoculated pigs, mean numbers were similar to those of non-inoculated pigs until 
3 days PI.  Mean numbers increased from 6.6 x106 at 3 days PI to a first maximum of 
41.4 x106 at 9 days PI, then remained at the same level until 20 days PI and reached a 
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second maximum of 63.0 x106 at 25 days PI.  From 35 days PI onwards, mean numbers 
of apoptotic cells of PRRSV-inoculated pigs were not different from those of non-
inoculated pigs. 
Double-labelings revealed that within the population of infected BAL cells, apoptosis 
was detected until 25 days PI with percentages ranging between 13 and 30%.  The 
majority of apoptotic cells (> 99%) were non-infected. 
Mean percentages of apoptotic cells remained constant in the total population of BAL 
cells and in the subpopulation of monocytes/macrophages (41D3+ cells).  In the 
subpopulation of T lymphocytes and natural killer cells, mean percentages reached a 
maximum at 7 (CD8+ cells) or 9 days PI (CD2+ and CD4+ cells), dropped thereafter and 
then remained at constant levels until 52 days PI.  In the subpopulation of B lymphocytes 
(IgM+ cells), apoptotic cells peaked at 5 to 9 days PI and dropped thereafter. 
 
IL-1, TNF-α and IL-10 production in BAL fluids. IL-1, TNF-α and IL-10 levels in 
BAL fluids throughout a PRRSV infection are presented in Figure 3.  A low level of IL-1 
(71 U/ml) was found in one out of the seven non-inoculated pigs.  The other control pigs 
had no detectable amounts of IL-1.  All PRRSV-inoculated pigs had detectable IL-1 
production.  The pig euthanized at 1 day PI had an IL-1 titre of 483 U/ml.  Mean IL-1 
titres increased from 240 U/ml at 3 days PI to a maximum of 1265 U/ml at 9 days PI, 
decreased to 263 U/ml at 14 days PI and remained at levels of 121-267 U/ml until 52 
days PI. 
All non-inoculated control pigs were negative for TNF-α.  After PRRSV inoculation, 
TNF-α was only found in the three pigs euthanized at 14 days PI, at low levels (32-109 
U/ml). 
All non-inoculated control pigs were negative for IL-10.  After PRRSV inoculation, IL-
10 was found starting from 5 days PI (19 pg/ml).  Mean IL-10 levels reached a maximum 
of 139 pg/ml at 9 days PI, decreased to 14 pg/ml at 14 days PI and remained at levels of 
8-17 pg/ml until 25 days PI. 
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Fig. 3. Interleukin (IL)-1, tumour necrosis factor-alpha (TNF-α) and IL-10 levels in 
broncho-alveolar lavage (BAL) fluids throughout a PRRSV infection. Dots represent 
individual cytokine levels; lines represent means. 
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Quantification of apoptotic cells after in vitro treatment with recombinant porcine 
IL-1β or IL-10. No morphological features of apoptosis, such as cell shrinkage and 
cytoplasm hypervacuolization, were observed in the monocyte and macrophage cultures 
throughout the experiment.  Four days after treatment with recombinant porcine IL-1β or 
IL-10, the relative number of apoptotic blood monocytes and alveolar macrophages did 
not differ from that of untreated cells.  Only 2.0% of the untreated blood monocytes and 
6.5% of the untreated alveolar macrophages showed apoptosis.  After treatment with 
recombinant porcine IL-1β, percentages of apoptotic blood monocytes and alveolar 
macrophages were 2.4 and 5.3%, respectively.  Similar results were obtained after 
treatment with the different concentrations of recombinant porcine IL-10.  Between 2.5 
and 4.0% of blood monocytes and between 5.1 and 6.9% of alveolar macrophages were 
apoptotic. 
 
Discussion 
 
The present study showed a clear relation between the peak of virus replication and the 
onset of apoptosis in the lungs of PRRSV-infected pigs.  Apoptosis occurred both in 
virus-infected and in non-infected cells.  Most apoptotic cells were non-infected, which is 
in agreement with previous studies (Sirinarumitr et al., 1998; Sur et al., 1998; Choi & 
Chae, 2002). 
The pattern of apoptosis in the non-infected cells was different in lung tissue 
compared to broncho-alveolar spaces.  In lung tissue, apoptosis peaked at 14 days PI and 
occurred predominantly in monocytes/macrophages.  Earlier studies showed that a 
PRRSV infection induces a two- to fivefold increase of the number of broncho-alveolar 
monocytes/macrophages (Labarque et al., 2000).  Since apoptosis is a homeostatic 
process that serves primarily to eliminate redundant cells during normal development and 
to eradicate defective cells (Metzstein et al., 1998), apoptosis of interstitial 
monocytes/macrophages throughout a PRRSV infection may be a mechanism of cell 
population control.  However, the process of apoptosis is apparently not sufficient to 
control completely the massive influx of new monocytes since abundant 
monocytes/macrophages cross the interstitium towards the broncho-alveolar spaces 
(Labarque et al., 2000). 
The mechanism of apoptosis in non-infected interstitial monocytes/macrophages is not 
known.  It has been suggested that TNF-α may be responsible for the induction of 
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apoptosis in these cells (Choi & Chae, 2002).  However, in the present study, only a very 
weak TNF-α production was detected at 14 days PI.  Our in vivo data suggest that IL-1 
and IL-10 are better candidates to be involved in the induction of apoptosis in non-
infected interstitial monocytes/macrophages.  IL-1 and IL-10 levels peaked at 9 days PI 
and coincided with a significant increase in apoptotic cell numbers.  Though, both 
cytokines probably do not play a role in the induction of apoptosis in non-infected 
interstitial monocytes/macrophages, since we failed to induce apoptosis in blood 
monocytes or alveolar macrophages in vitro with recombinant porcine IL-1β or IL-10.  
Using similar in vitro experiments, both cytokines were shown to induce apoptosis in 
human cells.  IL-1β was shown to induce apoptosis in a glioblastoma-derived human cell 
line when concentrations between 1 and 200 U/ml were used (Castigli et al., 2000).  
Similarly, human monocytes/macrophages underwent apoptosis following treatment with 
10 ng/ml of IL-10 (Wang et al., 2001).  Thus, the exact mechanism by which PRRSV 
triggers apoptosis in non-infected interstitial monocytes/macrophages is still under 
debate.  In addition to cytokines, macrophages may produce a lot of other apoptogenic 
mediators, such as nitric oxide and reactive oxygen species, and any or all of these 
mediators may contribute to the induction of apoptosis in non-infected 
monocytes/macrophages.  Besides these apoptogenic mediators, viral glycoprotein GP5, 
incorporated in cellular debris, may also be responsible for the induction of apoptosis in 
non-infected cells.  This glycoprotein has clearly been shown to be involved in the 
induction of apoptosis (Suárez et al., 1996).  Perhaps, induction of apoptosis can also be 
alternatively accomplished by attachment of whole virus particles to the cell without 
penetration and ensuing viral infection.  Further, the phagocytic clearance of cellular 
debris in viral antigen-positive foci by monocytes/macrophages may also be responsible 
for the apoptosis of non-infected cells.  It has been demonstrated that phagocytosis 
triggers macrophage release of Fas ligand and induces apoptosis in bystander leukocytes 
(Brown & Savill, 1999).  Since monocytes/macrophages themselves express Fas, cross-
linking of Fas with soluble Fas ligand may induce apoptosis in non-infected bystander 
monocytes/macrophages.  Both GP5 and phagocytosis may explain why the highest 
number of apoptotic cells was found in the proximity of viral antigen-positive foci. 
In the broncho-alveolar spaces, two peaks of apoptosis were detected.  The first peak 
at 9 days PI involved mainly lymphocytes.  T helper cells  (CD2+CD4+CD8-), cytotoxic T 
cells and natural killer cells (CD2+CD4-CD8+), as well as B cells (IgM+) underwent 
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apoptosis.  The percentage of apoptotic cells in T lymphocytes was the highest at the 
peak of virus replication in BAL cells.  This suggests that the PRRSV infection induces 
apoptosis in broncho-alveolar T lymphocytes and natural killer cells.  This is not 
surprising since T lymphocytes, activated during the antiviral immune response, are 
predisposed to undergo apoptosis (Razvi & Welsh, 1995).  The second peak of apoptosis 
at 25 days PI can be explained by the fact that the total BAL cell numbers were the 
highest at that time point, as demonstrated in a previous study (Labarque et al., 2000). 
Apoptosis was detected in virus-infected macrophages during the persistent stage of 
the PRRSV infection.  Previous studies have demonstrated that the appearance of a 
PRRSV-specific immunity causes a significant decrease in the number of viral antigen-
positive cells starting at 9 days PI.  Nevertheless, a low number of single viral antigen-
positive cells persists in the lungs for several weeks (Labarque et al., 2000).  Why these 
single viral antigen-positive cells are able to persist despite the presence of immunity is 
not known, but may be in part attributable to the apoptotic process in infected cells.  It 
has been suggested that apoptosis of virus-infected cells may represent a very efficient 
mechanism for viruses to escape from humoral immunity.  Progeny virus which is present 
in apoptotic bodies can be taken up by neighbouring macrophages while protected from 
antibodies.  This type of immune-evasion has already been described for human 
immunodeficiency virus type 1 (Spetz et al., 1999), herpes simplex virus type 2 (Asano et 
al., 1999) and Epstein-Barr virus (Holmgren et al., 1999). 
Based on the results of the present study, apoptosis may play a significant role in the 
pathogenesis of a PRRSV infection in the lungs of pigs.  Taken together, apoptosis seems 
to have a homeostatic effect on the number of monocytes/macrophages during the 
massive influx of new monocytes in the lungs of PRRSV-infected pigs and may explain 
why a low number of single viral antigen-positive cells persists in the lungs for several 
weeks despite the presence of immunity. 
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Summary 
 
This study examined whether an infection with porcine reproductive and respiratory 
syndrome virus (PRRSV) potentiates respiratory signs upon exposure to 
lipopolysaccharide (LPS).  Five-week-old conventional pigs were inoculated 
intratracheally with the Lelystad strain of PRRSV and received 5 days later one or two 
intratracheal LPS administrations.  The necessary controls were included.  After LPS 
administration, pigs were intensively monitored for clinical signs.  Additionally, some 
pigs were euthanized after a second LPS administration for broncho-alveolar cell analysis 
and virological examinations of the lungs.  Broncho-alveolar lavage (BAL) cells were 
counted and differentiated.  Lung suspensions and BAL fluids were titrated for PRRSV.  
Exposure of pigs to PRRSV only resulted in a fever for time periods ranging from 1 to 5 
days and slight respiratory signs.  Exposure of pigs to LPS only resulted in general signs, 
characterized by fever and depression, but respiratory signs were slight or absent.  
PRRSV-LPS exposed pigs, on the other hand, developed severe respiratory signs upon 
LPS exposure, characterized by tachypnoea, abdominal breathing and dyspnoea.  Besides 
respiratory signs, these pigs also showed enhanced general signs, such as fever and 
depression.  Lung neutrophil infiltration was similar in non-infected and PRRSV-infected 
pigs upon LPS exposure.  PRRSV quantities were similar in lungs and BAL fluids of pigs 
infected with PRRSV only and PRRSV-LPS exposed pigs.  These data show a clear 
synergy between PRRSV and LPS in the induction of respiratory signs in conventional 
pigs.  The synergy was observed in 87% of the pigs.  Thus, it can be considered as 
reproducible and may be used to test the efficacy of preventive and therapeutic measures. 
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Introduction 
 
Porcine reproductive and respiratory syndrome virus (PRRSV), an arterivirus, causes 
infections in pigs worldwide.  The virus replicates highly in the respiratory tract and 
shows a distinct tropism for broncho-alveolar macrophages (Duan et al., 1997).  
However, a single PRRSV infection, particularly under experimental circumstances and 
with European isolates, fails to induce overt respiratory disease (Done & Paton, 1995).  
Also under field circumstances, most pigs become infected with PRRSV at growing age 
without respiratory disease.  Still, the frequency and severity of respiratory disease have 
increased since the enzootic occurrence of PRRSV (Done & Paton, 1995).  This has 
stimulated research into the combined effects of PRRSV and other infectious agents.  
Consequently, experimentel dual infections have been performed with PRRSV followed 
by various bacteria such as Haemophilus parasuis, Pasteurella multocida, Salmonella 
Choleraesuis, Streptococcus suis, Actinobacillus pleuropneumoniae, and Bordetella 
bronchiseptica (Galina et al., 1994; Cooper et al., 1995; Pol et al., 1997; Brockmeier et 
al., 2000).  We ourselves have performed dual infections with PRRSV followed by 
enzootic viruses, notably porcine respiratory coronavirus (PRCV) or swine influenza 
virus (SIV) (Van Reeth et al., 1996).  The clinical effects of these combinations were 
extremely severe in some cases, but almost completely subclinical in other.  Most 
important, none of the dual infections mentioned provides a reliable model to study 
pathogenetic features or to test control measures.  We hypothesized therefore that the 
clinical outcomes of dual inoculations with two infectious agents are influenced by 
factors that are very difficult to control, such as the stage of replication and the viral or 
bacterial load. 
Lipopolysaccharides (LPS) or endotoxins, a major constituent of the cell wall of 
Gram-negative bacteria, are released in high concentrations in the lungs upon infection 
with Gram-negative bacteria (Pugin et al., 1992; Lamp et al., 1996; Kadurugamuwa & 
Beveridge, 1997) and these endotoxins are present in varying concentrations in dust in 
swine buildings (Rylander, 1994; Zejda et al., 1994; Zhiping et al., 1996).  The release of 
LPS by Gram-negative bacteria, such as Actinobacillus pleuropneumoniae and Bordetella 
bronchiseptica may explain the more severe disease in the experimental dual infections 
with PRRSV and these bacteria (Pol et al., 1997; Brockmeier et al., 2000).  Van Reeth et 
al. (2000) recently demonstrated that dual inoculations with PRCV followed by LPS 
seriously aggravate respiratory signs in gnotobiotic pigs, while the respective single 
98  Chapter 4 
________________________________________________________________________________________ 
inoculations were subclinical.  Therefore, we wanted to examine if exposure of PRRSV-
infected pigs to LPS similarly enhances respiratory signs.  PRRSV may lend itself 
excellently as a predisposing agent for synergy with LPS, because all pigs become 
infected at ages varying from 4 weeks to fattening age (Albina et al., 1994; Houben et al., 
1995).  Also, PRRSV persists in the lungs for 40 (Labarque et al., 2000) to 49 
(Mengeling et al., 1995) days after inoculation.  We have examined the clinical course of 
inoculations with PRRSV followed by LPS, and the effect of the timing and frequency of 
LPS administrations.  Additionally, some preliminary investigations of cellular and 
virological aspects in the lungs were performed. 
 
Materials and Methods 
 
Virus and LPS. A fifth passage on pulmonary alveolar macrophages (PAMs) of the 
Lelystad strain of PRRSV (Wensvoort et al., 1991) was used in this study.  The 
inoculation dose was 106.0 TCID50/pig. 
Escherichia coli LPS (O111:B4) was obtained from Difco Laboratories and used at a 
dose of 20 µg/kg body weight.  This dose was based on data from previous experiments 
in gnotobiotic pigs, and selected to cause no respiratory signs (Van Reeth et al., 2000). 
 
Pigs and experimental design. Forty-six conventional pigs, originating from twelve 
PRRSV-negative sows, were used.  Pigs were weaned at 4 weeks of age and placed in 
isolation.  They were allowed to acclimatize during 7 days before initiation of the 
experiments.  PRRSV inoculations and LPS administrations occurred intratracheally as 
described by Van Reeth et al. (2000).  Briefly, the pigs were held in vertical position with 
their neck extended.  A needle was inserted through the skin cranial to the sternum and 
the inoculum was injected.  The intratracheal administration was chosen to ensure that all 
pigs received exactly the same dose in the lungs.  Three experiments were performed. 
In a first experiment, fifteen pigs were inoculated with PRRSV and received one LPS 
administration 5 days later.  Seven pigs were inoculated with PRRSV only.  Eight pigs, 
not previously inoculated with PRRSV, received one LPS administration.  Clinical 
monitoring was performed daily during 5 consecutive days after PRRSV inoculation and 
every 2 hours during the first 12 hours after LPS administration. 
In a second experiment, eight pigs were inoculated with PRRSV and, 5 days later, they 
received two LPS administrations with a 3-hour interval.  Four pigs, not previously 
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inoculated with PRRSV, received two LPS administrations with a 3-hour interval.  
Clinical monitoring was performed daily during 5 consecutive days after PRRSV 
inoculation and at 1, 3, 5, 7, and 9 hours after the second LPS administration. 
In a third experiment, eleven out of the fifteen PRRSV-LPS exposed pigs, described in 
the first experiment, received a second LPS administration, 24 hours after the first one.  
These pigs were divided in two subgroups.  One subgroup of six pigs was again 
monitored for clinical signs every 2 hours until 12 hours after the second LPS 
administration.  One subgroup of five pigs was euthanized between 5 and 7 hours after 
the second LPS administration for study of the broncho-alveolar lavage (BAL) cell 
population and for virological and bacteriological examinations of the lungs.  From the 
seven PRRSV control pigs, described in the first experiment, four pigs were again 
monitored for clinical signs every two hours for 12 hours at day 6 after PRRSV 
inoculation.  The remaining three pigs were euthanized at time points corresponding to 
those of the PRRSV-LPS exposed pigs and served as controls for the broncho-alveolar 
cell and virological examinations.  All eight LPS-exposed pigs, described in the first 
experiment, received a second LPS administration, 24 hours after the first one.  Four pigs 
were again monitored for clinical signs every 2 hours until 12 hours after the second LPS 
administration and four pigs were euthanized between 5 and 7 hours after the second LPS 
administration for broncho-alveolar cell and virological examinations.  Four non-
inoculated pigs were euthanized for the same purpose. 
 
Clinical monitoring. Pigs were monitored for general signs, notably fever and 
depression, and for respiratory signs, notably tachypnoea, abdominal breathing and 
dyspnoea.  Scores were given for these five clinical parameters.  Body temperatures of 
≤39.9°C were scored as 0, temperatures between ≥40.0°C and ≤40.9°C were scored as 1 
and temperatures of ≥41.0°C were scored as 2.  Respiration rates of ≤45 were scored as 0, 
rates between ≥46 and ≤59 were scored as 1 and rates of ≥60 were scored as 2.  
Depression, abdominal breathing and dyspnoea were each scored as 0 (absent) or 1 
(present).  Scores were added up and a mean of the cumulative general and respiratory 
scores per group was calculated. 
 
Broncho-alveolar cell examinations. At necropsy, the lungs were removed.  The right 
lung was used for broncho-alveolar cell examination after broncho-alveolar lavage using 
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the method described by Van Reeth et al. (1998).  The BAL fluid was centrifuged 
(400xg, 10 minutes, 4°C) to separate the cells and the cell-free lavage fluid.  Aliquots of 
the cell-free lavage fluid were stored at –70°C until virus titration on PAMs.  BAL cells 
were counted in a Türk chamber and cytocentrifuge preparations were stained with 
DiffQuik (Baxter) to determine the percentage of mononuclear cells and neutrophils. 
 
Virological and bacteriological examinations. The left lung was used for virological 
and bacteriological examinations.  Twenty percent suspensions of lung lobes were made 
in phosphate-buffered saline, clarified by centrifugation and the supernatant was used for 
PRRSV titration.  Virus titration of lung suspensions and of cell-free BAL fluids was 
performed on PAMs, as described by Labarque et al. (2000). 
For bacteriology, samples of lung tissue were plated on bovine blood agar and cultured 
aerobically.  A nurse colony of coagulase-positive Staphylococcus species was streaked 
diagonally on each plate.  Plates were inspected for bacterial growth after 48 and 72 
hours. 
 
Statistical analysis. Non-parametric tests were used, because of lack of normality in the 
data.  Standard two-sample Mann-Whitney tests were used to compare general and 
respiratory clinical scores between groups.  P<0.05 was taken as the level of statistical 
significance.  Statistical analyses were performed using SPSS 6.1. 
 
Results 
 
Clinical signs after PRRSV only. Twenty-six of the total of thirty PRRSV-infected pigs 
developed fever for time periods ranging from 1 to 5 days.  Respiratory signs were 
absent, except for two pigs, which showed tachypnoea and abdominal breathing. 
In experiment 1, six of the seven PRRSV control pigs showed fever until the end of 
the monitoring period.  Respiratory signs were slight in one pig and absent in the other 
pigs.  The mean respiratory score was 1.0 (Table 1). 
In experiment 3, all four PRRSV control pigs showed fever until the end of the 
monitoring period.  Respiratory signs, characterized by increased respiration rates, were 
observed in one of the four pigs.  The mean respiratory score was 2.5 (Table 1). 
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Table 1. Mean general and respiratory scores after the last LPS administration in PRRSV-
LPS exposed pigs and their controls. 
Exp. Exposure No. of Mean ± S.D. of the cumulative … scores 
  pigs general1 respiratory2 
1 PRRSV-5d-LPS 15 10.0 ± 3.4A 11.8 ± 8.0A 
 PRRSV 7 6.0 ± 2.9B 1.0 ± 2.6B 
 LPS 8 4.0 ± 1.5B 0.6 ± 1.8B 
2 PRRSV-5d-LPS-3h-LPS 8 8.8 ± 3.7A 15.5 ± 6.0A 
 LPS-3h-LPS 4 4.3 ± 1.9B 7.0 ± 5.5B 
3 PRRSV-5d-LPS-24h-LPS 6 9.8 ± 3.1A 11.0 ± 4.2A 
 PRRSV 4 8.5 ± 0.6A 2.5 ± 5.0AB 
 LPS-24h-LPS 4 0.5 ± 0.6B 0.0 ± 0.0B 
1: body temperature (0: ≤39.9°C; 1: ≥40.0°C-≤40.9°C; 2: ≥41.0°C) and depression (0: absent; 1: present) 
2: respiration rate/minute (0: ≤45; 1: ≥46-≤59; 2: ≥60), abdominal breathing (0: absent; 1: present) and 
dyspnoea (0: absent; 1: present) 
A,B: Within each experiment, values with different superscripts in the same column are significantly 
different by standard two-sample Mann-Whitney test (P<0.05) 
 
Clinical signs after one LPS administration. In non-infected pigs, a single LPS 
administration induced transient general signs (Figure 1).  Respiratory signs were slight 
or absent and the mean respiratory score was only 0.6 (Table 1).  In PRRSV-infected 
pigs, however, LPS induced severe clinical signs with fever in all pigs and respiratory 
signs in 87% of the pigs (Figure 1).  Respiratory signs were characterized by tachypnoea 
(peak 154 breaths per minute), abdominal breathing and dyspnoea and lasted until the end 
of the monitoring period.  Two out of fifteen pigs did not show respiratory signs after 
LPS administration.  Mean general and respiratory scores were significantly higher in 
PRRSV-LPS exposed pigs than in singly LPS-exposed pigs (Table 1). 
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mean general score: body temperature (0:≤39.9°C; 1:≥40.0°C-≤40.9°C; 2:≥41.0°C) and depression 
(0: absent; 1: present) 
mean respiratory score: respiration rate (0:≤45; 1:≥46-≤59; 2: ≥60), abdominal breathing (0: 
absent; 1: present) and dyspnoea (0: absent; 1: present) 
 
Fig. 1. Evolution of clinical signs after one LPS administration in PRRSV-infected and 
non-infected pigs. 
 
Clinical signs after two LPS administrations with a 3-hour interval. In non-infected 
pigs, which received two LPS administrations with a 3-hour interval, both general and 
respiratory signs were observed (Figure 2).  Clinical signs were significantly higher in 
PRRSV-infected pigs, not only with regard to the number of affected pigs but also with 
regard to the clinical scores.  All pigs reacted severely.  The mean clinical scores after the 
second LPS administration are presented in Table 1. 
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for legend: see Fig. 1. 
 
Fig. 2. Evolution of clinical signs after two LPS administrations with a 3-hour interval in 
PRRSV-infected and non-infected pigs. 
 
Clinical signs after two LPS administrations with a 24-hour interval. Non-infected 
pigs had recovered at the time of the second LPS administration, 24 hours after the first 
one.  This second LPS administration again induced general signs within 2 hours, but no 
respiratory signs (Figure 3).  PRRSV-infected pigs had not yet recovered 24 hours after 
the first LPS administration (Figure 3).  The second LPS administration, however, 
increased the number of pigs with general and respiratory signs and mean clinical scores 
(Figure 3).  Here again, mean general and respiratory scores were significantly higher in 
PRRSV-LPS exposed pigs than in singly LPS-exposed pigs. 
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Fig. 3. Evolution of clinical signs after two LPS administrations with a 24-hour interval 
in PRRSV-infected and non-infected pigs. 
 
Lung inflammatory findings. Total BAL cell numbers and differentials are shown in 
Table 2.  BAL cell numbers and differentials in PRRSV-LPS exposed pigs were 
essentially similar to those of pigs, exposed to PRRSV or LPS only.  However, there was 
great individual variation within all three groups. 
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Table 2. Broncho-alveolar lavage (BAL) cell study of PRRSV-LPS exposed pigs and 
their controls at 5-7 hours after a second LPS administration. 
Exposure No.  BAL cells 
 of Total (x 106) Differentiation (%) 
 pigs mean (range) monocytes/macrophages 
mean (range) 
neutrophils 
mean (range) 
PRRSV-LPS 5 1874 (600-3360) 35 (20-46) 60 (46-76) 
PRRSV only 3 1087 (500-1500) 67 (54-83) 24 (8-36) 
LPS only 4 1698 (700-2180) 37 (28-39) 59 (48-67) 
none 4 510 (460-560) 93 (88-96) 0.5 (0-1) 
 
Mean PRRSV titres in lungs and BAL fluids are shown in Table 3.  Virus titres were 
similar in lungs and BAL fluids of singly PRRSV-inoculated pigs and PRRSV-LPS 
exposed pigs.  The lungs and BAL fluids of LPS controls and non-inoculated controls 
were negative for PRRSV. 
Bacterial culture of lung tissue yielded negative results for all pigs. 
 
Table 3. Virological study of lungs and broncho-alveolar lavage (BAL) fluids of PRRSV-
LPS exposed pigs and their controls at 6 days after PRRSV inoculation. 
Exposure No. of Mean PRRSV titres (range) in … 
 pigs lung tissue (log10 
TCID50/g) 
BAL fluids (log10 TCID50/ml) 
PRRSV-LPS 5 7.1 (6.3–7.9) 6.5 (5.8–7.8) 
PRRSV only 3 6.5 (5.8-7.2) 6.0 (4.8-6.6) 
LPS only 4 negative negative 
none 4 negative negative 
 
Discussion 
 
It has become generally accepted that PRRSV plays an important role in respiratory 
disease problems in the field, particularly in multi-factorial respiratory disease.  However, 
it has been most difficult to reproduce respiratory signs in experimental infections studies 
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with PRRSV and a second infectious agent.  The present PRRSV-LPS combination 
induces clear respiratory signs in 87% of the pigs.  Unlike in our previous studies with 
PRRSV-SIV and PRRSV-PRCV combinations (Van Reeth et al., 1996), mean clinical 
scores were higher than those of control pigs in each experiment.  Only two out of fifteen 
PRRSV-infected pigs did not develop respiratory signs upon LPS exposure.  It is 
important to mention, however, that individual variation in disease severity is 
unavoidable with respiratory pathogens.  Such an individual variation has even been 
reported in experimental infection studies with primary respiratory pathogens such as 
Actinobacillus pleuropneumoniae (Baarsch et al., 2000) or swine influenza virus (Van 
Reeth et al., 1998). 
We used two LPS administrations with the purpose to extend the duration of clinical 
signs.  The clinical effect of a second LPS administration was dependent on the time 
interval between the two LPS administrations.  In non-infected pigs, a second LPS 
administration at a 24-hour interval caused milder clinical signs than the first one.  On the 
other hand, a second LPS administration within a 3-hour interval seriously aggravated 
and prolonged clinical signs.  These observations suggest that two LPS administrations 
within a short time interval lead to an accumulation of LPS in the lungs.  Indeed, it has 
been demonstrated that the clinico-pathological manifestations of LPS are strictly dose-
dependent.  For example, if sufficient amounts of LPS are given to animals and man, 
cytokine induction, lung inflammation and decreased lung function are observed.  
Slightly smaller LPS doses, on the other hand, will cause only a mild lung inflammation 
(Michel et al., 1997).  In PRRSV-infected pigs, the clinical effect of a second LPS 
administration was difficult to assess since pigs had not yet recovered at the moment of 
the second LPS administration, 3 or 24 hours after the first one.  There is little 
information on the effect of repeated LPS administrations to farm animals in the 
literature.  It appears logical, however, that the mediators or mechanisms responsible for 
the clinical effects of LPS may become exhausted if high LPS doses are administered 
frequently. 
Respiratory signs following PRRSV-LPS exposure could not be explained by the 
degree of virus replication or inflammatory changes in the lungs.  Indeed, virus titres 
were similar in PRRSV-LPS or singly PRRSV-inoculated pigs.  Total BAL cell numbers 
and neutrophil infiltration were similar in PRRSV-LPS or singly LPS-exposed pigs.  
Also, the two PRRSV-LPS exposed pigs, which remained healthy, had similar BAL cell 
profiles as their clinically affected group mates.  This suggests that inflammatory changes 
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in the lungs have little or no effect on the synergy between PRRSV and LPS.  We 
hypothesize, therefore, that functional lung changes, such as bronchial hyper-
responsiveness, are more important in the pathogenesis of PRRSV-LPS induced disease 
than structural changes.  Similar findings were made in a previous experimental infection 
study with PRCV followed by LPS (Van Reeth et al., 2000).  In this study, disease 
development was tightly correlated with lung production of pro-inflammatory cytokines, 
among which tumour necrosis factor-alpha (TNF-α).  Interestingly, TNF-α has been 
shown to cause bronchial hyper-responsiveness in laboratory animal models and humans 
(Kips et al., 1992; Thomas et al., 1995). 
Under field circumstances, most pigs become infected with PRRSV at growing age 
and they are continuously exposed to airborne endotoxins.  Also, during Gram-negative 
infections of the lungs, excessive amounts of endotoxins are released locally.  The present 
PRRSV-LPS infection model, therefore, is relevant for the study of PRRSV-induced 
respiratory problems in the field.  The synergy was observed in 87% of the pigs.  Thus, it 
can be considered as reproducible and may be used to test the efficacy of preventive and 
therapeutic measures. 
 
Acknowledgements 
 
This work was supported by grant 5772A from the Belgian Ministry of Agriculture.  
The authors would like to thank Fernand De Backer, Krista De Winne, Lieve Sys, 
Chantal Vanmaercke and Carla De Winter for excellent technical assistance.  Geoffrey 
Labarque was supported by grant 011D5898 from the Research Council of Ghent 
University. 
 
108  Chapter 4 
________________________________________________________________________________________ 
References 
 
Albina, E., Madec, F., Cariolet, R. & Torrison, J. (1994). Immune response and 
persistence of the porcine reproductive and respiratory syndrome virus in infected pigs 
and farm units. Veterinary Record 134, 567-573. 
Baarsch, M.J., Foss, D.L. & Murtaugh, M.P. (2000). Pathophysiologic correlates of acute 
porcine pleuropneumonia. American Journal of Veterinary Research 61, 684-690. 
Brockmeier, S.L., Palmer, M.V. & Bolin, S.R. (2000). Effects of intranasal inoculation of 
porcine reproductive and respiratory syndrome virus, Bordetella bronchiseptica, or a 
combination of both organisms in pigs. American Journal of Veterinary Research 61, 
892-899. 
Cooper, V.L., Doster, A.R., Hesse, R.A. & Harris, N.B. (1995). Porcine reproductive and 
respiratory syndrome: NEB-1 PRRSV infection did not potentiate bacterial pathogens. 
Journal of Veterinary Diagnostic Investigation 7, 313-320. 
Done, S.H. & Paton, D.J. (1995). Porcine reproductive and respiratory syndrome: clinical 
disease, pathology and immunosuppression. Veterinary Record 136, 32-35. 
Duan, X., Nauwynck, H.J. & Pensaert, M.B. (1997). Effects of origin and state of 
differentiation and activation of monocytes/macrophages on their susceptibility to 
PRRSV. Archives of Virology 142, 2483-2497. 
Galina, L., Pijoan, C., Sitjar, M., Christianson, W.T., Rossow, K. & Collins, J.E. (1994). 
Interaction between Streptococcus suis serotype 2 and porcine reproductive and 
respiratory syndrome virus in specific pathogen-free piglets. Veterinary Record 134, 
60-64. 
Houben, S., Van Reeth, K. & Pensaert, M.B. (1995). Pattern of infection with the porcine 
reproductive and respiratory syndrome virus on swine farms in Belgium. Journal of 
Veterinary Medicine B 42, 209-215. 
Kadurugamuwa, J.L. & Beveridge, T.J. (1997). Natural release of virulence factors in 
membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside 
antibiotics on their release. Journal of Antimicrobial Chemotherapy 40, 615-621. 
Kips, J.C., Tavernier, J. & Pauwels, R.A. (1992). Tumor necrosis factor causes bronchial 
hyperresponsiveness in rats. American Revue of Respiratory Disease 145, 332-336. 
Labarque, G.G., Nauwynck, H.J., Van Reeth, K. & Pensaert, M.B. (2000). Effect of 
cellular changes and onset of humoral immunity on the replication of porcine 
reproductive and respiratory syndrome virus in the lungs of pigs. Journal of General 
Virology 81, 1327-1334. 
Lamp, K.C., Rybak, M.J., McGrath, B.J. & Summers, K.K. (1996). Influence of antibiotic 
and E5 monoclonal immunoglobulin M interactions on endotoxin release from 
Escherichia coli and Pseudomonas aeruginosa. Antimicrobial Agents and 
Chemotherapy 40, 247-252. 
Mengeling, W.L., Lager, K.M. & Vorwald, A.C. (1995). Diagnosis of porcine 
reproductive and respiratory syndrome. Journal of Veterinary Diagnostic Investigation 
7, 3-16. 
Michel, O., Nagy, A., Schroeven, M., Duchateau, J., Nève, J., Fondu, P. & Sergysels, R. 
(1997). Dose-response relationship to inhaled endotoxin in normal subjects. American 
Journal of Respiratory and Critical Care Medicine 156, 1157-1164. 
Pol, J.M.A., van Leengoed, L.A.M.G., Stockhofe, N., Kok, G. & Wensvoort, G. (1997). 
Dual infections of PRRSV / influenza or PRRSV / Actinobacillus pleuropneumoniae 
in the respiratory tract. Veterinary Microbiology 55, 259-264. 
Synergy between PRRSV and LPS  109 
________________________________________________________________________________________ 
 
Pugin, J., Auckenthaler, R., Delaspre, O., van Gessel, E. & Suter, P.M. (1992). Rapid 
diagnosis of Gram negative pneumonia by assay of endotoxin in bronchoalveolar 
lavage fluid. Thorax 47, 547-549. 
Rylander, R. (1994). Endotoxins. In: Rylander, R. & Jacobs, R.R. (Eds.). Organic dusts: 
exposure, effects, and prevention. 1st edition Boca Rotan, Lewis Publishers, 73-78. 
Thomas, P.S., Yates, D.H. & Barnes, P.J. (1995). Tumor necrosis factor-α increases 
airway responsiveness and sputum neutrophilia in normal human subjects. American 
Journal of Respiratory and Critical Care Medicine 152, 76-80. 
Van Reeth, K., Nauwynck, H.J. & Pensaert, M.B. (1996). Dual infections of feeder pigs 
with porcine reproductive and respiratory syndrome virus followed by porcine 
respiratory coronavirus or swine influenza virus: a clinical and virological study. 
Veterinary Microbiology 48, 325-335. 
Van Reeth, K., Nauwynck, H.J. & Pensaert, M.B. (1998). Broncho-alveolar interferon-α, 
tumor necrosis factor-α, interleukin-1 and inflammation during acute influenza in 
pigs: a possible model for humans? Journal of Infectious Diseases 177, 1076-1079. 
Van Reeth, K., Nauwynck, H. & Pensaert, M. (2000). A potential role for tumour 
necrosis factor-α in synergy between porcine respiratory coronavirus and bacterial 
lipopolysaccharide in the induction of respiratory disease in pigs. Journal of Medical 
Microbiology 49, 613-620. 
Wensvoort, G., Terpstra, C., Pol, J.M.A., ter Laak, E.A., Bloemraad, M., de Kluyver, 
E.P., Kragten, C., van Buiten, L., den Besten, A., Wagenaar, F., Broekhuijsen, J.M., 
Moonen, P.L.J.M., Zetstra, T., de Boer, E.A., Tibben, H.J., de Jong, M.F., van ’t Veld, 
P., Groenland, G.J.R., van Gennep, J.A., Voets, M.T., Verheijden, J.H.M. & 
Braamskamp, J. (1991). Mystery swine disease in the Netherlands: the isolation of 
Lelystad virus. Veterinary Quarterly 13, 121-130. 
Zejda, J.E., Barber, E., Dosman, J.A., Olenchock, S.A., McDuffie, H.H., Rhodes, C.  & 
Hurst, T. (1994). Respiratory health status in swine producers relates to endotoxin 
exposure in the presence of low dust levels. Journal of Occupational and 
Environmental Medicine 36, 49-56. 
Zhiping, W., Malmberg, P., Larsson, B.M., Larsson, K., Larsson, L. & Saraf, A. (1996). 
Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. 
American Journal of Respiratory and Critical Care Medicine 154, 1261-1266. 
 
  
 
 
 
 
                         4.2. 
 
REPLICATION OF ATTENUATED PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS STRAINS IN LUNGS AND SENSITIZATION FOR RESPIRATORY 
SIGNS UPON EXPOSURE TO LIPOPOLYSACCHARIDE 
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Summary 
 
Previous studies have shown a clear clinical synergy between the virulent Lelystad 
strain of porcine reproductive and respiratory syndrome virus (PRRSV) and 
lipopolysaccharide (LPS).  The present study examines whether this synergy also exists 
with attenuated PRRSV strains.  Two experiments were performed.  In each experiment, 
five-week-old conventional pigs were inoculated intratracheally with a commercial 
modified live PRRSV vaccine, based on either an attenuated American strain or an 
attenuated European strain.  The inoculation doses of both attenuated virus strains were 
104.5 and 106.0 TCID50 per pig in experiments 1 and 2, respectively.  Pigs inoculated 
intratracheally with 106.0 TCID50 of Lelystad virus (only in experiment 2) and non-
inoculated pigs were included as controls.  At 5 days after virus inoculation, pigs were 
exposed to Escherichia coli LPS (20 µg/kg body weight) by intratracheal route.  Clinical 
signs were recorded every 2 hours from 0 until 12 hours after LPS administration and 
evaluated by means of a scoring system.  Additionally, pigs of the second experiment 
were euthanized at 12 hours after LPS administration for virological examinations of lung 
tissue and broncho-alveolar lavage (BAL) fluids (virus titration and quantification of 
infected cells).  Exposure of non-inoculated pigs to LPS resulted in slight (exp. 2; 
score=1.0) to moderate (exp. 1; score=4.8) respiratory signs.  Lelystad virus-inoculated 
pigs, on the other hand, experienced severe respiratory signs upon LPS exposure (exp. 2; 
score=14.6), characterized by tachypnoea, abdominal breathing and dyspnoea.  
Respiratory signs of vaccine virus-LPS exposed pigs were clearly lower than those of 
Lelystad virus-LPS exposed pigs.  Mean scores of pigs inoculated with the attenuated 
American strain were 6.0 and 8.4 in experiments 1 and 2, respectively.  Mean scores of 
pigs inoculated with the attenuated European strain were 3.0 and 2.6 in experiments 1 and 
2, respectively.  Mean virus titres and numbers of infected cells in lung tissue and BAL 
fluids were similar in both vaccine virus-inoculated groups, but clearly lower than those 
of Lelystad virus-inoculated pigs. 
In summary, the present study shows that there exists a clinical synergy between 
attenuated PRRSV strains and LPS, but the severity is less pronounced than with the 
virulent Lelystad strain. 
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Introduction 
 
It has become generally accepted that porcine reproductive and respiratory syndrome 
virus (PRRSV) plays an important role in respiratory disease problems in the field, 
particularly in multi-factorial respiratory disease (Done & Paton, 1995).  However, it has 
been most difficult to reproduce respiratory signs in experimental infections with PRRSV 
and a second infectious agent.  Recent research conducted in our laboratory has 
demonstrated that an infection with the virulent Lelystad strain of PRRSV predisposes 
pigs for respiratory signs when they are, 5 days later, exposed to lipopolysaccharide 
(LPS) (Labarque et al., 2002).  LPS, a major constituent of the cell wall of Gram-negative 
bacteria, are released in high concentrations in the lungs upon infection and colonization 
with Gram-negative bacteria (Pugin et al., 1992; Lamp et al., 1996; Kadurugamuwa & 
Beveridge, 1997) and are present in varying concentrations in dust in swine buildings 
(Rylander, 1994; Zejda et al., 1994; Zhiping et al., 1996).  Clinical signs upon PRRSV-
LPS exposure consisted of fever, depression, tachypnoea, abdominal breathing and 
dyspnoea whereas control pigs which had been exposed to PRRSV or LPS only, 
experienced a transient fever with mild or no respiratory signs.  The synergy was 
observed in 87% of the pigs. 
Similar to wild-type strains, attenuated PRRSV strains are able to replicate in the lungs 
of pigs (Thacker et al., 2000).  While safety tests with vaccine viruses have yielded 
satisfactory results under experimental circumstances, it is not excluded that, as with the 
field virus, replication in the lungs may be predisposing for the appearance of multi-
factorial respiratory disease problems under field circumstances.  Therefore, safety tests 
with the vaccine virus alone may not be sufficient and the PRRSV-LPS combination may 
be required.  The purpose of the present study was to examine whether there exists a 
clinical synergy between attenuated PRRSV strains and LPS.  Two commercial modified 
live PRRSV vaccines, one based on an American virus strain and one based on a 
European virus strain, were used. 
 
 
 
 
 
Materials and Methods 
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Vaccines, virus and LPS. Two commercial modified live PRRSV vaccines were used.  
One PRRSV vaccine was based on an American virus strain (designated attAm) and the 
other was based on a European virus strain (designated attEur). 
A fifth passage on pulmonary alveolar macrophages (PAMs) of the Lelystad strain of 
PRRSV (Wensvoort et al., 1991) was used as virulent virus. 
Escherichia coli LPS (O111:B4) was obtained from Difco Laboratories and used at a 
dose of 20 µg/kg body weight.  This dose was based on data from previous studies, and 
selected to cause mild or no respiratory signs (Van Reeth et al., 2000; Labarque et al., 
2002). 
 
Pigs and experimental design. Thirty-five conventional pigs, originating from seven 
PRRSV-seronegative sows, were used at 5 weeks of age.  Virus inoculations and LPS 
administrations occurred intratracheally.  The intratracheal administration was chosen to 
ensure that all pigs received exactly the same dose in the lungs.  Two experiments were 
performed. 
In a first experiment, ten pigs were inoculated with 104.5 TCID50 of the attenuated 
American (n=5) or the attenuated European strain (n=5) and were exposed to LPS 5 days 
later.  Five pigs, not previously inoculated with vaccine virus, received one LPS 
administration and were included as LPS control pigs.  Clinical monitoring was 
performed every 2 hours from 0 until 12 hours after LPS administration. 
In a second experiment, ten pigs were inoculated with a higher titre, namely 106.0 
TCID50 of the attenuated American (n=5) or the attenuated European strain (n=5) and 
were exposed to LPS 5 days later.  Five pigs, inoculated with 106.0 TCID50 of the virulent 
Lelystad strain and exposed to LPS 5 days later, were included as virulent virus-LPS 
control pigs.  Five pigs, not previously inoculated with vaccine or virulent virus, received 
one LPS administration and were included as LPS control pigs.  Clinical monitoring was 
performed every 2 hours from 0 until 12 hours after LPS administration and at 12 hours 
after LPS, all pigs were euthanized for virological examinations.  At necropsy, blood and 
lungs were collected.  The right lung was lavaged using the method described by Van 
Reeth et al. (1998).  The broncho-alveolar lavage (BAL) fluid was centrifuged (400xg, 10 
minutes, 4°C) to separate the cells and the cell-free lavage fluid.  Fractions of the cell-
free lavage fluid were stored at –70°C until virus titration.  Cell pellets were resuspended 
in phosphate-buffered saline (PBS) and cytocentrifuge preparations were made by 
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centrifuging at 140xg for 5 minutes.  Samples from the left lung lobes were collected for 
virological examinations (virus titration and quantification of PRRSV-infected cells). 
 
Clinical monitoring. Pigs were monitored for general signs, notably fever and 
depression, and for respiratory signs, notably tachypnoea, abdominal breathing and 
dyspnoea.  Scores were given for these five clinical parameters according to a previously 
described system (Labarque et al., 2002).  Briefly, body temperatures of ≤39.9°C were 
scored as 0, temperatures between ≥40.0°C and ≤40.9°C as 1 and temperatures of 
≥41.0°C as 2.  Depression was scored as 0 (absent) or 1 (present).  Respiration rates of 
≤45 were scored as 0, rates between ≥46 and ≤59 as 1 and rates of ≥60 as 2.  Abdominal 
breathing and dyspnoea were each scored as 0 (absent) or 1 (present).  Scores were added 
up and a mean of the cumulative general and respiratory scores per group was calculated. 
 
Virological examinations. Twenty percent suspensions of lung tissue were made in PBS 
and clarified by centrifugation.  Virus titrations of supernatants of the lung suspensions, 
of cell-free BAL fluids and of serum samples were performed on three-day cultivated 
MARC-145 cells for both attenuated strains (Bøtner et al., 1999; Stadejek et al., 1999) 
and on one-day cultivated PAMs (Labarque et al., 2000) for the Lelystad strain. 
For the detection of PRRSV-infected cells in BAL cells and lung tissue, a streptavidin-
biotin immunofluorescence technique was used.  In lung tissue, a distinction was made 
between single infected cells and viral antigen-positive foci.  Viral antigen-positive foci 
are defined as areas in lung tissue consisting of groups of three or more PRRSV-infected 
cells and cellular debris (Labarque et al., 2000).  Three lung sections per pig were 
examined.  Cytocentrifuge preparations and lung sections were incubated first with 
monoclonal antibodies (MAbs) against PRRSV, subsequently with biotinylated sheep 
anti-mouse antibodies (Amersham) (dilution 1/200), and then with streptavidin-
fluorescein isothiocyanate (FITC) (Amersham) (dilution 1/200).  The MAbs used were 
WBE1 and WBE4-6 (Drew et al., 1995) for the Lelystad virus-inoculated pigs, MR40 
(Nelson et al., 1996) for the pigs inoculated with the attenuated American strain and 
P3/27 (Wieczorek-Krohmer et al., 1996) for the pigs inoculated with the attenuated 
European strain. 
Statistical analysis. Standard two-sample Mann-Whitney tests were used to compare 
clinical scores between groups.  Differences in numbers of infected cells were analyzed 
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using an analysis of variance (ANOVA).  Least significant differences (LSD) were used 
to compare the groups.  P<0.05 was taken as the level of statistical significance.  
Statistical analyses were performed using SPSS 6.1. 
 
Results 
 
Clinical signs after LPS administration. The means of the cumulative general and 
respiratory scores after LPS administration are shown in Table 1. 
 
Table 1. Cumulative clinical scores after LPS administration in vaccine virus-inoculated 
pigs and their controls. 
Experiment Exposure No. of Mean ± S.D. of the cumulative ... scores 
  pigs general1 respiratory2 
1 attAm-5d-LPS 5 9.6 ± 2.2B 6.0 ± 3.2A 
 attEur-5d-LPS 5 4.2 ± 1.5C 3.0 ± 2.7A 
 LPS only 5 1.6 ± 0.5A 4.8 ± 2.8A 
2 attAm-5d-LPS 5 8.8 ± 2.2A 8.4 ± 6.5BC 
 attEur-5d-LPS 5 8.4 ± 1.9A 2.6 ± 2.4AC 
 Lelystad virus-5d-LPS 5 15.0 ± 1.0B 14.6 ± 7.6B 
 LPS only 5 6.4 ± 3.8A 1.0 ± 1.0A 
1: body temperature (0: ≤39.9°C; 1: ≥40.0°C-≤40.9°C; 2: ≥41.0°C) and depression (0: absent; 1: present) 
2: respiration rate/minute (0: ≤45; 1: ≥46-≤59; 2: ≥60), abdominal breathing (0: absent; 1: present) and 
dyspnoea (0: absent; 1: present) 
A,B,C: Within each experiment, values with different superscripts in the same column are significantly 
different by standard two-sample Mann-Whitney test (P<0.05) 
 
Experiment 1 - All LPS control pigs developed general and respiratory signs upon LPS 
exposure.  General signs were characterized by a mild fever, which lasted until 2 to 4 
hours after the LPS administration.  Respiratory signs, characterized by tachypnoea and 
dyspnoea, lasted until 6 hours after the LPS administration.  The mean respiratory score 
was 4.8.  In pigs inoculated with the attenuated American strain, LPS induced more 
pronounced clinical signs.  All pigs were affected.  General signs were characterized by 
fever and depression and lasted until the end of the monitoring period.  Respiratory signs, 
characterized by tachypnoea and abdominal breathing, lasted until 8 to 10 hours after the 
LPS administration.  The mean respiratory score was 6.0.  In pigs inoculated with the 
attenuated European strain, LPS induced general signs in all pigs and respiratory signs in 
Synergy with attenuated PRRSV strains  117 
________________________________________________________________________________________ 
 
four out of the five pigs.  General signs were characterized by fever and depression and 
lasted until 6 to 10 hours after the LPS administration.  Respiratory signs, characterized 
by tachypnoea, lasted until 10 hours after the LPS administration.  The mean respiratory 
score was 3.0.  The differences in respiratory scores between LPS control pigs and 
vaccine virus-LPS exposed pigs were not significant (P>0.05). 
 
Experiment 2 - In LPS control pigs, LPS induced mainly general signs.  Respiratory signs, 
characterized by a mild tachypnoea, were observed in three out of the five pigs.  The 
mean respiratory score was 1.0.  In Lelystad virus-inoculated pigs, on the other hand, LPS 
induced severe general and respiratory signs in all pigs.  General signs included fever and 
severe depression.  Respiratory signs were characterized by tachypnoea, abdominal 
breathing and dyspnoea and lasted until the end of the monitoring period.  Mean general 
and respiratory scores were significantly higher than those of LPS control pigs (P<0.05).  
In pigs inoculated with the attenuated American strain, LPS induced clear general and 
respiratory signs in all pigs.  The mean respiratory score (8.4) was significantly higher 
than that of LPS control pigs (P<0.05) and not significantly different from that of Lelystad 
virus-LPS exposed pigs (P>0.05).  In pigs inoculated with the attenuated European strain, 
LPS induced mainly general signs and only slight respiratory signs.  The mean respiratory 
score (2.6) was not significantly different from that of the LPS control pigs (P>0.05) and 
significantly lower than that of the Lelystad virus-LPS exposed pigs (P<0.05). 
 
Virus titration of BAL fluids, lung tissue and sera. The results of virus titrations of 
BAL fluids, lung tissue and sera are shown in Table 2.  All LPS control pigs were 
negative for PRRSV.  PRRSV was isolated from BAL fluids and lung tissue of all 
Lelystad virus-LPS exposed pigs.  Mean PRRSV titres were 106.7 TCID50 per ml BAL 
fluid and 107.1 TCID50 per gram lung tissue.  Vaccine virus was detected in BAL fluids of 
four out of the five attAm-LPS exposed pigs and of three out of the five attEur-LPS 
exposed pigs.  Mean virus titres of the positive animals were 104.7 and 103.6 TCID50 per ml 
BAL fluid for the attAm- and attEur-inoculated pigs, respectively.  In lung tissue, three 
out of the five attAm-LPS exposed pigs and one out of the five attEur-LPS exposed pigs 
tested positive for virus.  Mean virus titres of the positive animals were 104.0 and 102.1 
TCID50 per gram lung tissue for the attAm- and attEur-inoculated pigs, respectively.  
Viraemia was detected in all Lelystad virus- and vaccine virus-inoculated pigs. 
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Table 2. Virus titres in broncho-alveolar lavage (BAL) fluids, lung tissue and serum 
samples of vaccine virus-LPS exposed pigs and their controls. 
Exposure Mean virus titres of virus-positive pigs in …  
 BAL fluids 
(log10 TCID50/ml) 
lung tissue 
(log10 TCID50/gram) 
serum samples 
(log10 TCID50/ml) 
attAm-5d-LPS 4.7 (4/5)1 4.0 (3/5) 3.0 (5/5) 
attEur-5d-LPS 3.6 (3/5) 2.1 (1/5) 2.5 (5/5) 
Lelystad virus-5d-LPS 6.7 (5/5) 7.1 (5/5) 3.8 (5/5) 
LPS only negative negative negative 
1: number of virus-positive pigs/total number of pigs 
 
Quantification of PRRSV-infected cells in BAL cells and lung tissue. The results of 
immunofluorescence stainings of BAL cells and lung tissue are shown in Table 3.  
 
Table 3. Quantification of infected broncho-alveolar lavage (BAL) cells and of single 
infected cells and/or viral antigen-positive foci in lung tissue of vaccine virus-LPS 
exposed pigs and their controls. 
Exposure Mean numbers of … 
 infected 
BAL cells 
single infected cells 
in lung tissue 
viral antigen-positive 
foci in lung tissue1 
 (x106) (/100 mm2) (/100 mm2) 
attAm-5d-LPS 4.1 (5/5)2 8.0 (5/5) none 
attEur-5d-LPS 3.1 (5/5) 4.7 (5/5) none 
Lelystad virus-5d-LPS 45.5 (5/5) 71.2 (5/5) 41.2 (5/5) 
LPS only none none none 
1: areas in lung tissue, consisting of groups of three or more PRRSV-infected cells and cellular debris 
2: number of positive pigs/total number of pigs 
 
PRRSV-infected cells were not observed in BAL cells and lung tissue of LPS control 
pigs.  PRRSV-infected cells were observed in BAL cells and lung tissue of all vaccine 
virus-LPS exposed pigs.  Mean numbers of infected BAL cells were 4.1 x106 in attAm-
inoculated pigs and 3.1 x106 in attEur-inoculated pigs.  Mean numbers of single PRRSV-
infected cells in lung tissue were 8.0 per 100 mm2 tissue in attAm-inoculated pigs and 4.7 
per 100 mm2 in attEur-inoculated pigs.  Mean numbers of infected BAL cells (45.5 x106) 
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and of infected cells in lung tissue (71.2 per 100 mm2) of Lelystad virus-LPS exposed 
pigs were significantly higher than those of vaccine virus-LPS exposed pigs (P<0.05).  
Viral antigen-positive foci were only observed in lung tissue of Lelystad virus-LPS 
exposed pigs. 
 
Discussion 
 
The present study demonstrates that a clinical synergy may occur between attenuated 
PRRSV strains and LPS.  Though, the clinical scores of vaccine virus-LPS exposed pigs 
were clearly lower than those of virulent Lelystad virus-LPS exposed pigs.  The 
differences between virulent virus- and vaccine virus-inoculated pigs may be attributed to 
the pattern and degree of virus replication in the lungs.  Mean virus titres and mean 
numbers of infected cells were indeed clearly higher in virulent virus-inoculated pigs 
compared to vaccine virus-inoculated ones.  Furthermore, viral antigen-positive foci, 
consisting of groups of three or more PRRSV-infected cells and cellular debris, were only 
observed in the lung tissue of virulent virus-inoculated pigs. 
There were small differences in clinical scores between both vaccine virus-LPS 
exposed groups.  The attenuated American strain induced more respiratory signs than the 
attenuated European strain upon LPS exposure.  However, due to large variation in 
between pigs, these differences were not at all statistically significant.  All vaccine virus-
inoculated pigs were exposed to LPS 5 days after inoculation with the vaccine viruses.  
This interval was chosen based on the clear clinical synergy between virulent Lelystad 
virus and LPS (Labarque et al., 2002).  It is uncertain, however, whether this 5-day 
interval is optimal for comparing vaccine viruses.  It is possible that vaccine viruses differ 
from each other and from virulent viruses in their interactions with and in their degree of 
virus replication in the respiratory tract.  To make correct conclusions about differences in 
clinical synergy between vaccine viruses, the kinetics of replication of vaccine viruses in 
the lungs and the time point of maximal virus replication should be determined.  An LPS 
administration at that time point will allow definite conclusions.  Preliminary virological 
investigations demonstrated a higher degree of virus replication in the lungs of vaccine 
virus-inoculated pigs at 10 and 12 days after virus inoculation (data not shown).  
Therefore, it may be hypothesized that the interval of 5 days between vaccine virus 
inoculation and LPS administration in the present study may have been too short to 
sensitize the lungs.  This short interval may also explain why virus could not be isolated 
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from the lungs of some pigs and why the numbers of infected cells in lungs were very 
low, especially when compared with the data of the Lelystad virus-inoculated pigs. 
The PRRSV-LPS combination may be considered as a tool for the safety testing of 
modified live PRRSV vaccines.  However, to that purpose, our PRRSV-LPS model 
should be ameliorated.  Further research, especially with regard to the kinetics of vaccine 
virus replication in the lungs, has to show whether other time intervals between PRRSV 
vaccine virus inoculation and LPS administration may allow to use this combination for 
safety testing of vaccines. 
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Summary 
 
In this study, the efficacy of two modified live porcine reproductive and respiratory 
syndrome virus (PRRSV) vaccines was assessed in experimental pigs.  The virological 
protection in the lungs of vaccinated pigs upon challenge was studied.  Also, challenged 
pigs were exposed to lipopolysaccharide (LPS) to evaluate clinical protection.  Two 
experiments were performed.  In each experiment, six-week-old conventional pigs were 
immunized intramuscularly with commercial vaccines based on either an attenuated 
American or an attenuated European virus strain.  Non-immunized and infection-immune 
pigs were included as controls.  Six weeks after immunization, pigs were challenged 
either intratracheally (experiment A) or intranasally (experiment B) with 106.0 TCID50 of 
Lelystad virus, and 3 and 6 days later intratracheally exposed to Escherichia coli LPS (20 
µg/kg body weight).  After LPS administration, pigs were monitored for clinical signs.  
At 4 and 7 days after challenge, some pigs were euthanized to determine virus quantities 
in broncho-alveolar lavage (BAL) fluids and in lung tissue.  Challenge virus was 
recovered from three out of eight infection-immune pigs that had been inoculated with 
the virulent Lelystad strain and challenged 6 weeks later with the same virulent strain.  
The two vaccines reduced virus isolation rates and mean virus titres to different degrees.  
Fifteen out of sixteen pigs immunized with the attenuated American strain were positive 
for challenge virus and their mean virus titres were similar to those of the non-immunized 
challenge controls.  Eleven out of sixteen pigs immunized with the attenuated European 
strain were positive for challenge virus and their mean virus titres were 2.0-2.5 log10 
lower than those of the non-immunized challenge controls.  The clinical outcome upon 
LPS exposure in vaccinated pigs varied between experiments.  In experiment A, pigs 
immunized with the attenuated American strain experienced severe general and 
respiratory signs upon LPS exposure, whereas pigs immunized with the attenuated 
European strain only showed mild general signs.  In experiment B, on the other hand, 
pigs of both immunized groups developed clear general and respiratory signs. 
In conclusion, the present study shows that the virological protection in the lungs 
of infection-immune and vaccinated pigs upon challenge was incomplete, but was 
more pronounced in the homologous situation.  The variable clinical outcome upon 
LPS exposure in vaccinated pigs within and between both experiments hampers the 
use of the combined PRRSV-LPS exposure for testing of the clinical efficacy of 
modified live PRRSV vaccines. 
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Introduction 
 
Porcine reproductive and respiratory syndrome virus (PRRSV), an arterivirus, is 
widespread in the pig population.  The virus replicates highly in the respiratory tract 
(Duan et al., 1997) and is claimed to play an important role in multi-factorial respiratory 
disease problems in the field (Done & Paton, 1995).  The high economical impact of 
these problems has stimulated the development of PRRSV vaccines.  Currently, several 
modified live PRRSV vaccines are commercially available for use in feeder pigs.  Since 
experimental infections with European PRRSV isolates fail to induce overt respiratory 
signs (Plana-Durán et al., 1992; Ramos et al., 1992; Van Reeth et al., 1996), the efficacy 
of PRRSV vaccines is usually assessed by determining the degree of reduction in 
viraemia after challenge with a virulent virus (Christopher-Hennings et al., 1997; Nielsen 
et al., 1997; van Woensel et al., 1998; Labarque et al., 2000b).  At present, no 
information is available about the degree of reduction of challenge virus replication in the 
respiratory tract.  This information would be useful since replication of wild-type virus in 
the lungs of vaccinated pigs might predispose for multi-factorial respiratory disease 
problems. 
Since a PRRSV infection does not induce respiratory signs, the clinical efficacy of 
modified live PRRSV vaccines cannot be assessed.  This problem may be solved by a 
combined challenge of PRRSV-vaccinated pigs with PRRSV and lipopolysaccharide 
(LPS).  We have previously demonstrated that infection with the virulent Lelystad strain 
of PRRSV sensitizes the lungs of pigs for respiratory signs when they are, 5 days later, 
exposed to LPS (Labarque et al., 2002).  Clinical signs consisted of fever, depression, 
tachypnoea, abdominal breathing and dyspnoea, whereas control pigs, which had been 
exposed to PRRSV or LPS only, experienced a transient fever and mild or no respiratory 
signs.  The clinical synergy was observed in 87% of the pigs. 
It was the purpose of the present study to assess the virological protection in the lungs 
of vaccinated pigs and to examine if the challenge virus replication in the lungs of these 
pigs may still predispose for respiratory signs upon LPS exposure.  To this purpose, two 
commercial modified live PRRSV vaccines, one based on an American virus strain and 
one based on a European virus strain, were tested using a challenge with the European 
Lelystad strain followed by LPS. 
 
Materials and Methods 
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Vaccines, virus and LPS. Two commercial modified live PRRSV vaccines and one 
virulent PRRSV strain were used for active immunization of the pigs.  One PRRSV 
vaccine was based on an American virus strain and the other was based on a European 
virus strain.  A fifth passage on pulmonary alveolar macrophages (PAMs) of the Lelystad 
strain of PRRSV (Wensvoort et al., 1991) was used as virulent virus.  The inoculation 
dose of each vaccine or virulent strain was 106.0 TCID50 per pig. 
The virulent Lelystad strain of PRRSV was used as challenge virus.  The inoculation 
dose was 106.0 TCID50 per pig. 
Escherichia coli LPS (O111:B4) (Difco Laboratories; Sigma) was used at a dose of 20 
µg/kg body weight.  This dose was based on data from previous studies and selected to 
cause mild or no respiratory signs (Van Reeth et al., 2000; Labarque et al., 2002). 
 
Pigs and experimental design. A total of fifty-eight pigs, originating from eight 
PRRSV-seronegative sows, were used.  Two experiments were performed.  In each 
experiment, pigs were divided into four groups and housed in isolation units.  The 
designation of the groups is shown in Table 1. 
At 6 weeks of age, pigs of groups A1 and B1, and of groups A2 and B2, were 
immunized intramuscularly with one of the two commercial PRRSV vaccines.  Pigs of 
groups A3 and B3 were immunized intramuscularly with the virulent Lelystad strain and 
served as infection-immune pigs.  Pigs of groups A4 and B4 were not immunized and 
served as challenge control pigs.  Six weeks after immunization, all pigs were challenged 
with Lelystad virus.  The challenge was performed intratracheally in experiment A and 
intranasally in experiment B.  At 3 and 6 days after challenge, pigs of all groups were 
exposed intratracheally to LPS.  After LPS administration, clinical signs were recorded 
and at 24 hours after LPS administration (i.e. at 4 and 7 days after challenge), some of the 
pigs were euthanized for virological examinations of broncho-alveolar lavage (BAL) 
fluids, lung tissue and serum samples. 
 
 
 
 
Table 1. Experimental design. 
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Exp. Group Strain used for Route of No. of pigs examined for ... 
  intramuscular challenge with clinical signs*  virus titres 
  immunization Lelystad virus 3 days PC 6 days PC 4 days PC 7 days PC 
A A1 attAm intratracheal 6 3 3 3 
 A2 attEur intratracheal 6 3 3 3 
 A3 virEur intratracheal 4 2 2 2 
 A4 none intratracheal 10 5 5 5 
B B1 attAm intranasal 10 5 5 5 
 B2 attEur intranasal 10 5 5 5 
 B3 virEur  intranasal 4 2 2 2 
 B4 none intranasal 8 4 4 4 
attAm: attenuated American strain; attEur: attenuated European strain; virEur: virulent European strain 
(Lelystad virus) 
PC: post challenge 
*: clinical signs upon intratracheal LPS exposure (20 µg/kg body weight) 
 
Serological examinations. Blood samples of all pigs were collected at the time of 
immunization and immediately before challenge.  Serum samples were examined for 
PRRSV-specific antibody titres using immunoperoxidase monolayer assays (IPMAs).  
MARC-145 cells infected with a European PRRSV isolate (94V360) were used.  Serum 
samples of the pigs immunized with the attenuated American strain were also tested in an 
IPMA with MARC-145 cells infected with an American PRRSV isolate (US5). 
 
Clinical monitoring. Clinical signs were recorded every two hours from 0 until 12 hours 
after LPS administration.  Pigs were monitored for general signs, notably fever and 
depression, and for respiratory signs, notably tachypnoea, abdominal breathing and 
dyspnoea.  Scores were given for these five clinical parameters according to a previously 
described system (Labarque et al., 2002).  Briefly, body temperatures of ≤39.9°C were 
scored as 0, temperatures between ≥40.0°C and ≤40.9°C as 1 and temperatures of 
≥41.0°C as 2.  Depression was scored as 0 (absent) or 1 (present).  Respiration rates of 
≤45 were scored as 0, rates between ≥46 and ≤59 as 1 and rates of ≥60 as 2.  Abdominal 
breathing and dyspnoea were each scored as 0 (absent) or 1 (present).  Scores were added 
up and a mean of the cumulative general and respiratory scores per group was calculated. 
 
Virological examinations of BAL fluids, lung tissue and serum samples. Blood 
samples of all pigs were collected at challenge.  At necropsy, blood and lungs were 
collected.  The right lung was lavaged using a previously described method (Van Reeth et 
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al., 1998).  The BAL fluid was centrifuged (400xg, 10 minutes, 4°C) to separate the cells 
and the cell-free lavage fluid.  Twenty percent suspensions of the left lung lobes were 
made in phosphate-buffered saline, clarified by centrifugation and the supernatant was 
used for PRRSV titration. 
Virus titrations of the cell-free BAL fluids, of the supernatants of the lung suspensions, 
and of the serum samples were performed on PAMs, according to standard procedures 
(Labarque et al., 2000a). 
 
Statistical analysis. Standard two-sample Mann-Whitney tests were used to compare 
clinical scores between groups.  Differences in PRRSV titres were analyzed using an 
analysis of variance (ANOVA).  Least significant differences (LSD) were used to 
compare the groups.  Samples which tested negative for virus were given a numeric value 
of 0.2 log10 TCID50 per ml BAL fluid or serum (detection limit 0.3 log10) and 0.9 log10 
TCID50 per gram lung tissue (detection limit 1.0 log10).  P<0.05 was taken as the level of 
statistical significance.  Statistical analyses were performed using SPSS 6.1. 
 
Results 
 
Serological response to immunization. All pigs were negative for PRRSV-specific 
antibodies at the start of the experiments.  At challenge, all immunized pigs had 
developed antibodies against PRRSV.  Pigs immunized with the attenuated American 
strain had mean antibody titres of 25.3 (group A1) and 25.7 (group B1), when a European 
serotype virus was used in the IPMA.  When an American serotype virus was used in the 
IPMA, these pigs had mean PRRSV-specific antibody titres of 28.3 (group A1) and 210.5 
(group B1).  When a European serotype virus was used in the IPMA, pigs immunized 
with the attenuated European strain had mean antibody titres of 211.7 (group A2) and 211.1 
(group B2), and pigs immunized with the virulent Lelystad strain had mean antibody 
titres of 211.8 (group A3) and 213.3 (group B3).  Non-immunized pigs (groups A4 and B4) 
were seronegative at challenge. 
 
Clinical signs upon LPS exposure. Table 2 shows the mean cumulative clinical scores 
upon LPS administrations at 3 and 6 days after intratracheal (experiment A) or intranasal 
(experiment B) Lelystad virus challenge. 
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Table 2. Cumulative clinical scores after LPS administrations at 3 and 6 days after 
Lelystad virus challenge. 
Exp. Group Strain used for Route of Time interval No. Mean ± S.D. of the cumulative 
  intramuscular challenge with challenge -  of … scores after LPS 
  immunization Lelystad virus LPS exposure pigs general1 respiratory2 
A A1 attAm intratracheal 3 days 6 14.5 ± 1.6A 10.8 ± 4.3A 
 A2 attEur intratracheal  6 3.7 ± 0.8B 0.0 ± 0.0B 
 A3 virEur intratracheal  4 5.0 ± 1.4B 0.0 ± 0.0B 
 A4 none intratracheal  10 12.9 ± 4.0A 9.8 ± 7.2A 
 A1 attAm intratracheal 6 days 3 13.3 ± 2.3A 12.3 ± 7.1A 
 A2 attEur intratracheal  3 0.7 ± 0.6B 0.3 ± 0.6B 
 A3 virEur intratracheal  2 1.0 ± 1.4B 0.0 ± 0.0B 
 A4 none intratracheal  5 9.8 ± 3.6A 9.5 ± 3.1A 
B B1 attAm intranasal 3 days 10 7.3 ± 1.6B 4.0 ± 3.3B 
 B2 attEur intranasal  10 6.6 ± 1.5B 8.7 ± 4.9A 
 B3 virEur intranasal  4 4.3 ± 4.9B 3.3 ± 3.3B 
 B4 none intranasal  8 12.1 ± 2.6A 14.8 ± 7.4A 
 B1 attAm intranasal 6 days 5 6.0 ± 2.1B 7.6 ± 5.0A 
 B2 attEur intranasal  5 5.0 ± 4.5BC 6.6 ± 4.5A 
 B3 virEur intranasal  2 0.5 ± 0.7BC 1.0 ± 0.0A 
 B4 none intranasal  4 10.0 ± 
0.8AC 
13.0 ± 9.1A 
attAm: attenuated American strain; attEur: attenuated European strain; virEur: virulent European strain 
(Lelystad virus) 
1: body temperature (0: ≤39.9°C; 1: ≥40.0°C-≤40.9°C; 2: ≥41.0°C) and depression (0: absent; 1: present) 
2: respiration rate/minute (0: ≤45; 1: ≥46-≤59; 2: ≥60), abdominal breathing (0: absent; 1: present) and 
dyspnoea (0: absent; 1: present) 
A,B,C: Within each experiment, values with different superscripts in the same column are significantly 
different by standard two-sample Mann-Whitney test (P<0.05) 
 
Experiment A - In non-immunized challenged pigs (group A4), LPS induced severe 
general and respiratory signs in all pigs.  General signs were characterized by fever (peak 
42.0°C) and severe depression.  Pigs were dull and made no effort to rise when disturbed.  
Respiratory signs were characterized by tachypnoea (peak 109 breaths per minute), 
labored abdominal breathing and occasionally dyspnoea.  Mean respiratory scores at 3 
and 6 days after challenge were 9.8 and 9.5, respectively.  Infection-immune pigs (group 
A3), on the other hand, experienced only transient general signs upon challenge and LPS 
exposure.  Respiratory signs were absent.  Clinical scores of these pigs were significantly 
lower than those of non-immunized challenged pigs (P<0.05).  In pigs immunized with 
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the attenuated American strain (group A1), LPS administrations at 3 and 6 days after 
challenge induced severe general and respiratory signs in all pigs.  General signs were 
characterized by fever (peak 42.1°C) and depression.  Respiratory signs were 
characterized by tachypnoea (peak 123 breaths per minute), abdominal breathing and 
occasionally dyspnoea.  Mean respiratory scores at 3 and 6 days after challenge (10.8 and 
12.3, respectively) were similar to those of non-immunized challenged pigs (P>0.05).  In 
pigs immunized with the attenuated European strain (group A2), LPS induced mainly 
transient general signs.  Respiratory signs were minimal or absent.  Mean respiratory 
scores at 3 and 6 days after challenge (0.0 and 0.3, respectively) were significantly lower 
than those of non-immunized challenged pigs (P<0.05). 
 
Experiment B - In non-immunized challenged pigs (group B4), LPS induced again severe 
general and respiratory signs in all pigs.  General signs were characterized by fever (peak 
41.8°C) and severe depression.  Pigs huddled together while showing signs of chilling, 
listlessness and inappetence.  Respiratory signs were characterized by tachypnoea (peak 
116 breaths per minute), labored abdominal breathing and dyspnoea.  Mean respiratory 
scores at 3 and 6 days after challenge were 14.8 and 13.0, respectively.  Infection-
immune pigs (group B3), on the other hand, experienced very mild general and 
respiratory signs upon challenge and LPS exposure.  Clinical scores of these pigs were 
clearly lower than those of non-immunized challenged pigs.  In pigs immunized with the 
attenuated American strain (group B1), LPS administrations at 3 and 6 days after 
challenge induced moderate to severe clinical signs.  All pigs exhibited fever (peak 
41.4°C) and depression.  Respiratory signs were observed in 80% of the pigs.  There was 
tachypnoea (peak 96 breaths per minute), abdominal breathing and occasionally 
dyspnoea.  The mean respiratory score at 3 days after challenge (4.0) was significantly 
lower than that of non-immunized challenged pigs (P<0.05), whereas the mean 
respiratory score at 6 days after challenge (7.6) did not differ from that of non-immunized 
challenged pigs (P>0.05).  In pigs immunized with the attenuated European strain (group 
B2), LPS induced general and respiratory signs in all pigs.  General signs included fever 
(peak 41.4°C) and depression.  Respiratory signs were characterized by tachypnoea (peak 
120 breaths per minute) and abdominal breathing.  Mean respiratory scores at 3 and 6 
days after challenge (8.7 and 6.6, respectively) did not differ from those of non-
immunized challenged pigs (P>0.05). 
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Virus titration of BAL fluids and lung tissue. The results of virus titrations of BAL 
fluids and lung tissue of the individual pigs of the different groups, euthanized at 4 and 7 
days after intratracheal (experiment A) or intranasal (experiment B) Lelystad virus 
challenge are shown in Figure 1.   Challenge virus was isolated from BAL fluids and lung 
tissue of all non-immunized challenge control pigs (groups A4 and B4) at both times 
examined.  Virus titres in BAL fluids and lung tissue were similar.  When the challenge 
virus was inoculated by intratracheal route (group A4), the highest virus titres were 
reached at 4 days after challenge (106.2 TCID50 per ml BAL fluid and per gram lung 
tissue).  When the challenge virus was inoculated by intranasal route (group B4), the 
highest virus titres were reached at 7 days after challenge (106.2 TCID50 per ml BAL fluid 
and per gram lung tissue). 
Upon intratracheal challenge, two out of two (4 days after challenge) and one out of 
two (7 days after challenge) infection-immune pigs (group A3) were virus-positive.  
Their mean virus titres (102.0 TCID50 per gram lung tissue) were significantly lower than 
those of the non-immunized challenge control pigs (P<0.05).  Upon intranasal challenge, 
all four infection-immune pigs (group B3) were virus-negative. 
The two commercial vaccines reduced the number of virus-positive pigs and the virus 
titres to different degrees.  In experiment A, all six pigs immunized with the attenuated 
American strain (group A1) were virus-positive.  The mean virus titres at 4 days after 
challenge (105.9 and 106.4 TCID50 per ml BAL fluid and per gram lung tissue, 
respectively) did not differ significantly from those of the non-immunized challenge 
control pigs (P>0.05).  The mean virus titres at 7 days after challenge (103.4 and 104.5 
TCID50 per ml BAL fluid and per gram lung tissue, respectively) were significantly lower 
than those of the non-immunized challenge control pigs (P<0.05).  In the group 
immunized with the attenuated European strain (group A2), all six pigs tested positive for 
virus in the BAL fluids.  The three pigs, euthanized at 7 days after challenge, were 
positive for PRRSV in BAL fluids, but not in lung tissue.  The mean virus titres in BAL 
fluids (103.8 and 101.9 TCID50 per ml BAL fluid at 4 and 7 days after challenge, 
respectively) and lung tissue (103.6 and 100.9 TCID50 per gram lung tissue at 4 and 7 days 
after challenge, respectively) were significantly lower than those of the non-immunized 
challenge control pigs (P<0.05). 
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Fig. 1. Virus titres in broncho-alveolar lavage (BAL) fluids (log10 TCID50/ml), lung tissue 
(log10 TCID50/gram) and serum samples (log10 TCID50/ml) at 4 and 7 days after 
intratracheal (experiment A) or intranasal (experiment B) challenge with Lelystad virus. 
Triangles represent individual virus titres in BAL fluids (σ) and lung tissue (∆).  Bullets 
represent individual virus titres in sera (Ο).  Dashes represent group means at each time 
point. 
attAm : attenuated American strain, attEur : attenuated European strain 
In experiment B, nine out of the ten pigs immunized with the attenuated American 
strain (group B1) were virus-positive and the mean virus titres in BAL fluids (104.3 and 
106.8 TCID50 per ml BAL fluid at 4 and 7 days after challenge, respectively) and lung 
tissue (104.9 and 106.3 TCID50 per gram lung tissue at 4 and 7 days after challenge, 
respectively) did not differ from those of the non-immunized challenge control pigs 
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(P>0.05).  In the group immunized with the attenuated European strain (group B2), virus 
was isolated from only three out of the five pigs at 4 days after challenge and from only 
two out of the five pigs at 7 days after challenge.  The mean virus titre in lung tissue at 4 
days after challenge (102.2 TCID50 per gram lung tissue) was significantly lower than that 
of the non-immunized challenge control pigs (P<0.05), while the reduction in virus titre 
was just not significant in the BAL fluids (102.7 TCID50 per ml BAL fluid) (P>0.05).  At 
7 days after challenge, the mean virus titres in BAL fluids and lung tissue (101.6 TCID50 
per ml BAL fluid and 101.5 TCID50 per gram lung tissue) were significantly lower than 
those of the non-immunized challenge control pigs (P<0.05). 
 
Virus titration of serum samples. At the time of challenge, neither vaccine nor virulent 
virus was detected in serum of any of the pigs. 
The results of virus titrations of serum samples of the individual pigs of the different 
groups, euthanized at 4 and 7 days after intratracheal (experiment A) or intranasal 
(experiment B) Lelystad virus challenge are shown in Figure 1.  Challenge virus was 
isolated from the sera of all non-immunized challenge control pigs (groups A4 and B4), 
except for one pig euthanized at 7 days after intranasal challenge.  All infection-immune 
pigs (groups A3 and B3) were virus-negative in their serum.  Fourteen of the total of 
sixteen pigs immunized with the attenuated American strain were virus-positive in their 
serum.  Their mean virus titres were similar to those of the non-immunized challenge 
control pigs (P>0.05), except at 7 days after intratracheal challenge (P<0.05).  In contrast, 
only two of the total of sixteen pigs immunized with the attenuated European strain 
(groups A2 and B2) were virus-positive in their serum. 
 
Discussion 
 
To our knowledge, this is the first study on virological protection of the respiratory 
tract of pigs vaccinated with modified live PRRSV vaccines.  Under the given 
experimental circumstances, vaccination against PRRSV provides only partial virological 
protection of the lungs.  Protection against infection with the European Lelystad strain 
was better after vaccination with a European strain than with an antigenically and 
genetically more distant American strain.  One of the most surprising results was that 
infection-immune pigs, which were immunized with virulent Lelystad virus and were 
challenged with the same virulent Lelystad strain, did not show a complete virological 
134  Chapter 5 
________________________________________________________________________________________ 
protection in the lungs.  Thus, even in this fully homologous situation, PRRSV is still 
able to replicate in the lungs. 
The present experimental study shows that vaccines, whether based on American or 
European virus strains, are not able to afford a complete virological protection in the 
lungs.  Thus, it is not likely that vaccination, even if extensively applied, will be able to 
drastically reduce or eliminate PRRSV circulation in the swine population.  This may be 
particularly true if field strains are genetically and antigenically divergent from the 
vaccine strains.  Such genetic diversity exists between American and European PRRSV 
isolates (Wensvoort et al., 1992; Bautista et al., 1993), but also appears to exist among 
European field isolates.  A recent study has demonstrated that, in Western Europe, 
PRRSV field isolates show so much genetic diversity in their open reading frames 5 and 
7 that three clusters were identified: a Lelystad-like cluster, a purely Danish cluster and a 
highly diverse Italian-like cluster (Forsberg et al., 2002).  These findings may have 
important consequences with regard to vaccine efficacy and the selection of virus strains 
for vaccine purposes.  Thus, a continuous update of vaccine strains may be necessary to 
reach an acceptable level of protection in the field, even within geographical areas of 
limited size.  Possibly, PRRSV vaccines containing different genotypes may be needed in 
the future to compensate for such genetic diversity.  
We compared intranasal and intatracheal challenge methods because we hypothesized 
that the challenge virus replication might be lower after intranasal than after intratracheal 
inoculation.  However, the route of inoculation apparently did not affect the degree of 
challenge virus replication in the lungs.  Our data indicate that replication of the 
challenge virus may be delayed after intranasal inoculation, but certainly not reduced, 
when compared with an intratracheal challenge. 
 Correlations between virus titres in the lungs and those in serum were significant at 
group level, but not in the individual pigs.  Eleven of the total of thirty-two vaccinated 
pigs were negative for challenge virus in their sera, whereas their BAL fluids and/or lung 
tissue were positive.  Duan et al. (1997) obtained similar results in naive pigs inoculated 
with PRRSV.  In their study, five of twelve pigs examined at ≥ 21 days post inoculation 
had PRRSV-negative sera, while they were still virus-positive in the lungs.  All these 
results demonstrate that efficacy tests of modified live PRRSV vaccines should not be 
based on virus titres in blood alone, but should also focus on the degree of virus 
replication in the lungs upon challenge.  Based on the present data, we recommend to 
perform virus titrations on both BAL fluids and lung tissue.  Pigs with high PRRSV titres 
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had positive BAL fluids and lungs, but this was not always the case for pigs with low 
titres (≤ 103.3 TCID50).  Lung samples of six of the total of twenty-four pigs immunized 
with a European strain were negative for challenge virus, whereas BAL fluids were virus-
positive, or vice versa. 
The present experiments were also undertaken to examine if the challenge virus 
replication in the lungs of vaccinated pigs predisposes for respiratory signs upon LPS 
exposure.  Singly LPS-exposed pigs were not included because of the limited number of 
pigs available for these experiments.  Earlier experiments had demonstrated that singly 
LPS-exposed pigs developed transient general signs and no, or only mild respiratory 
signs (Labarque et al., 2002).  Respiratory signs were mild or absent in infection-immune 
pigs.  Non-immunized challenged pigs, on the other hand, suffered from severe 
respiratory signs upon LPS exposure, such as tachypnoea, abdominal breathing and 
dyspnoea.  In contrast, the clinical outcome upon LPS exposure of pigs that had been 
vaccinated and six weeks later challenged with PRRSV was highly variable within and 
between experiments.  Pigs immunized with the attenuated European strain experienced 
no respiratory signs in experiment A, whereas they developed clear respiratory signs in 
experiment B.  Similarly, all pigs immunized with the attenuated American strain 
developed severe respiratory signs upon LPS exposure in experiment A, whereas in 
experiment B, respiratory signs were milder and similar to those of the pigs immunized 
with the attenuated European strain.  Thus, we were unable to reproduce the clinical 
results in two subsequent attempts.  The severity of the clinical signs upon LPS exposure 
was not correlated with the degree of virus replication in the lungs of individual pigs.  
Thus, it remains unclear why clinical synergy occurs reproducibly in PRRSV-infected 
pigs, but not in PRRSV-vaccinated and challenged pigs even though challenge virus 
replication occurs.  
Taken together, the present data show that the virological protection in the lungs of 
infection- and vaccination-immune pigs upon challenge is incomplete, but is more 
pronounced in the homologous situation.  The variable clinical outcome upon LPS 
exposure of vaccinated pigs hampers the use of the combined PRRSV-LPS exposure for 
testing of the clinical efficacy of modified live PRRSV vaccines.  
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General discussion 
 
It was shown in the present studies that two stages can be considered during a porcine 
reproductive and respiratory syndrome virus (PRRSV) infection in the lungs of pigs: an 
acute stage comprising the first two weeks of infection during which high amounts of 
virus are present, and a persistent stage of 3 to 4 weeks characterized by lower levels of 
virus replication.  Virus replication was highest at 7 to 9 days post inoculation (PI) and 
decreased thereafter.  The number of PRRSV-infected cells in lung tissue and in broncho-
alveolar spaces showed a marked decrease after 9 days PI.  Our data suggest that this 
decrease is the result of the appearance of anti-PRRSV antibodies in the lungs and major 
changes in the population of well-differentiated macrophages, the PRRSV target cells 
(Duan et al., 1997b), leading to depletion of susceptible cells.  A low number of PRRSV-
infected cells was able to persist in lungs and broncho-alveolar lavage (BAL) fluids until 
35 to 40 days PI.  This persistence may be explained by the late appearance of immune 
mechanisms capable of eliminating the virus, i.e. virus-neutralizing antibodies and virus-
specific T lymphocytes.  Antibodies generated during the early phase of infection were 
non-neutralizing.  Though non-neutralizing antibodies can mediate the killing of infected 
cells by complement or by cells of the innate immune system, virus-neutralizing 
antibodies are generally thought to be more efficient in virus clearance.  Such virus-
neutralizing antibodies appeared much later and were only detected starting from 25 days 
PI in the present study and also in other studies (Yoon et al., 1995; Albina et al., 1998).  
Further, other researchers reported that PRRSV-specific T lymphocytes were only 
detected starting from 28 days PI (Bautista & Molitor, 1997; López-Fuertes et al., 1999).  
Why the PRRSV-specific immune response is characterized by an unusual delay of some 
arms of the humoral and cellular immune response is not yet known.  Meier et al. (2000) 
suggested that cytokines such as interleukin (IL)-10 may be responsible for the 
suppression of the cellular immune response against PRRSV.  The latter hypothesis is 
supported by our studies, since IL-10 was found in BAL fluids during a prolonged period, 
i.e. from 5 until 25 days PI. 
The virus persistence in individual pigs has important epidemiological consequences.  
PRRSV-infected pigs function as long-term virus excretors transmitting the virus to 
susceptible contact pigs for long periods of time.  Thus, PRRSV persists at herd and 
population level which makes control and/or elimination of PRRSV difficult.  The virus 
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persistence also hampers a proper diagnosis of respiratory disease problems in nursery 
and fattening pigs.  In swine herds with respiratory disease problems, PRRSV is often 
incriminated as the causative agent based on a positive isolation from the lungs.  
However, this diagnosis should be interpreted with caution since PRRSV may not be of 
major significance in causing respiratory disease problems during the persistent stage of 
the infection. 
The present studies revealed important cellular changes in the lungs throughout a 
PRRSV infection, especially in the population of monocytes/macrophages.  The total 
number of broncho-alveolar monocytes/macrophages markedly increased from 5 until 52 
days PI with a maximum at 25 days PI.  Also, the composition of the population of 
monocytes/macrophages showed important shifts throughout the infection.  It was 
demonstrated that susceptible well-differentiated pulmonary macrophages, carrying the 
PRRSV receptor, became destroyed, either by cell lysis due to virus replication or by 
apoptosis, and were replaced by blood monocytes.  With time, these blood monocytes 
differentiated into macrophages as demonstrated by morphological changes and 
expression of the PRRSV receptor.  The rather specific influx of monocytes is indicative 
of a very selective chemotactic signal.  During this massive influx of blood monocytes, 
the total number of monocytes/macrophages in the lungs appears to be partially regulated 
by apoptosis.  This was indicated by the observation that high numbers of interstital 
monocytes/macrophages underwent apoptosis during the time period in which blood 
monocytes entered the broncho-alveolar spaces.  However, the process of apoptosis was 
apparently not sufficient to control the massive influx of blood monocytes since abundant 
monocytes/macrophages crossed the interstitium towards the broncho-alveolar spaces.  
The occurrence of apoptosis in the lungs of PRRSV-infected pigs may also explain why 
only a very mild lung inflammation (Pol et al., 1991) with low percentages of neutrophils 
(Van Reeth et al., 1999) is present during a PRRSV infection.  A general feature of 
apoptotic cell death is that apoptotic bodies are phagocytised by resident macrophages 
without provoking an inflammatory response. 
A single PRRSV infection, particularly under experimental circumstances and with 
European isolates, fails to induce overt respiratory signs (Plana-Durán et al., 1992; 
Ramos et al., 1992; Van Reeth et al., 1996).  Also under field circumstances, most pigs 
become infected with PRRSV without respiratory disease (Houben et al., 1995).  Still, the 
frequency and severity of respiratory disease problems in the field have increased since 
the enzootic occurrence of PRRSV (Done & Paton, 1995).  In herds with respiratory 
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disease problems, PRRSV has been isolated in combination with several bacteria and 
viruses.  These observations have stimulated research into the combined effects of 
PRRSV and other pathogens.  Consequently, experimental dual infections with PRRSV 
followed by various bacteria and viruses have been performed.  Variation in the severity 
of clinical signs and lack of reproducibility were the main problems with these 
experimental dual infections.  Even single experimental infections with respiratory 
viruses show variation in clinical and inflammatory parameters.  A second infection with 
a virus or bacterium may enhance this variation.  Therefore, we have performed 
experiments in which PRRSV-infected pigs were 5 days later exposed to a non-
replicating agent, namely lipopolysaccharide (LPS).  LPS was chosen because of 
epidemiological and pathogenetic reasons.  LPS are present in varying concentrations in 
dust in swine confinement units (Rylander, 1994; Zejda et al., 1994; Zhiping et al., 1996) 
and are released in the lungs upon infection and colonization with Gram-negative bacteria 
(Pugin et al., 1992).  Further, LPS is known to stimulate cells of the 
monocyte/macrophage lineage and our pathogenesis studies have shown important 
cellular changes in this cell population.  The PRRSV-LPS combination induced clear 
respiratory signs in 90% of the pigs and was reproducible within and between 
experiments. 
Respiratory signs as a result of the synergy between PRRSV and LPS could not be 
explained by an enhancement of inflammatory changes in the lungs.  The finding that 
inflammatory cell profiles in the BAL fluids of PRRSV-LPS exposed pigs were merely 
an accumulation of those observed with PRRSV only and LPS only suggests that 
inflammatory changes in the lungs are not responsible for the clinical synergy between 
PRRSV and LPS.  Functional lung changes such as bronchial hyper-responsiveness 
appear to be responsible for the observed respiratory signs.  Van Gucht et al. (2002) 
demonstrated that respiratory signs were clearly associated with levels of pro-
inflammatory cytokines.  Peak tumour necrosis factor-alpha (TNF-α) and IL-1 titres were 
10 to 100 times higher in PRRSV-LPS exposed pigs than in PRRSV and LPS control 
pigs and they correlated with respiratory signs.  Interestingly, both TNF-α and IL-1 have 
been demonstrated to cause bronchial hyper-responsiveness (Kips et al., 1992; Thomas et 
al., 1995), leading to an increased and sustained bronchoconstriction.    Taken together, 
the production of TNF-α and IL-1 in PRRSV-LPS exposed pigs will likely play a role in 
the induction of respiratory signs.  Similar findings were made in a previous experimental 
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study, in which porcine respiratory coronavirus-infected pigs were exposed to LPS (Van 
Reeth et al., 2000).  The mechanisms whereby PRRSV can trigger the lungs for an 
enhanced cytokine production upon LPS exposure remain to be defined.  Cells of the 
monocyte/macrophage lineage are the main target cells for LPS and they are potent 
producers of the pro-inflammatory cytokines TNF-α and IL-1.  Thus, it seems logical that 
the massive influx of new monocytes in the lungs, as shown in our pathogenesis studies, 
may contribute to an enhanced response to LPS. 
The PRRSV-LPS combination seems to be relevant under field circumstances.  All 
pigs become infected with PRRSV at ages varying from 4 weeks to fattening age (Albina 
et al., 1994; Houben et al., 1995; Mateusen et al., 2002) and PRRSV persists in the lungs 
for 35 to 49 days after inoculation (Mengeling et al., 1995; Duan et al., 1997a; Labarque 
et al., 2000a).  Thus, there is a long time period during which the lungs of PRRSV-
infected pigs may become exposed to airborne or locally produced LPS.  Still, the true 
significance of the PRRSV-LPS combination for multi-factorial respiratory disease 
problems in the field remains to be defined.  In our experimental studies, LPS was 
administered to pigs at a dose of 20 µg/kg body weight.  This dose was used because 
previous studies had shown that this dose caused mild or no respiratory signs in naive 
pigs (Van Reeth et al., 2000).  It is difficult to calculate the daily exposure to LPS under 
field circumstances.  Assuming a respiratory volume of 0.3 m3/hour in an environment 
with an endotoxin concentration of 5 µg/m3 air (Zhiping et al., 1996), pigs of the same 
age as in our experimental model would be exposed to a total dose of airborne endotoxins 
of approximately 36 µg per day.  The amount of LPS which is released in the lungs upon 
infection with Gram-negative bacteria in pigs has not been measured until now.  In 
humans, Pugin et al. (1992) demonstrated endotoxin concentrations of 0.375 µg in BAL 
fluids of one lung lobe of patients with a severe Gram-negative bacterial pneumonia.  
Thus, it seems that pigs in the field are exposed to lower doses of LPS than those used 
experimentally.  Moreover, LPS tolerance can be induced by continuous LPS exposure.  
Naive humans exposed acutely to swine confinement buildings display more intense lung 
functional and inflammatory changes than workers exposed chronically to this 
environment (Larsson et al., 1994; Cormier et al., 1997).  Experimental evidence of LPS 
tolerance has already been demonstrated in laboratory animals, which were daily exposed 
to LPS during 15 minutes (Shimada et al., 2000).  In conclusion, the relevance of the 
PRRSV-LPS combination to the field situation needs further investigation.  Nevertheless, 
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the PRRSV-LPS combination has been proven to be reproducible and straightforward 
under experimental circumstances.  It is one of the few combined inoculations in pigs that 
has proven to consistently induce respiratory signs.  Therefore, we believe that this 
combination is appropriate for the study of the pathogenesis of multi-factorial respiratory 
disease problems. 
Multi-factorial respiratory disease problems remain an economically important 
problem in swine production worldwide.  Since PRRSV is an important contributor to 
these problems (Done & Paton, 1995), several modified live PRRSV vaccines have been 
developed and licensed for use in feeder pigs.  Important safety and efficacy concerns 
have been addressed concerning these vaccines. 
A major safety concern relating to modified live vaccines is the dissemination of the 
vaccine virus throughout the body after vaccination.  The presence of vaccine virus in 
blood has been documented by several research groups (Christopher-Hennings et al., 
1996; Bøtner et al., 1997; Stadejek & Pejsak, 1998; Astrup & Riising, 2002), but 
information about the replication of vaccine viruses in target organs of PRRSV, such as 
lymphoid organs and lungs, is scarce.  Our studies demonstrated that vaccine virus strains 
are able to replicate in the lungs for at least 12 days after intratracheal inoculation.  Based 
on these findings, it is possible that vaccine virus replication in the lungs may predispose 
for the appearance of multi-factorial respiratory disease problems under field 
circumstances.  In this regard, it was shown in the present studies that vaccine viruses can 
sensitize the lungs for respiratory signs upon LPS exposure, but the clinical signs were 
less severe and of shorter duration than with the virulent Lelystad strain.   
Efficacy tests for modified live PRRSV vaccines are nowadays based on the degree of 
reduction in viraemia (van Woensel et al., 1998; Labarque et al., 2000b).  Until now, no 
information was available about the degree of virological protection in the lungs, the 
main target organ of the virus.  In order to address this question, pigs were vaccinated 
with a modified live PRRSV vaccine, either based on a European or an American virus 
strain.  The challenge was performed with a European wild-type strain 6 weeks later, and 
pigs were euthanized at 4 and 7 days after challenge for virological examinations of lungs 
and sera.  Challenge virus replication in the lungs still occurred in both vaccinated 
groups, but the virological protection was better in pigs vaccinated with the European 
serotype vaccine compared to pigs vaccinated with the American serotype vaccine.  Thus, 
the antigenic and genetic differences between European and American PRRSV strains 
(Wensvoort et al., 1992; Bautista et al., 1993) clearly affect the degree of cross-protection 
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in the lungs.  However, even infection-immune pigs, which were infected with virulent 
virus, built up antibodies and were challenged six weeks later with the same virulent 
PRRSV strain, did not show a complete virological protection in the lungs.  Although the 
mechanisms that mediate protective immunity against PRRSV are unknown, it is 
reasonable to suggest that the late appearance of both neutralizing antibodies and virus-
specific T lymphocytes following either a PRRSV wild-type infection or vaccination is 
responsible for the incomplete virological protection in the lungs.  The development of 
more effective PRRSV vaccines will require a better understanding of the mechanisms 
that regulate the humoral and cellular immune response against this virus.  Since it has 
been demonstrated that the clearance of PRRSV from the lungs coincides with the 
appearance of both neutralizing antibodies and virus-specific T lymphocytes, stimulation 
of these immune components by vaccination may enhance vaccine efficacy.  In theory, it 
is possible to locate and define the epitopes on viral proteins that elicit neutralizing 
antibodies or that are recognized by T lymphocytes.  Artificial constructs of such 
epitopes, so-called synthetic peptide vaccines, have already been used for vaccination 
against other viral diseases.  Further, it is worth examining whether cytokines such as IL-
10 may hamper the cellular immune response against PRRSV and whether anti-cytokine 
strategies can solve this problem. 
The present virological data may have some practical consequences with regard to 
vaccination under field circumstances.  Our findings demonstrate that if vaccinated pigs 
become infected with wild-type virus, this virus still replicates in the lungs of these pigs.  
Thus, it is likely that this virus will be able to spread substantially among pigs.  However, 
caution should be taken to extrapolate the results of these vaccination-challenge 
experiments to effectiveness of vaccination under field conditions.  In the present 
experiments, pigs were challenged with a very high dose of virulent virus and it is 
unlikely that pigs will encounter such high virus doses under field conditions. 
The incomplete virological protection in the lungs also raises the question whether the 
field virus replication in the lungs of vaccinated pigs may predispose for multi-factorial 
respiratory disease problems under field circumstances.  The LPS administration was 
used to examine that aspect.  Vaccinated and subsequently challenged pigs were exposed 
to LPS 3 and 6 days after challenge.  The clinical outcome upon LPS exposure was 
highly variable within and between two subsequent experiments. 
Although correlations between virological results in lungs and viraemia were 
significant at group level, important differences were found at individual level.  Serum 
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samples of a considerable number of vaccinated pigs were negative for challenge virus, 
whereas their corresponding BAL fluids and/or lung samples were virus-positive.  The 
latter finding was supported by Duan et al. (1997a), who showed that PRRSV-infected 
pigs became virus-negative more rapidly in serum samples than in lung tissue.  Thus, 
viraemia parameters are not an accurate indicator of the virological protection in 
vaccinated pigs and efficacy tests should not be based on virus titres in blood alone, but 
should also focus on the degree of virus replication in the lungs upon challenge. 
In conclusion, the present studies have shown that the safety and efficacy of the 
current modified live PRRSV vaccines are not that satisfactory under experimental 
circumstances.  A better understanding of the mechanisms that regulate the immunity 
against PRRSV will be essential for the development of more effective vaccines.  Based 
on the findings of the present studies, it is recommended that safety and efficacy assays 
for PRRSV vaccine candidates should focus on the main target organ of the virus, the 
lungs.  
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Summary 
 
Respiratory disease causes worldwide important financial losses in swine husbandry.  
This disease has a multi-factorial background and porcine reproductive and respiratory 
syndrome virus (PRRSV) is generally recognized as one of the major infectious agents 
involved in this disease. 
The aims of this thesis were (i) to extend the knowledge on the pathogenesis of a 
PRRSV infection in the lungs, (ii) to investigate the interaction between PRRSV and 
lipopolysaccharide (LPS) and (iii) to assess the efficacy of modified live PRRSV 
vaccines using virological and clinical parameters of protection. 
In chapter 1, a review was given on PRRSV with special attention to the pathogenesis, 
clinical disease and vaccination.  Further, a brief introduction was given about 
lipopolysaccharides or endotoxins and their role in respiratory disease problems. 
In chapter 3, the pathogenesis of a single PRRSV infection in the lungs was studied 
with a European strain.  Special attention was given to cellular changes in lung tissue and 
broncho-alveolar lavage (BAL) cells and these events were correlated with virus 
replication and appearance of neutralizing and non-neutralizing antibodies. 
In part 3.1., a number of pathogenetic events in the lungs of PRRSV-infected 
gnotobiotic pigs were studied in detail with the purpose to relate the degree and pattern of 
virus replication with cellular changes and the onset of PRRSV-specific antibodies.  
Four- to five-week-old gnotobiotic pigs were inoculated intranasally with the Lelystad 
strain of PRRSV and euthanized between 1 and 52 days post inoculation (PI).  The BAL 
cell population was morphologically and phenotypically characterized, together with the 
pattern and degree of virus replication and the appearance of non-neutralizing and 
neutralizing antibodies.  The total number of monocytes/macrophages increased two- to 
fivefold between 9 and 52 days PI with a maximum at 25 days PI.  Flow cytometric 
analysis showed that the population of well-differentiated macrophages that express the 
PRRSV receptor (74-22-15+, 41D3+ cells) was reduced between 9 and 20 days PI and that 
between the same time interval small 74-22-15+, 41D3- cells, presumably blood 
monocytes, and small 74-22-15-, 41D3- cells, presumably lymphocytes, entered the 
alveolar spaces.  Virus replication peaked at 7 to 9 days PI, decreased slowly thereafter 
and was detected until 40 days PI.  PRRSV-specific antibodies were detected in BAL 
fluid starting at 9 days PI, whereas specific neutralizing antibodies were only 
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demonstrated in two pigs euthanized at the end of the study, at 35 and 52 days PI.  The 
decrease of virus replication in the lungs from 9 days PI can be attributed to (i) shortage 
of susceptible well-differentiated macrophages, (ii) lack of susceptibility of the newly 
infiltrated blood monocytes and (iii) appearance of PRRSV-specific antibodies in the 
lungs.  Neutralizing antibodies may contribute to the complete elimination of virus from 
the lungs. 
In part 3.2., the kinetics of apoptosis in the lungs were investigated with a European 
strain of PRRSV and it was examined if cytokines are involved in the induction of 
apoptosis.  Also, an attempt was made to clarify a possible role of apoptosis in the 
pathogenesis.  Lungs and BAL cells of the pigs, that had been used in part 3.1., were 
assessed both for virus replication and apoptosis, whereas BAL fluids were examined for 
interleukin (IL)-1, tumour necrosis factor-alpha (TNF-α) and IL-10 production.  Double-
labeling experiments were conducted to determine the relation between virus replication 
and apoptosis and for phenotypical identification of the apoptotic cells.  Apoptosis was 
detected in both infected and non-infected cells.  The mean percentages of infected cells, 
which were apoptotic, ranged between 9 and 39% in lung tissue and between 13 and 30% 
in BAL cells.  The majority of apoptotic cells (>99%) were, however, non-infected.  The 
pattern of apoptosis in the non-infected cells was different in the broncho-alveolar spaces 
compared to lung tissue.  In the broncho-alveolar spaces, two peaks of apoptosis were 
detected.  The first peak at 9 days PI involved mainly lymphocytes.  The second peak of 
apoptosis at 25 days PI can be explained by the fact that the total BAL cell numbers were 
the highest at that time point.  In lung tissue, apoptosis peaked at 14 days PI and occurred 
predominantly in monocytes/macrophages.  The peak of apoptosis in lung tissue was 
preceded by a peak in IL-1 and IL-10 production in BAL fluids at 9 days PI, suggesting a 
possible role of these both cytokines in the induction of apoptosis in non-infected 
interstitial monocytes/macrophages.  The latter hypothesis was, however, not confirmed 
by in vitro studies, since blood monocytes or alveolar macrophages did not undergo 
apoptosis upon treatment with recombinant porcine IL-1 or IL-10.  Thus, the exact 
mechanism by which PRRSV triggers apoptosis in non-infected interstitial 
monocytes/macrophages is still under debate. 
Based on the results, obtained in parts 3.1. and 3.2., the following hypothetical roles of 
apoptosis in the pathogenesis of a PRRSV infection in the lungs can be made.  Apoptosis 
of infected cells may be one of the explanations for the persistence of single PRRSV-
infected cells until 35 to 40 days PI, despite the presence of PRRSV-specific antibodies.  
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Apoptosis of non-infected interstitial monocytes/macrophages may be a process to 
regulate the number of monocytes/macrophages during the massive influx of monocytes 
in the lungs. 
In chapter 4, the interaction between PRRSV and LPS was examined.  The clinical 
course of inoculations with PRRSV followed by LPS, and the effect of the timing and 
frequency of LPS administrations were examined.  Furthermore, it was examined if the 
virulence of the PRRSV strain affects the interaction. 
In part 4.1., the clinical effect of an exposure with Escherichia coli LPS in PRRSV-
infected pigs was examined.  Additionally, some preliminary investigations of cellular 
and virological aspects in the lungs were performed.  Five-week-old conventional pigs 
were inoculated intratracheally with the Lelystad strain of PRRSV and received 5 days 
later one or two LPS administrations by intratracheal route.  Control groups consisted of 
pigs inoculated with PRRSV only or LPS only.  All pigs were intensively monitored for 
clinical signs after the LPS administrations.  Pigs were monitored for general (fever and 
depression) and respiratory (tachypnoea, abdominal breathing and dyspnoea) signs.  
Some pigs were euthanized after the second LPS administration for broncho-alveolar cell 
analysis and virological examinations of the lungs.  PRRSV-LPS exposed pigs developed 
clear respiratory signs, characterized by tachypnoea, abdominal breathing and dyspnoea.  
This was in contrast to PRRSV and LPS control pigs, which developed no or only very 
mild respiratory signs.  Most PRRSV and LPS control pigs developed moderate fever, but 
no depression.  PRRSV-LPS exposed pigs, on the other hand, developed high fever and 
typically showed pronounced depression.  The clinical effect of a second LPS 
administration was dependent on the time interval between the two LPS administrations.  
In non-infected pigs, a second LPS administration at a 24-hour interval caused milder 
clinical signs than the first one.  On the other hand, a second LPS administration within a 
3-hour interval seriously aggravated and prolonged the clinical signs.  In PRRSV-infected 
pigs, the clinical effect of a second LPS administration was difficult to assess since pigs 
had not yet recovered at the moment of the second LPS administration, 3 or 24 hours 
after the first one.  Lung neutrophil infiltration was similar in non-infected and PRRSV-
infected pigs upon LPS exposure.  PRRSV titres in lung tissue and BAL fluids were 
similar in PRRSV control and PRRSV-LPS exposed pigs.  Thus, the respiratory signs 
following PRRSV-LPS exposure could not be explained by the degree of virus 
replication or inflammatory changes in the lungs.  In conclusion, this study showed a 
clear synergy between PRRSV and LPS in the induction of respiratory signs in 
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conventional pigs.  The synergy was observed in 87% of the pigs and was reproducible 
upon subsequent experiments. 
In part 4.2., it was examined if there exists also a clinical synergy between attenuated 
PRRSV strains and LPS.  Two experiments were performed.  In each experiment, five-
week-old conventional pigs were inoculated intratracheally with a commercial modified 
live PRRSV vaccine, based on either an attenuated European virus strain or an attenuated 
American virus strain.  Pigs inoculated intratracheally with Lelystad virus and non-
inoculated pigs were included as controls.  At 5 days after virus inoculation, pigs were 
exposed to Escherichia coli LPS by intratracheal route.  All pigs were followed clinically 
every two hours from 0 until 12 hours after the LPS administration.  As in part 4.1., pigs 
were monitored for general (fever and depression) and respiratory (tachypnoea, 
abdominal breathing and dyspnoea) signs.  Additionally, pigs of the second experiment 
were euthanized at 12 hours after the LPS administration for virological examinations of 
lungs and BAL fluids (virus titration and quantification of infected cells).  Exposure of 
non-inoculated pigs to LPS resulted in slight to moderate respiratory signs.  Lelystad 
virus-LPS exposed pigs experienced severe respiratory signs, characterized by 
tachypnoea, abdominal thumping and dyspnoea.  Respiratory signs of vaccine virus-LPS 
exposed pigs were less pronounced and of shorter duration than those of Lelystad virus-
LPS exposed pigs.  The differences between virulent virus- and vaccine virus-inoculated 
pigs may be attributed to the pattern and degree of virus replication in the lungs.  Mean 
virus titres and mean numbers of infected cells were indeed clearly higher in virulent 
virus-inoculated pigs compared to vaccine virus-inoculated ones.  Furthermore, viral 
antigen-positive foci, consisting of groups of three or more infected cells and cellular 
debris, were only observed in the lung tissue of virulent virus-inoculated pigs.  In 
summary, the present study shows that there exists a clinical synergy between attenuated 
PRRSV strains and LPS, but the severity is less pronounced than with the virulent 
Lelystad strain. 
In chapter 5, strategies to prevent multi-factorial respiratory disease problems were 
examined by evaluating the virological and clinical protection provided by modified live 
PRRSV vaccines.  The virological protection was assessed in the lungs, the main target 
organ of PRRSV.  To our knowledge, this was the first study demonstrating the degree of 
virological protection in the lungs of PRRSV-vaccinated pigs.  For the evaluation of the 
clinical efficacy of PRRSV vaccines, the PRRSV-LPS combination was used.  Two 
experiments were performed.  In each experiment, six-week-old conventional pigs were 
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immunized intramuscularly with commercial vaccines, based on either an attenuated 
European virus strain or an attenuated American virus strain.  Non-immunized pigs and 
pigs immunized intramuscularly with the virulent Lelystad strain (infection-immune pigs) 
were included as controls.  Six weeks after immunization, pigs were challenged 
intratracheally (exp. 1) or intranasally (exp. 2) with the European Lelystad strain, and 3 
and 6 days later exposed to Escherichia coli LPS by intratracheal route.  After the LPS 
administration, pigs were monitored for clinical signs.  At 4 and 7 days after challenge, 
some pigs were euthanized for virological examinations of lungs.  Challenge virus 
replication in the lungs still occurred in both vaccinated groups, but the virological 
protection was better in pigs immunized with the attenuated European strain compared to 
pigs immunized with the attenuated American strain.  Thus, the genetic and antigenic 
differences between European and American PRRSV strains clearly affected the degree 
of virological protection in the lungs.  Even infection-immune pigs did not show a 
complete virological protection in the lungs.  After LPS exposure, none or only very mild 
respiratory signs were observed in the infection-immune pigs.  Non-immunized challenge 
control pigs, on the other hand, suffered from severe respiratory signs upon LPS 
exposure.  The clinical outcome in pigs immunized with the attenuated virus strains was 
highly variable within and between experiments.  Pigs immunized with the attenuated 
European strain experienced no respiratory signs in experiment 1, whereas in experiment 
2, all pigs suffered from severe respiratory signs.  Similarly, all pigs immunized with the 
attenuated American strain in the first experiment developed severe respiratory signs 
upon LPS exposure, whereas in experiment 2, respiratory signs were less pronounced and 
restricted to 80% of the pigs.  Thus, we were unable to reproduce our clinical results upon 
two subsequent attempts and therefore, we were unable to make conclusions about the 
clinical protection provided by modified live PRRSV vaccines. 
As a general conclusion, it can be stated that a single PRRSV infection induces 
multiple marked changes in the lungs even though respiratory signs remain absent.  It was 
further demonstrated that apoptosis, either as a cause or as a result, may be associated 
with these cellular changes. 
With the PRRSV-LPS combination, it was clearly demonstrated that a PRRSV 
infection is able to sensitize the lungs for respiratory signs upon exposure to LPS.  In 
contrast to previous dual inoculation experiments with PRRSV followed by other viruses 
and/or bacteria, the PRRSV-LPS combination has been proven to induce reproducible 
Summary  157 
________________________________________________________________________________________ 
 
respiratory disease.  Therefore, we believe that this combination is a good model to study 
the pathogenesis of multi-factorial respiratory disease problems. 
Our vaccination/challenge experiments clearly demonstrated that the virological 
protection in the lungs of PRRSV-vaccinated pigs is only partial.  Thus, it cannot be 
excluded that the challenge virus replication in the lungs of vaccinated pigs might still 
predispose for multi-factorial respiratory disease problems. 
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Samenvatting 
 
Ademhalingsproblemen veroorzaken wereldwijd zware economische verliezen in de 
varkenssector.  Deze ademhalingsproblematiek heeft een multifactoriële achtergrond en 
het wordt algemeen aanvaard dat het porcien reproductief en respiratoir syndroom virus 
(PRRSV) een belangrijke rol speelt in het ontstaan van deze problemen. 
De doelstellingen van deze thesis bestonden erin om (i) de kennis omtrent de 
pathogenese van een PRRSV infectie in de longen uit te breiden, (ii) de interactie tussen 
PRRSV en lipopolysacchariden (LPS) te onderzoeken en (iii) de werkzaamheid van 
levend verzwakte PRRSV vaccins te beoordelen aan de hand van virologische en 
klinische parameters. 
In hoofdstuk 1 werd een overzicht gegeven over PRRSV met speciale aandacht voor 
de pathogenese, het ziektebeeld en de vaccinatie.  Verder werd een korte inleiding 
gegeven over lipopolysacchariden of endotoxinen en hun rol in ademhalingsproblemen. 
In hoofdstuk 3 werd de pathogenese van een infectie met een Europese PRRSV stam 
in de longen onderzocht.  Speciale aandacht werd geschonken aan cellulaire 
veranderingen in het longinterstitium en de broncho-alveolaire ruimten en deze 
veranderingen werden gecorreleerd met de virusvermeerdering en het verschijnen van 
neutraliserende en niet-neutraliserende antistoffen. 
In deel 3.1. werden een aantal pathogenetische gebeurtenissen in de longen van 
PRRSV-geïnfecteerde gnotobiotische biggen in detail bestudeerd met de bedoeling om 
correlaties te vinden tussen de virusvermeerdering enerzijds en bepaalde cellulaire 
veranderingen en het opkomen van PRRSV-specifieke antistoffen anderzijds.  Hiertoe 
werden gnotobiotische biggen op 4 tot 5 weken leeftijd intranasaal geïnoculeerd met 
Lelystad virus en 1 tot 52 dagen later geëuthanaseerd.  De broncho-alveolaire cellen 
werden morfologisch en fenotypisch gekarakteriseerd.  Verder werden de graad en het 
patroon van de virusvermeerdering en het opkomen van neutraliserende en niet-
neutraliserende antistoffen bestudeerd.  Het totaal aantal monocyten/macrofagen steeg 
met een factor twee tot vijf tussen 9 en 52 dagen na inoculatie met een maximaal aantal 
op 25 dagen na inoculatie.  Flowcytometrisch onderzoek toonde aan dat de populatie 
sterk-gedifferentieerde alveolaire macrofagen, die de PRRSV receptor tot expressie 
brengen (74-22-15+, 41D3+ cellen), sterk gereduceerd was tussen 9 en 20 dagen na 
inoculatie.  Gedurende ditzelfde tijdsinterval werd een massale influx van zowel 74-22-
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15+, 41D3- cellen, vermoedelijk bloedmonocyten, als van 74-22-15-, 41D3- cellen, 
vermoedelijk lymfocyten, waargenomen.  De virusvermeedering was maximaal op 7 tot 9 
dagen na inoculatie, nam daarna geleidelijk af en werd waargenomen tot 40 dagen na 
inoculatie.  PRRSV-specifieke antistoffen in de broncho-alveolaire ruimten werden het 
eerst waargenomen vanaf 9 dagen na inoculatie, maar neutraliserende antistoffen werden 
uitsluitend waargenomen bij twee dieren, die geëuthanaseerd werden op het einde van de 
studie, namelijk op 35 en 52 dagen na inoculatie.  Het afnemen van de 
virusvermeerdering in de longen vanaf 9 dagen na inoculatie kan toegeschreven worden 
aan (i) het tekort aan gevoelige sterk-gedifferentieerde macrofagen, (ii) het niet gevoelig 
zijn van de nieuw aangetrokken monocyten en (iii) het verschijnen van PRRSV-
specifieke antistoffen in de longen.  Neutraliserende antistoffen zijn wellicht betrokken 
bij de uiteindelijke eliminatie van PRRSV uit de longen. 
In deel 3.2. werd de kinetiek van apoptose in de longen van PRRSV-geïnfecteerde 
biggen bestudeerd met de bedoeling om een mogelijke rol van dit proces in de 
pathogenese te bepalen.  Verder werd onderzocht of cytokinen betrokken zijn in de 
inductie van apoptose.  Daartoe werden de longen en de broncho-alveolaire cellen van de 
dieren, die gebruikt werden in deel 3.1., onderzocht voor virusvermeerdering en apoptose 
en de overeenkomstige longwasvloeistoffen werden onderzocht voor de productie van 
interleukine (IL)-1, tumor necrosis factor-alfa (TNF-α) en IL-10.  Dubbelkleuringen 
werden uitgevoerd om de relatie na te gaan tussen virusvermeerdering en apoptose en 
voor de fenotypische identificatie van de apoptotische cellen.  Apoptose werd zowel 
waargenomen in geïnfecteerde cellen, als in niet-geïnfecteerde cellen.  De gemiddelde 
percentages geïnfecteerde cellen, die apoptose vertoonden, varieerden tussen 9 en 39% in 
het interstitium en tussen 13 en 30% in de broncho-alveolaire ruimten.  De meerderheid 
van de apoptotische cellen (>99%) waren echter niet geïnfecteerd.  Het patroon van 
apoptose in de niet-geïnfecteerde cellen was verschillend in de broncho-alveolaire 
ruimten en het interstitium.  In de broncho-alveolaire ruimten werden twee pieken van 
apoptose waargenomen.  De eerste piek op 9 dagen na inoculatie betrof voornamelijk 
lymfocyten, terwijl de tweede piek op 25 dagen na inoculatie hoogstwaarschijnlijk te 
maken heeft met het feit dat het totaal aantal broncho-alveolaire cellen het hoogst was op 
dat tijdstip.  In het interstitium werd de piek van apoptose waargenomen op 14 dagen na 
inoculatie en het waren voornamelijk monocyten/macrofagen, die apoptose vertoonden.  
De piek van apoptose in het interstitium werd voorafgegaan door een piek van IL-1 en 
IL-10 productie in de broncho-alveolaire ruimten op 9 dagen na inoculatie.  Dit 
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suggereert dat beide cytokinen betrokken kunnen zijn in de inductie van apoptose in de 
niet-geïnfecteerde monocyten/macrofagen in het interstitium.  Deze hypothese kon echter 
in vitro niet bevestigd worden, aangezien zowel bloedmonocyten als alveolaire 
macrofagen geen apoptose ondergingen na een behandeling met recombinant porcien IL-
1 of IL-10.  Het exact mechanisme waarop PRRSV apoptose induceert in niet-
geïnfecteerde monocyten/macrofagen in het interstitium kon dus tot op heden niet 
achterhaald worden. 
Op basis van de studies, zoals uitgevoerd in deel 3.1. en deel 3.2., kunnen de volgende 
pathogenetische aspecten in de longen van PRRSV-geïnfecteerde biggen eventueel 
toegeschreven worden aan apoptose.  Het optreden van apoptose in geïnfecteerde cellen 
kan mogelijks één van de verklaringen zijn waarom PRRSV-geïnfecteerde cellen kunnen 
persisteren tot 35-40 dagen na inoculatie, ondanks de aanwezigheid van PRRSV-
specifieke antistoffen.  Het optreden van apoptose in niet-geïnfecteerde 
monocyten/macrofagen in het interstitium kan beschouwd worden als een homeostatisch 
proces waardoor het aantal monocyten/macrofagen gedeeltelijk onder controle wordt 
gehouden tijdens de massale influx van nieuwe monocyten. 
In hoofdstuk 4 werd de interactie tussen PRRSV en LPS onderzocht.  Het klinisch 
verloop bij PRRSV-LPS blootgestelde dieren en het effect van de frequentie van LPS 
toedieningen en het tijdsinterval daartussen werden nagegaan.  Tevens werd onderzocht 
of de virulentie van de PRRSV stam de interactie beïnvloedt. 
In deel 4.1. werd onderzocht of een PRRSV infectie de longen vatbaar maakt voor het 
ontstaan van ademhalingsstoornissen wanneer deze blootgesteld worden aan Escherichia 
coli LPS.  Tevens werden een aantal cellulaire en virologische aspecten van de longen 
van deze dieren onderzocht.  Conventionele biggen werden op 5 weken leeftijd 
intratracheaal geïnoculeerd met Lelystad virus en 5 dagen later werden ze één- of 
tweemaal intratracheaal geïnoculeerd met LPS.  Enkelvoudig PRRSV- en LPS-
geïnoculeerde dieren werden ingesloten als controles.  Na de LPS toedieningen werden 
de dieren klinisch opgevolgd voor zowel algemene (koorts en depressie) als respiratoire 
(tachypnee, flankenslag en dyspnee) symptomen.  Een aantal dieren werd na de tweede 
LPS toediening geëuthanaseerd voor onderzoek van de broncho-alveolaire cellen en 
virologisch onderzoek van de longen.  PRRSV-LPS blootgestelde dieren vertoonden 
uitgesproken ademhalingssymptomen, gekenmerkt door tachypnee, flankenslag en 
dyspnee.  De PRRSV en LPS controledieren vertoonden daarentegen geen of slechts 
milde ademhalingsproblemen.  De meeste PRRSV en LPS controledieren vertoonden 
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weliswaar wel milde koorts, maar depressie werd niet waargenomen.  De PRRSV-LPS 
blootgestelde dieren, daarentegen, vertoonden hoge koorts en een sterk uitgesproken 
depressie.  Het effect van een tweede LPS toediening was afhankelijk van het 
tijdsinterval tussen de twee LPS toedieningen.  Bij de LPS controledieren veroorzaakte 
een tweede LPS toediening, 24 uren na de eerste, minder kliniek dan de eerste.  Een 
tweede LPS toediening, 3 uren na de eerste, zorgde daarentegen voor een uitgesproken 
verergering van de klinische symptomen.  Het effect van een tweede LPS toediening bij 
PRRSV-geïnfecteerde biggen kon moeilijk beoordeeld worden, aangezien de dieren nog 
niet hersteld waren op het ogenblik van de tweede LPS toediening, 3 of 24 uren na de 
eerste.  De infiltratie van neutrofielen in de longen tengevolge van de LPS toediening was 
gelijkaardig bij niet-geïnfecteerde en PRRSV-geïnfecteerde dieren.  De virustiters in de 
longen waren gelijkaardig bij PRRSV-geïnfecteerde dieren, onafhankelijk van het feit of 
ze al dan niet aan LPS blootgesteld waren geweest.  De ademhalingssymptomen na de 
PRRSV-LPS blootstelling konden dus niet verklaard worden door de graad van 
virusvermeerdering of door ontstekingsverschijnselen in de longen.  Uit deze studie kan 
besloten worden dat er een duidelijk synergisme bestaat tussen PRRSV en LPS in de 
inductie van ademhalingssymptomen.  Het klinisch synergisme werd waargenomen in 
87% van de dieren en was sterk reproduceerbaar. 
In deel 4.2. werd onderzocht of er eveneens een synergisme bestaat tussen verzwakte 
PRRSV stammen en LPS.  Daartoe werden twee experimenten uitgevoerd.  In beide 
experimenten werden conventionele biggen op 5 weken leeftijd intratracheaal 
geïnoculeerd met een levend verzwakt PRRSV vaccin, gebaseerd op enerzijds een 
Europees serotype of een Amerikaans serotype.  Lelystad virus-geïnoculeerde en niet-
geïnoculeerde dieren werden ingesloten als controles.  Vijf dagen na de virusinoculatie 
werden de dieren intratracheaal geïnoculeerd met Escherichia coli LPS.  De dieren 
werden om de 2 uren klinisch opgevolgd vanaf 0 tot en met 12 uren na de LPS 
toediening.  Net als in deel 4.1. werden de dieren opgevolgd voor zowel algemene (koorts 
en depressie) als voor respiratoire (tachypnee, flankenslag en dyspnee) symptomen.  Alle 
dieren uit het tweede experiment werden 12 uren na de LPS toediening geëuthanaseerd 
voor virologisch onderzoek van het longinterstitium en de broncho-alveolaire ruimten 
(virustitratie en kwantificatie van het aantal geïnfecteerde cellen).  De LPS controledieren 
vertoonden lichte tot matige ademhalingssymptomen.  Lelystad virus-LPS blootgestelde 
dieren, daarentegen, ontwikkelden uitgesproken ademhalingssymptomen na de LPS 
blootstelling.  De ademhalingssymptomen van vaccinvirus-LPS blootgestelde dieren 
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waren minder uitgesproken en van kortere duur dan deze van de Lelystad virus-LPS 
controledieren.  Deze verschillen kunnen eventueel verklaard worden door verschillen in 
het patroon en de graad van virusvermeerdering in de longen.  De gemiddelde virustiters 
en het gemiddeld aantal geïnfecteerde cellen waren immers duidelijk lager bij de 
vaccinvirus-LPS blootgestelde dieren dan bij de Lelystad virus-LPS blootgestelde dieren.  
Viraal antigeen-positieve haardjes, bestaande uit groepjes van drie of meer geïnfecteerde 
cellen en celafval, werden bovendien uitsluitend waargenomen in het interstitium van de 
Lelystad virus-geïnoculeerde dieren.  Deze studie toont aan dat er een synergisme bestaat 
tussen verzwakte PRRSV stammen en LPS, maar de klinische symptomen zijn minder 
uitgesproken dan met de virulente Lelystad stam. 
In hoofdstuk 5 werd, met het oog op de preventie van de ademhalingsproblematiek bij 
varkens, aandacht besteed aan de virologische en klinische bescherming opgewekt door 
levend verzwakte PRRSV vaccins.  De virologische bescherming werd nagegaan ter 
hoogte van de longen, het belangrijkste doelwitorgaan voor PRRSV.  Naar ons weten is 
dit de eerste studie die de graad van virologische bescherming nagaat ter hoogte van de 
longen van PRRSV-gevaccineerde dieren.  Voor de evaluatie van de klinische 
werkzaamheid werd gebruik gemaakt van het PRRSV-LPS model.  Twee experimenten 
werden uitgevoerd.  In beide experimenten werden conventionele dieren op zes weken 
leeftijd intramusculair geïmmuniseerd met een levend verzwakt PRRSV vaccin, 
gebaseerd op enerzijds een Europees serotype of een Amerikaans serotype.  Niet-
geïmmuniseerde dieren en dieren, intramusculair geïmmuniseerd met de virulente 
Lelystad stam (infectie-immune dieren), werden ingesloten als controles.  De dieren 
werden zes weken na de immunisatie onderworpen aan een intratracheale (exp. 1) of 
intranasale (exp. 2) challenge met de Europese Lelystad stam.  Drie en zes dagen na de 
challenge werden de dieren intratracheaal geïnoculeerd met Escherichia coli LPS.  Na de 
LPS toediening werden de dieren klinisch opgevolgd.  Vier en zeven dagen na de 
challenge werden dieren geëuthanaseerd voor virologisch onderzoek van de longen.  De 
virologische bescherming ter hoogte van de longen was onvolledig bij beide 
gevaccineerde groepen, maar de vermeerdering van het challengevirus was meer 
gereduceerd bij de dieren geïmmuniseerd met de verzwakte Europese stam.  De 
genetische en antigene verschillen tussen Europese en Amerikaanse PRRSV isolaten 
bepalen dus de graad van virologische bescherming ter hoogte van de longen.  Ook de 
infectie-immune dieren vertoonden geen volledige virologische bescherming ter hoogte 
van de longen.  Bij de infectie-immune dieren werden geen of slechts lichte 
Samenvatting  163 
________________________________________________________________________________________ 
 
ademhalingssymptomen waargenomen na de LPS toediening.  Niet-geïmmuniseerde 
challenge controledieren, daarentegen, vertoonden uitgesproken ademhalingssymptomen 
na de LPS toediening.  Het klinisch verloop na de LPS toediening bij de gevaccineerde 
groepen was sterk variabel binnen en tussen beide experimenten.  Géén van de dieren 
geïmmuniseerd met de verzwakte Europese stam ontwikkelden ademhalingssymptomen 
in experiment 1, terwijl in experiment 2 alle dieren uitgesproken ademhalingssymptomen 
vertoonden.  Alle dieren geïmmuniseerd met de verzwakte Amerikaanse stam vertoonden 
ernstige ademhalingssymptomen in het eerste experiment, terwijl de 
ademhalingssymptomen minder uitgesproken waren bij de dieren uit het tweede 
experiment.  We waren dus niet in staat om bij de gevaccineerde dieren reproduceerbare 
klinische resultaten te bekomen en het was dus onmogelijk om conclusies te trekken 
aangaande de klinische bescherming opgewekt door levend verzwakte PRRSV vaccins. 
Als algemene conclusie kan gesteld worden dat een enkelvoudige PRRSV infectie 
duidelijke cellulaire veranderingen veroorzaakt ter hoogte van de longen en 
desalniettemin leidt dit niet tot ademhalingsproblemen.  De pathogenese studies toonden 
ook aan dat apoptose wellicht een belangrijke rol speelt bij deze cellulaire veranderingen, 
hetzij als oorzaak, hetzij als gevolg. 
Met de PRRSV-LPS combinatie werd duidelijk aangetoond dat een PRRSV infectie in 
staat is om de longen vatbaar te maken voor ademhalingsproblemen wanneer deze 
vervolgens blootgesteld worden aan LPS.  In tegenstelling met vroeger uitgevoerde 
dubbelinfecties met PRRSV en andere virussen of bacteriën, is de PRRSV-LPS 
combinatie bovendien duidelijk reproduceerbaar.  Deze combinatie kan dan ook 
beschouwd worden als een goed model om de pathogenese van multifactoriële 
ademhalingsproblemen te bestuderen. 
Onze vaccinatie/challenge experimenten hebben duidelijk aangetoond dat de 
virologische bescherming in de longen van gevaccineerde dieren slechts partieel is.  Het 
kan bijgevolg niet uitgesloten worden dat de vermeerdering van challengevirus in de 
longen van gevaccineerde dieren deze dieren nog kan vatbaar maken voor multifactoriële 
ademhalingsproblemen. 
164   
________________________________________________________________________________________ 
Curriculum vitae 
 
PERSONALIA 
 
Geoffrey Labarque werd op 28 september 1973 geboren te Kortrijk.  In 1991 
beëindigde hij zijn secundaire opleiding aan het Sint-Amandscollege te Kortrijk en 
behaalde hij het getuigschrift van hoger secundair onderwijs (Klassieke talen Latijn met 
wiskunde).  In 1997 werd het diploma dierenarts behaald aan de faculteit 
diergeneeskunde van de universiteit Gent.  Vanaf juli 1997 tot en met april 1998 was hij 
tewerkgesteld in het laboratorium voor virologie op het project “Gecombineerde 
intranasale – intramusculaire vaccinatie voor eliminatie van het Aujeszkyvirus in de 
Vlaamse varkenspopulatie in het kader van het eradikatieplan” gefinancierd door het 
Ministerie van Middenstand en Landbouw.  In november 1998 kreeg hij een 
onderzoeksmandaat van het Bijzonder Onderzoeksfonds (BOF) van de universiteit Gent 
in het laboratorium voor virologie voor het project “Studie van de interactie tussen 
longmacrofagen en het porcien arterivirus bij het varken”.  In juni 2002 behaalde hij het 
getuigschrift voor zijn doctoraatsopleiding. 
Curriculum vitae  165 
________________________________________________________________________________________ 
PUBLICATIES 
 
Publicaties in internationale wetenschappelijke tijdschriften 
 
Labarque, G.G., Nauwynck, H.J., Maes, D.G. & Pensaert, M.B. (1999). Protection of 
fattening pigs against challenge with Aujeszky’s disease virus after a successive 
intranasal/intramuscular vaccination. Veterinary Quarterly 21, 104-107. 
 
Nauwynck, H.J., Labarque, G.G. & Pensaert, M.B. (1999). Efficacy of an intranasal 
immunization with gEgC and gEgI double-deletion mutants of Aujeszky’s disease virus in 
maternally immune pigs and the effects of a successive intramuscular booster with 
commercial vaccines. Journal of Veterinary Medicine B 46, 713-722. 
         
Van Reeth, K., Labarque, G., Nauwynck, H. & Pensaert, M. (1999). Differential 
production of proinflammatory cytokines in the pig lung during different respiratory virus 
infections: correlations with pathogenicity. Research in Veterinary Science 67, 47-52. 
      
Labarque, G.G., Nauwynck, H.J., Van Reeth, K. & Pensaert, M.B. (2000). Effect of 
cellular changes and onset of humoral immunity on the replication of porcine reproductive 
and respiratory syndrome virus in the lungs of pigs. Journal of General Virology 81, 
1327-1334. 
     
Labarque, G.G., Nauwynck, H.J., Mesu, A.P., & Pensaert, M.B. (2000). Seroprevalence 
of porcine circovirus types 1 and 2 in the Belgian pig population. Veterinary Quarterly 
22, 234-236. 
   
Van Reeth, K., Labarque, G., De Clercq, S. & Pensaert, M. (2001). Efficacy of 
vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge 
strain and different parameters of protection. Vaccine 19, 4479-4486. 
 
 
 
 
166   
________________________________________________________________________________________ 
Labarque, G., Van Reeth, K., Van Gucht, S., Nauwynck, H. & Pensaert, M. (2002). 
Porcine reproductive-respiratory syndrome virus infection predisposes pigs for respiratory 
signs upon exposure to bacterial lipopolysaccharide. Veterinary Microbiology 88, 1-12. 
 
Labarque, G., Van Gucht, S., Nauwynck, H., Van Reeth, K. & Pensaert, M. (2002). 
Apoptosis in the lungs of pigs infected with porcine reproductive and respiratory 
syndrome virus and associations with the production of apoptogenic cytokines. Veterinary 
Research, conditionally accepted. 
 
Publicaties in nationale wetenschappelijke tijdschriften 
 
Labarque, G.G., Nauwynck, H.J., Van Reeth, K. & Pensaert, M.B. (1999). Groeistilstand 
en wegkwijnen bij gespeende biggen: een nieuw virus-geassocieerd ziektesyndroom. 
Vlaams Diergeneeskundig Tijdschrift 68, 273-277. 
 
Vyt, P., Labarque, G., Bos, M., Nauwynck, H., Roels, S., Miry, C., Pensaert, M. & 
Ducatelle, R. (2000). Het ‘Post-Weaning Multisystemic Wasting Syndrome’ in België. 
Vlaams Diergeneeskundig Tijdschrift 69, 435-440. 
 
Van Reeth, K., Van Gucht, S., Labarque, G. & Pensaert, M. (2002). Viral infections and 
porcine respiratory disease: New insights in pathogenesis. Dansk Veterinaertidsskrift 85, 
6-11. 
 
Pensaert, M., Van Reeth, K., Van Gucht, S. & Labarque, G. (2002). Poznanie 
patogenezy zespotu oddechowego swin podstawa opracowania skutecznych metod 
zwalczania choroby. Magazyn Weterynaryjny – Suplement Swinie, 13-16. 
 
Proceedings 
 
Labarque, G.G., Nauwynck, H.J., Van Reeth, K. & Pensaert, M.B. (1998). Field 
evaluation of the efficacy of an intranasal/intramuscular vaccination approach in pigs with 
different status of maternal immunity. In: Proceedings of the 15th Congress of the 
International Pig Veterinary Society, Birmingham, England, Volume 2, p. 184. 
Curriculum vitae  167 
________________________________________________________________________________________ 
 
Nauwynck, H.J., Labarque, G.G., Van Reeth, K. & Pensaert, M.B. (1998). An 
intranasal/intramuscular vaccination approach in view of an accelerated elimination of 
Aujeszky’s disease virus in regions with high prevalence. In: Proceedings of the 15th 
Congress of the International Pig Veterinary Society, Birmingham, England, Volume 2, p. 
185. 
    
Van Reeth, K., Labarque, G., Nauwynck, H. & Pensaert, M. (1998). Pathogenesis of 
combined infection with porcine reproductive-respiratory syndrome virus (PRRSV) and 
swine influenza virus (SIV). In: Proceedings of the 15th Congress of the International Pig 
Veterinary Society, Birmingham, England, Volume 2, p. 264.     
    
Labarque, G.G., Nauwynck, H.J., van Woensel, P.A.M., Visser, N. & Pensaert, M.B. 
(1999). Efficacy of an American and a European serotype PRRSV vaccine after challenge 
with American and European wild-type strains of the virus. In: Proceedings of the 3th 
International Symposium on PRRS and Aujeszky’s disease, Ploufragan, France, pp. 251-
252 (also published in Veterinary Research (2000) 31, 97). 
  
Labarque, G.G., Nauwynck, H.J. & Pensaert, M.B. (2000). Evolution of antibodies in 
pigs infected with porcine circovirus type 2 in the presence of maternally derived 
antibodies. In: Proceedings of the 5th ESVV Congress of Veterinary Virology, Brescia, 
Italy, pp. 261-262. 
 
Van Reeth, K., Labarque, G. & Pensaert, M. (2000). Pathogenicity of an H1N2 swine 
influenza virus isolated in Belgium. In: Proceedings of the 5th ESVV Congress of 
Veterinary Virology, Brescia, Italy, pp. 313-314. 
 
van Woensel, P., Labarque, G., Nauwynck, H., Paul, G., Bonde Larsen, A., Eggen, A. & 
Visser, N. (2000). Differentiation of European and North-American serotypes of PRRSV: 
Prevalence and vaccine efficacy. In: Proceedings of the 16th Congress of the International 
Pig Veterinary Society, Melbourne, Australia, p. 586. 
 
 
 
168   
________________________________________________________________________________________ 
Vyt, P., Labarque, G., Pensaert, M., Nauwynck, H., Miry, C. & Castryck, F. (2000). 
Prevalence of porcine circovirus types 1 and 2 in the Belgian pig population. In: 
Proceedings of the 16th Congress of the International Pig Veterinary Society, Melbourne, 
Australia, p. 627. 
  
Labarque, G.G., Nauwynck, H.J., Van Reeth, K. & Pensaert, M.B. (2001). Apoptosis in 
the lungs of pigs during an infection with a European strain of porcine reproductive and 
respiratory syndrome virus. VIIIth International Symposium on Nidoviruses 
(Coronaviruses and Arteriviruses), Pennsylvania, United States, Advances in 
Experimental Medicine and Biology 494, 691-697. 
 
Nauwynck, H.J., Labarque, G.G., Van Reeth, K. & Pensaert, M.B. (2001). Influence of 
changes in the population of target cells and appearance of specific antibodies on the 
replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs. 
VIIIth International Symposium on Nidoviruses (Coronaviruses and Arteriviruses), 
Pennsylvania, United States, Advances in Experimental Medicine and Biology 494, 385-
393. 
  
Labarque, G., Van Reeth, K., Van Gucht, S., Nauwynck, H. & Pensaert, M. (2002). 
Synergy between PRRS virus and bacterial lipopolysaccharides in the induction of 
respiratory signs in pigs. In: Proceedings of the 17th Congress of the International Pig 
Veterinary Society, Ames, Iowa, USA, Volume 1, p. 247. 
 
Labarque, G., Magyar, T., Kovács, F., Van Reeth, K., Nauwynck, H. & Pensaert, M. 
(2002). Efficacy testing of a modified live PRRSV vaccine using the clinical synergy 
between PRRS virus and bacterial lipopolysaccharides. In: Proceedings of the 17th 
Congress of the International Pig Veterinary Society, Ames, Iowa, USA, Volume 2, p. 
430. 
 
Van Gucht, S., Labarque, G., Van Reeth, K., Nauwynck, H. & Pensaert, M. (2002). 
Effect of a cytokine inhibitor on PRRS virus-bacterial endotoxin induced respiratory 
disease in pigs. In: Proceedings of the 17th Congress of the International Pig Veterinary 
Society, Ames, Iowa, USA, Volume 2, p. 349. 
Curriculum vitae  169 
________________________________________________________________________________________ 
 
Monografieën Ministerie van Middenstand en Landbouw 
 
Pensaert, M., Nauwynck, H., Kritas, S., Labarque, G., Maes, D., Van Reeth, K., 
Willems, L., Zonnekeyn, V., Goddeeris, B., Vanderpooten, A., Billiau, A. & 
Vandenbroeck, K. (1998). Aujeszky bij het varken: studies over pathogenese en 
vaccinatie. 
 
Van Reeth, K., Labarque, G., Van Gucht, S., Nauwynck, H. & Pensaert, M. (2001). 
Porcien reproductief en respiratoir syndroom virusinfectie als gangmaker voor 
ademhalingsstoornissen bij biggen. 
170   
________________________________________________________________________________________ 
 
Dankwoord 
 
Bij de afronding van dit proefschrift wil ik graag de vele mensen bedanken die aan het 
tot stand komen ervan direct of indirect hun steentje hebben bijgedragen. 
Prof. Dr. Hans Nauwynck, mijn promotor, jou wil ik bedanken voor je vertrouwen, 
steun en adviezen.  Hans, jij weet als geen ander hoe moeilijk ik het soms heb gehad 
tijdens mijn onderzoek.  Zonder jouw steun en grenzeloos enthousiasme had ik het 
hoogstwaarschijnlijk niet volgehouden.  Jij weet als geen ander hoe je een mens moet 
motiveren.  Al van bij onze eerste kennismaking heeft het onmiddellijk geklikt tussen ons.  
Onze Westvlaamse roots zullen daar wellicht wel voor iets tussen zitten. 
Dr. Kristien Van Reeth, mijn co-promotor, ik wil je bedanken voor het kritisch 
doornemen van mijn publikaties en thesis.  Kristien, jouw baanbrekend onderzoek over 
respiratoire virussen en LPS vormen de basis van mijn proefschrift.  Jouw thesis heb ik 
meermaals ter hand genomen en was voor mij een goede bron van inspiratie. 
Prof. Dr. M. Pensaert, ik wil u bedanken voor de opleiding in het wetenschappelijk 
onderzoek.  Ik heb grote waardering voor uw inzet om de wetenschappelijke kwaliteit van 
mijn proefschrift te garanderen.  Bovendien hebt u me niet alleen wetenschappelijk, maar 
ook persoonlijk veel bijgebracht.  Zonder u was ik waarschijnlijk nog steeds de verlegen 
student van vijf jaar geleden.  Het heeft u en mij veel moeite gekost, maar de ‘vlieger’ 
hangt eindelijk toch in de lucht. 
De leden van de begeleidingscommissie, Prof. Dr. F. Haesebrouck, Prof. Dr. M. 
Verdonck, Prof. Dr. P. Deprez en Prof. Dr. P.-P. Pastoret wil ik zeer hartelijk bedanken 
voor hun kritische en constructieve opmerkingen tijdens het doornemen van de thesis 
onder een enorme tijdsdruk. 
Ik ben ook veel dank verschuldigd aan de Universiteit Gent, die mij via een 
doctoraatsbeurs van het Bijzonder Onderzoeksfonds in staat stelde om dit onderzoek uit te 
voeren.  Verder wil ik het Ministerie van Middenstand en Landbouw (DG6) bedanken 
voor de financiële ondersteuning van de klinische en vaccinatie-experimenten. 
Vijf jaar heb ik doorgebracht op het laboratorium voor virologie en in deze periode zijn 
veel collega’s echte vrienden geworden.  Beste Karen, we hebben enorm veel tijd met 
elkaar doorgebracht in ons bureau.  Altijd stond je klaar voor mij.  Je hebt me meer dan 
eens opgemonterd wanneer ik in een wetenschappelijk of persoonlijk dalletje vertoefde.  
Bedankt voor alles.  Steven, jouw optimisme en enthousiasme hebben me meermaals weer 
Dankwoord  171 
________________________________________________________________________________________ 
 
op de rails gezet.  Je bent dikwijls voor mij in de bres gesprongen.  Ik hoop dat ik steeds 
mijn waardering en dank daarvoor heb laten blijken.  Herman, jij bent steeds mijn grote 
voorbeeld geweest.  Tevens heb jij ervoor gezorgd dat ik me goed heb weten te integreren 
op het labo.  Bedankt voor de vele gezellige uren zowel op het werk als daarbuiten.  
Gerlinde en Geert, bij jullie kon ik steeds terecht voor een niet-wetenschappelijk praatje.  
Geert, ook bedankt voor de leuke en ontspannende uren op de voetbal, die meestal 
eindigden aan de toog.  Peter en Nathalie, bij jullie kon ik altijd terecht om “moleculaire” 
problemen en vraagstukken op te lossen.  Romeo, your endless motivation to obtain a 
PhD was very encouraging for me.  Peter en Kristin, jullie heb ik het minst lang gekend, 
maar jullie zijn goede collega’s, maar bovenal heel fijne mensen.  Bovendien bedankt dat 
ik jullie computer mocht lenen tijdens het eindstadium van mijn schrijfwerk.  
Een zeer hartelijk woordje van dank gaat uit naar Fernand.  Fernand, jij hebt me alles 
geleerd.  Toen ik op het labo kwam, had ik geen praktische ervaring met varkens.  Maar 
dankzij jouw geduld, ervaring en deskundige uitleg, ben ik het snoeren, bloed nemen en 
inoculeren van varkens gaan beheersen.  Bedankt ook voor je enorme flexibiliteit.  Nooit 
heb ik een negatief stemgeluid opgemerkt, wanneer ik weer al eens aandraafde met 
weekend-werk.  Kortom, het was zeer aangenaam om met jou samen te werken.  Lieve en 
Chantal, jullie hulp en interesse tijdens mijn onderzoek heb ik altijd ten zeerste 
gewaardeerd.  Bedankt voor de honderden longspoelingen, cytokine-testen en 
virustitraties.  Jullie beiden vormen echt wel de “pilaren” van het labo.  Carine, bij jou 
kon ik altijd terecht tijdens mijn mega-experimenten.  Niets was te veel voor jou; 
integendeel, je bood steeds zelf je hulp aan.  Mijn gemeende dank en waardering 
daarvoor.  Chris, hartelijk bedankt voor de honderden kleuringen.  Een extra dank voor 
het snijden van de talrijke vriescoupes.  Ik heb het eens nagerekend en alleen al voor mijn 
werk met PRRSV heb je meer dan 400 coupes gesneden.  Liliane en Gert, bedankt dat 
jullie steeds bereid waren om mij administratief bij te springen.  Dirk, mijn computer 
heeft het ondanks zijn ietwat beperkt geheugen toch volgehouden tot op het einde.  
“Zullen we hem nu op pensioen laten gaan?”  In ieder geval bedankt dat je mijn 
computerproblemen steeds met de glimlach hebt opgelost.  Dieter, bedankt voor het 
punctueel uitvoeren van de kleuringen.  Trees, bedankt voor het aanmaken van allerlei 
produkten.  Marijke, bedankt voor het proper houden van mijn bureau, maar vooral voor 
de ontspannende babbels over onze beestjes. 
Ook de mensen die het labo ondertussen verlaten hebben, wil ik bedanken voor de 
gezellige uren die we met elkaar hebben doorgebracht.  Hierbij denk ik in het bijzonder 
172   
________________________________________________________________________________________ 
aan Saskia en Tini.  Ook Krista wil ik heel speciaal bedanken, want zij stond mede aan de 
wieg van het PRRSV-LPS model. 
Een speciaal woordje van dank is voorbehouden voor Bart.  Mijn SPF biggen zijn 
steeds in goede handen geweest bij jou.  Maar vooral bedankt voor de vele gezellige uren 
in Merelbeke en zijn mooie omgeving.  Door jou toedoen zal ik niet zo vlug meer 
verdwalen en zeker geen dorst lijden wanneer ik Scheldewindeke, Moortsele, Wetteren 
Ten Eede, Gontrode, Bottelare en Balegem doorkruis. 
Heel speciaal wil ik mijn familie bedanken.  Peter en meter, jullie hebben mede de 
basis gelegd voor dit proefschrift.  Jullie weten wel wat ik bedoel.  Bedankt.  Speciale 
dank gaat naar Valery, Emmanuel, Jonathan, Douglas, Fitzgerald, Virginie, Michael, 
Davina, Gaëlla, Kenneth, Elisah, Sarah, Ashley, Dylan, Alexia en Axana.  Lieve broers en 
zussen, vanaf nu mogen jullie doctor tegen mij zeggen.  Maar ik blijf bovenal jullie grote 
broer en jullie weten het: “Eén voor allen, allen voor één!”.  Pa en ma, ik heb heel veel 
aan jullie te danken.  Jullie hebben me de mogelijkheid gegeven om te studeren en hebben 
me altijd onvoorwaardelijk gesteund in mijn beslissingen.  Bedankt daarvoor. 
Tot slot gaat mijn allergrootste dank naar mijn gezin.  Wie me echt kent, weet hoe 
belangrijk zij voor mij zijn.  Annick, bedankt voor de nooit aflatende steun, vooral tijdens 
de eindfaze.  Bedankt voor het begrip wanneer het weekend weer al eens moest worden 
opgeofferd aan de wetenschap.  Ik heb je de laatste maanden verwaarloosd, maar ik beloof 
je, “Abby” is terug van weggeweest.  Manou, jouw glimlach wanneer ik ’s avonds moe en 
uitgeput thuis kwam, heeft me over de schreef getrokken.  Aan jou draag ik dan ook dit 
werk op. 
